The 70th Annual General Assembly and Scientific Meeting of the Japan College of Rheumatology MICEnavi

－____－________Opening Ceremony____－

NO1

Opening Ceremony

－____－________General Assembly____－

NO2

General Assembly

－____－________Society Prize for Encouragement Lecture____－

NO3

Society Prize for Encouragement Lecture

KeishiFujio{FUJIOKEISHI藤尾圭志ふじおけいし}|ShinsukeYasuda{YASUDASHINSUKE保田晋助やすだしんすけ}|MasayukiNishide{NISHIDEMASAYUKI西出真之にしでまさゆき}|SatoshiKubo{KUBOSATOSHI久保智史くぼさとし}|DavidA.Isenberg{ISENBERGDAVIDA.}____TatsuyaAtsumi{ATSUMITATSUYA渥美達也あつみたつや}|YoshiyaTanaka{TANAKAYOSHIYA田中良哉たなかよしや}____NaokiKimura{KIMURANAOKI木村直樹きむらなおき}|MariKamiya{KAMIYAMARI神谷麻理かみやまり}|HirokazuSasaki{SASAKIHIROKAZU佐々木広和ささきひろかず}|MarinaKise{KISEMARINA木瀬真吏奈きせまりな}|NatsukaUmezawa{UMEZAWANATSUKA梅澤夏佳うめざわなつか}|ShingoNakayamada{NAKAYAMADASHINGO中山田真吾なかやまだしんご}____Symposium 1____Mechanisms Underlying Refractory Disease in Systemic Lupus Erythematosus|Idiopathic inflammatory myopathies|Understanding the Pathogenesis of ANCA-Associated Vasculitis through Single-Cell and Spatial Omics Analysis|Pathogenesis and recent findings in Mixed Connective Tissue Disease (MCTD)|Biologic therapies for SLE - What's In, What's Out, What's Coming?

S1

Symposium 1

Chair：Tatsuya Atsumi, Chair：Yoshiya Tanaka

Speaker：Keishi Fujio

Speaker：Shinsuke Yasuda

Speaker：Masayuki Nishide

Speaker：Satoshi Kubo

Speaker：David A. Isenberg

KeiIkeda{IKEDAKEI池田啓いけだけい}____YoshiyaTanaka{TANAKAYOSHIYA田中良哉たなかよしや}________Luncheon Seminar 1What's New in Rheumatoid Arthritis Treatment?: Key to Achieving Early Remission____What's New in Rheumatoid Arthritis Treatment?: Key to Achieving Early Remission

LS1

Luncheon Seminar 1
What's New in Rheumatoid Arthritis Treatment?: Key to Achieving Early Remission

【Sponsored by AbbVie GK】

Chair：Yoshiya Tanaka

Speaker：Kei Ikeda

MieKurata{KURATAMIE倉田美恵くらたみえ}|MakotoSugihara{SUGIHARAMAKOTO杉原誠人すぎはらまこと}|HajimeYoshifuji{YOSHIFUJIHAJIME吉藤元よしふじはじめ}|TakahikoSugihara{SUGIHARATAKAHIKO杉原毅彦すぎはらたかひこ}|YoshikazuNakaoka{NAKAOKAYOSHIKAZU中岡良和なかおかよしかず}____NaotoTamura{TAMURANAOTO田村直人たむらなおと}|TakaoFujii{FUJIITAKAO藤井隆夫ふじいたかお}____NobumasaWatanabe{WATANABENOBUMASA渡邊伸昌わたなべのぶまさ}|HideyaKawaji{KAWAJIHIDEYA川路英哉かわじひでや}____Symposium 5____Pathology and Pathophysiology of Takayasu Arteritis: Structural and Immunological Basis of Large-Vessel Predilection|Update on the Pathology and Pathophysiology of Giant Cell Arteritis|2026 Revision of the Japanese Diagnostic Criteria for Takayasu Arteritis: Considerations to Avoid Missed Diagnoses|Differential Diagnosis Between Giant Cell Arteritis and Takayasu Arteritis and Updates in Imaging for Giant Cell Arteritis|Key points and its impact of "JCS 2026 Guideline on Management of Large Vessel Vasculitis"

S5

Symposium 5

Chair：Naoto Tamura, Chair：Takao Fujii

Speaker：Mie Kurata

Speaker：Makoto Sugihara

Speaker：Hajime Yoshifuji

Speaker：Takahiko Sugihara

Speaker：Yoshikazu Nakaoka

TakuyaHarada{HARADATAKUYA原田拓弥はらだたくや}|RanNakashima{NAKASHIMARAN中嶋蘭なかしまらん}|NatsukaUmezawa{UMEZAWANATSUKA梅澤夏佳うめざわなつか}|TakumaKoga{KOGATAKUMA古賀琢眞こがたくま}|MiwaKanaji{KANAJIMIWA金地美和かなじみわ}|KoshoIwao{IWAOKOSHO岩尾浩昭いわおこうしょう}____MasaruTakeshita{TAKESHITAMASARU竹下勝たけしたまさる}|RanNakashima{NAKASHIMARAN中嶋蘭なかしまらん}____HiroyukiYamashita{YAMASHITAHIROYUKI山下裕之やましたひろゆき}|AmiIsoda{ISODAAMI礒田杏実いそだあみ}|KenKawaue{KAWAUEKEN川上健かわうえけん}|RyoKoizumi{KOIZUMIRYO小泉諒こいずみりょう}|MayukoHayashi{HAYASHIMAYUKO林繭子はやしまゆこ}|YuraroMisawa{MISAWAYURARO三澤佑太郎みさわゆうたろう}|ArutoYamamoto{YAMAMOTOARUTO山本有人やまもとあると}|MiyuWakatsuki{WAKATSUKIMIYU若槻実祐わかつきみゆ}|YuyaAkiyama{AKIYAMAYUYA秋山優弥あきやまゆうや}|SetsukoOyama{OYAMASETSUKO大山節子おおやませつこ}|KyokoMotomura{MOTOMURAKYOKO本村杏子もとむらきょうこ}|HiroyukiTakahashi{TAKAHASHIHIROYUKI高橋広行たかはしひろゆき}|AkikoMitsuo{MITSUOAKIKO満尾晶子みつおあきこ}|YuichiGoto{GOTOYUICHI後藤雄一ごとうゆういち}|EiseiNoiri{NOIRIEISEI野入英世のいりえいせい}|HiroshiKaneko{KANEKOHIROSHI金子礼志かねこひろし}|KeisukeHirobe{HIROBEKEISUKE廣部圭祐ひろべけいすけ}|AtsubumiOgawa{OGAWAATSUBUMI小川惇史おがわあつぶみ}|YasuhiroNohda{NOHDAYASUHIRO納田安啓のうだやすひろ}|TsuneoSasai{SASAITSUNEO笹井恒雄ささいつねお}|MireiShirakashi{SHIRAKASHIMIREI白柏魅怜しらかしみれい}|RyosukeHiwa{HIWARYOSUKE日和良介ひわりょうすけ}|HideakiTsuji{TSUJIHIDEAKI辻英輝つじひであき}|ShujiAkizuki{AKIZUKISHUJI秋月修治あきづきしゅうじ}|HajimeYoshifuji{YOSHIFUJIHAJIME吉藤元よしふじはじめ}|AkioMorinobu{MORINOBUAKIO森信暁雄もりのぶあきお}|TakunaTsubata{TSUBATATAKUNA鍔田拓那つばたたくな}|RihanDa{DARIHAN達日罕だりはん}|TestuyaSatio{SATIOTESTUYA齋藤鉄也さいとうてつや}|ShinsukeYasuda{YASUDASHINSUKE保田晋助やすだしんすけ}|YoshiakiZaizen{ZAIZENYOSHIAKI財前圭晃ざいぜんよしあき}|ShinjiroKaieda{KAIEDASHINJIRO海江田信二郎かいえだしんじろう}|SuzunaSugi{SUGISUZUNA杉鈴奈すぎすずな}|NoaIsawa{ISAWANOA石和望愛いさわのあ}|YusukeNakano{NAKANOYUSUKE中野佑亮なかのゆうすけ}|ReikoMizue{MIZUEREIKO水江玲子みずえれいこ}|YudaiFukuda{FUKUDAYUDAI福田裕大ふくだゆうだい}|ChihiroAraki{ARAKICHIHIRO荒木ちひろあらきちひろ}|HiroakiIda{IDAHIROAKI井田弘明いだひろあき}|TomoakiHoshino{HOSHINOTOMOAKI星野友昭ほしのともあき}|KenjiIshiguro{ISHIGUROKENJI石黒賢志いしぐろけんじ}|KeitaYamauchi{YAMAUCHIKEITA山内啓太やまうちけいた}|ShuntaKaneko{KANEKOSHUNTA金子駿太かねこしゅんた}|JunKurihara{KURIHARAJUN栗原淳くりはらじゅん}|ShieOyama{OYAMASHIE小山詩絵おやましえ}|NobuhikoHidaka{HIDAKANOBUHIKO日髙伸彦ひだかのぶひこ}|AkariWada{WADAAKARI和田明香里わだあかり}|HarukaInoue{INOUEHARUKA井上悠いのうえはるか}|RisaKudou{KUDOURISA工藤理紗くどうりさ}|MasayukiMurai{MURAIMASAYUKI村井優之むらいまさゆき}|MasatoshiKimura{KIMURAMASATOSHI木村賢俊きむらまさとし}|YuukiRikitake{RIKITAKEYUUKI力武雄幹りきたけゆうき}|ChihiroIwao{IWAOCHIHIRO岩尾千紘いわおちひろ}|MaoRikitake{RIKITAKEMAO力武真央りきたけまお}|AyakoAizawa{AIZAWAAYAKO相澤彩子あいざわあやこ}|TakeshiKawaguchi{KAWAGUCHITAKESHI川口剛かわぐちたけし}|MotohiroMatsuda{MATSUDAMOTOHIRO松田基弘まつだもとひろ}|ShunichiMiyauchi{MIYAUCHISHUNICHI宮内俊一みやうちしゅんいち}|IchiroTakajo{TAKAJOICHIRO高城一郎たかじょういちろう}|KunihikoUmekita{UMEKITAKUNIHIKO梅北邦彦うめきたくにひこ}____Workshop 1Polymyositis and dermatomyositis (pathogenesis/images)____Spatial Transcriptomics Reveals Inflammatory Niches in Anti-glycyl tRNA Synthetase Syndrome -Insights from the GAPFREE4 Consortium|Epithelial-Macrophage Interaction via Chemokine Signaling in Anti-MDA5 Antibody-Positive Dermatomyositis-Associated Interstitial Lung Disease|RasGRP4 as a novel therapeutic target for inflammatory myopathies|Establishment of an anti-MDA5 antibody-induced autoimmune hepatitis mouse model and analysis of hepatitis induction mechanism|Treatment responsiveness and KL-6 reduction rate in anti-ARS antibody-positive polymyositis/dermatomyositis-associated interstitial lung disease with hypersensitivity pneumonitis/bronchiolitis-interstitial pneumonia-like findings|Prediction of Rapidly Progressive Interstitial Lung Disease in Anti-MDA5-Positive Dermatomyositis: Retrospective Analysis with the FLAW Model

W1

Workshop 1
Polymyositis and dermatomyositis (pathogenesis/images)

Chair：Masaru Takeshita, Chair：Ran Nakashima

YuyaImai{IMAIYUYA今井雄也いまいゆうや}|TomoakiHiguchi{HIGUCHITOMOAKI樋口智昭ひぐちともあき}|SatoshiOmura{OMURASATOSHI大村知史おおむらさとし}|HiroakiYazawa{YAZAWAHIROAKI矢澤宏晃やざわひろあき}|MitsusaIshimatsu{ISHIMATSUMITSUSA石松光紗いしまつみつさ}|KaitoAoki{AOKIKAITO青木海斗あおきかいと}____TakahisaGono{GONOTAKAHISA五野貴久ごのたかひさ}____RohitAggarwal{AGGARWALROHIT}|SebastianC.Rodriguez-Garcia{RODRIGUEZ-GARCIASEBASTIANC.}|AgnaNeto{NETOAGNA}|DespoinaPapadopoulou{PAPADOPOULOUDESPOINA}|BenVanBaelen{BAELENBENVAN}|PaulDuncombe{DUNCOMBEPAUL}|LeentjeDeCeuninck{CEUNINCKLEENTJEDE}|BasVanDerWoning{VANDERWONINGBAS}|HectorChinoy{CHINOYHECTOR}|TakahisaGono{GONOTAKAHISA五野貴久ごのたかひさ}|EriSugano{SUGANOERI菅野瑛梨すがのえり}|EisukeInoue{INOUEEISUKE井上永介いのうええいすけ}|YasushiKawaguchi{KAWAGUCHIYASUSHI川口鎮司かわぐちやすし}|YasuhikoYamano{YAMANOYASUHIKO山野泰彦やまのやすひこ}|AtsushiKawakami{KAWAKAMIATSUSHI川上純かわかみあつし}|ShinjiSato{SATOSHINJI佐藤慎二さとうしんじ}|TomoakiHoshino{HOSHINOTOMOAKI星野友昭ほしのともあき}|MasatakaKuwana{KUWANAMASATAKA桑名正隆くわなまさたか}|JunyaKitai{KITAIJUNYA北井順也きたいじゅんや}|YukiShimada{SHIMADAYUKI嶌田勇輝しまだゆうき}|TakuyaYanagida{YANAGIDATAKUYA柳田拓也やなぎだたくや}|HironoriInoue{INOUEHIRONORI井上弘之いのうえひろのり}|TomoyaSagawa{SAGAWATOMOYA佐川友哉さがわともや}|TakashiKida{KIDATAKASHI木田節きだたかし}|SenoTakahiro{TAKAHIROSENO妹尾高宏せのおたかひろ}|RanNakashima{NAKASHIMARAN中嶋蘭なかしまらん}|HideakiTsuji{TSUJIHIDEAKI辻英輝つじひであき}|TsuneoSasai{SASAITSUNEO笹井恒雄ささいつねお}|YasuhiroNohda{NOHDAYASUHIRO納田安啓のうだやすひろ}|YoichiNakayama{NAKAYAMAYOICHI中山洋一なかやまよういち}|YutoNakakubo{NAKAKUBOYUTO中窪悠登なかくぼゆうと}|AtsubumiOgawa{OGAWAATSUBUMI小川惇史おがわあつぶみ}|KazumaYoshida{YOSHIDAKAZUMA吉田和馬よしだかずま}|KeisukeHirobe{HIROBEKEISUKE廣部圭祐ひろべけいすけ}|TakuyaKotani{KOTANITAKUYA小谷卓矢こたにたくや}|TakayasuSuzuka{SUZUKATAKAYASU鈴鹿隆保すずかたかやす}|ShogoMatsuda{MATSUDASHOGO松田翔悟まつだしょうご}|KatsumasaOe{OEKATSUMASA大江克昌おおえかつまさ}|MahiroYamamoto{YAMAMOTOMAHIRO山本真大やまもとまひろ}|ChifumiAkiyama{AKIYAMACHIFUMI秋山千史あきやまちふみ}|HirofumiMiyake{MIYAKEHIROFUMI三宅啓史みやけひろふみ}|MasatakaKohno{KOHNOMASATAKA河野正孝こうのまさたか}|YutakaKawahito{KAWAHITOYUTAKA川人豊かわひとゆたか}|YujiroOkamura{OKAMURAYUJIRO岡村雄次郎おかむらゆうじろう}|RikuhiroToya{TOYARIKUHIRO鳥家陸寛とやりくひろ}|FumitoInayoshi{INAYOSHIFUMITO稲吉史登いなよしふみと}|TakehitoUeno{UENOTAKEHITO上野丈仁うえのたけひと}|SakonSakai{SAKAISAKON酒井左近さかいさこん}|KeitaOkamoto{OKAMOTOKEITA岡元啓太おかもとけいた}|NobuhitoOkumura{OKUMURANOBUHITO奥村信人おくむらのぶひと}|HiroshiKajiyama{KAJIYAMAHIROSHI梶山浩かじやまひろし}|KazuhiroYokota{YOKOTAKAZUHIRO横田和浩よこたかずひろ}|YasutoAraki{ARAKIYASUTO荒木靖人あらきやすと}|YuFunakubo{FUNAKUBOYU舟久保ゆうふなくぼゆう}|YujiAkiyama{AKIYAMAYUJI秋山雄次あきやまゆうじ}|KoumeiSakata{SAKATAKOUMEI坂田康明さかたこうめい}|YuriHorita{HORITAYURI堀田幸里ほりたゆり}|EikoMiyagawa{MIYAGAWAEIKO宮川英子みやがわえいこ}|ChiharuImada{IMADACHIHARU今田千晴いまだちはる}|MikakoIwakura{IWAKURAMIKAKO岩倉未香子いわくらみかこ}|ShinyaHirata{HIRATASHINYA平田真哉ひらたしんや}|KoImai{IMAIKO今井洸いまいこう}|YukoTakizawa{TAKIZAWAYUKO瀧澤祐子たきざわゆうこ}|NobuyukiEndo{ENDONOBUYUKI遠藤信幸えんどうのぶゆき}|YoshikiIshizaki{ISHIZAKIYOSHIKI石﨑克樹いしざきよしき}|TatsuyaKawasaki{KAWASAKITATSUYA川崎達也かわさきたつや}|YoshiokiYamasaki{YAMASAKIYOSHIOKI山崎宜興やまさきよしおき}|KimitoKawahata{KAWAHATAKIMITO川畑仁人かわはたきみと}____Workshop 2Polymyositis and dermatomyositis (clinical trial1)____Effect of Efgartigimod PH20 SC on Total Improvement Score, its Core Set Measures, and Patient/Clinician Impressions of Change: Results from the Randomized, Double-blinded, Placebo-controlled, Parallel-group, Multicenter, Phase 2 ALKIVIA Study of Adults with Active Idiopathic Inflammatory Myopathy (encore presentation)|Comparison of treatment outcomes with versus without initial triple-combination therapy in patients with anti-melanoma differentiation-associated gene 5-positive interstitial lung disease: an analysis from JAMI-2R cohort|Effectiveness of intravenous methylprednisolone pulse for interstitial lung disease associated with anti-aminoacyl-tRNA synthetase antibody-positive syndrome: an analysis using the Japanese multicentre MYKO Cohort|Clinical Study of Treatment Outcomes for Polymyositis/Dermatomyositis at Our Hospital|Clinical characteristics of refractory anti-MDA5 antibody-positive dermatomyositis in our hospital|A study of asymptomatic myocarditis in polymyositis/dermatomyositis

W2

Workshop 2
Polymyositis and dermatomyositis (clinical trial1)

Chair：Takahisa Gono

ShunNomura{NOMURASHUN野村俊のむらしゅん}|KeitaKimura{KIMURAKEITA木村圭汰きむらけいた}|ToshikiSugita{SUGITATOSHIKI杉田稔貴すぎたとしき}|MasakazuHatakeyama{HATAKEYAMAMASAKAZU畠山真和はたけやままさかず}|AyakaInoue{INOUEAYAKA井上綾華いのうえあやか}|MasayoshiSaida{SAIDAMASAYOSHI才田正義さいだまさよし}____HisanoriHasegawa{HASEGAWAHISANORI長谷川久紀はせがわひさのり}____WataruIshii{ISHIIWATARU石井亘いしいわたる}|HarukiMatsumoto{MATSUMOTOHARUKI松本聖生まつもとはるき}|TakeshiNakatsue{NAKATSUETAKESHI中枝武司なかつえたけし}|TakakoSaeki{SAEKITAKAKO佐伯敬子さえきたかこ}|KojiMishima{MISHIMAKOJI三嶋耕司みしまこうじ}|YoshinobuKoyama{KOYAMAYOSHINOBU小山芳伸こやまよしのぶ}|MakotoWada{WADAMAKOTO和田誠わだまこと}|AyaShimizu{SHIMIZUAYA清水彩しみずあや}|KazuhiroKurasawa{KURASAWAKAZUHIRO倉沢和宏くらさわかずひろ}|HirokaEda{EDAHIROKA江田尋香えだひろか}|RikaSato{SATORIKA佐藤理華さとうりか}|SaraKomatsu{KOMATSUSARA小松紗良こまつさら}|YukiAizawa{AIZAWAYUKI相澤有紀あいざわゆき}|YuhiYoshida{YOSHIDAYUHI吉田雄飛よしだゆうひ}|AnnaHasegawa{HASEGAWAANNA長谷川杏奈はせがわあんな}|TomokaHiyama{HIYAMATOMOKA檜山知佳ひやまともか}|KaitoNakamura{NAKAMURAKAITO中村海人なかむらかいと}|TomoyukiMiyao{MIYAOTOMOYUKI宮尾智之みやおともゆき}|AyaeTanaka{TANAKAAYAE田中彩絵たなかあやえ}|FujiiFujii{FUJIIFUJII藤井渉ふじいわたる}|SatokoArai{ARAISATOKO新井聡子あらいさとこ}|ReikaMaezawa{MAEZAWAREIKA前澤玲華まえざわれいか}|MasafumiArima{ARIMAMASAFUMI有馬雅史ありままさふみ}|KeiIkeda{IKEDAKEI池田啓いけだけい}|HirotoTsuboi{TSUBOIHIROTO坪井洋人つぼいひろと}|ReinaKikuchi{KIKUCHIREINA菊池怜菜きくちれいな}|YoshinoriTani{TANIYOSHINORI谷佳憲たによしのり}|KotaroTokunaga{TOKUNAGAKOTARO德永光太郎とくながこうたろう}|FumiyukiShibasaki{SHIBASAKIFUMIYUKI柴崎史行しばさきふみゆき}|NaokiSugita{SUGITANAOKI杉田直輝すぎたなおき}|AkiyoshiRai{RAIAKIYOSHI頼哲誼らいあきよし}|FuminaKawashima{KAWASHIMAFUMINA川島典奈かわしまふみな}|TaiheiNishiyama{NISHIYAMATAIHEI西山泰平にしやまたいへい}|MasaruShimizu{SHIMIZUMASARU清水優しみずまさる}|AyakoOhyama{OHYAMAAYAKO大山綾子おおやまあやこ}|AyakoKitada{KITADAAYAKO北田彩子きただあやこ}|SaoriAbe{ABESAORI安部沙織あべさおり}|HiromitsuAsashima{ASASHIMAHIROMITSU浅島弘充あさしまひろみつ}|HarukaMiki{MIKIHARUKA三木春香みきはるか}|YuyaKondo{KONDOYUYA近藤裕也こんどうゆうや}|IsaoMatsumoto{MATSUMOTOISAO松本功まつもといさお}|KazuhiroOgawa{OGAWAKAZUHIRO小川和浩おがわかずひろ}|KyokoTakita{TAKITAKYOKO田北響子たきたきょうこ}|ToshitakaYukishima{YUKISHIMATOSHITAKA雪嶋俊孝ゆきしまとしたか}|YusukeOkubo{OKUBOYUSUKE大久保悠介おおくぼゆうすけ}|ShogoFurukawa{FURUKAWASHOGO古川省悟ふるかわしょうご}|KumikoShimoyama{SHIMOYAMAKUMIKO下山久美子しもやまくみこ}|TakashiYamane{YAMANETAKASHI山根隆志やまねたかし}|AtsushiOnoe{ONOEATSUSHI尾上敦史おのえあつし}|YutakaMatsuyama{MATSUYAMAYUTAKA松山裕まつやまゆたか}|NoriakiYasuda{YASUDANORIAKI安田矩明やすだのりあき}|TakahisaOnishi{ONISHITAKAHISA大西貴久おおにしたかひさ}|MikiyaKomatsu{KOMATSUMIKIYA小松実樹也こまつみきや}|GoshiKomine{KOMINEGOSHI小峯豪心こみねごうし}|TsubasaMaeda{MAEDATSUBASA前田翼まえだつばさ}|MarikoSakai{SAKAIMARIKO堺真梨子さかいまりこ}|YukikoTakeyama{TAKEYAMAYUKIKO竹山悠希子たけやまゆきこ}|AkihitoMaruyama{MARUYAMAAKIHITO丸山暁人まるやまあきひと}|MitsuteruAkahosi{AKAHOSIMITSUTERU赤星光輝あかほしみつてる}____Workshop 15Polymyositis and dermatomyositis (clinical trial2)____Neuropsychiatric Symptoms in Polymyositis and Dermatomyositis: A multi-center retrospective study|Clustering of Prognostic Factors and Reproducibility of a Prognostic Model in Anti-MDA5 Antibody-Positive Dermatomyositis|Clinical significance of anti-Ro52 antibody (Ab) in anti-MDA5 Ab-positive clinically amyopathic dermatomyositis (CADM)|Analysis of patients with idiopathic inflammatory myositis (IIM) complicated by malignancy|Impact of Glucocorticoid Tapering on Relapse Risk in Anti-ARS Antibody-Positive Idiopathic Inflammatory Myopathies: A Single-Center Retrospective Cohort Study|Clinical Characteristics of Patients with Inflammatory Myopathies Complicated by Rheumatoid Arthritis

W15

Workshop 15
Polymyositis and dermatomyositis (clinical trial2)

Chair：Hisanori Hasegawa

TakanoriIto{ITOTAKANORI伊藤孝典いとうたかのり}|YohsukeOto{OTOYOHSUKE大藤洋介おおとうようすけ}|KeitaNinagawa{NINAGAWAKEITA蜷川慶太にながわけいた}|YoshikiIshizaki{ISHIZAKIYOSHIKI石﨑克樹いしざきよしき}|ToshikiKido{KIDOTOSHIKI木戸敏喜きどとしき}|NorikoSato{SATONORIKO佐藤法子さとうのりこ}____TohruTakeuchi{TAKEUCHITOHRU武内徹たけうちとおる}____MasayoriMoriyama{MORIYAMAMASAYORI守山昌利もりやままさより}|KentaroNoda{NODAKENTARO野田健太郎のだけんたろう}|TaroUkichi{UKICHITARO浮地太郎うきちたろう}|KenYoshida{YOSHIDAKEN吉田健よしだけん}|HarukaIino{IINOHARUKA飯野悠いいのはるか}|EriSugawara{SUGAWARAERI菅原恵理すがわらえり}|TakeshiSuzuki{SUZUKITAKESHI鈴木豪すずきたけし}|TakayukiMatsui{MATSUITAKAYUKI松井隆之まついたかゆき}|TakayasuAndou{ANDOUTAKAYASU安藤貴泰あんどうたかやす}|ShotaroSuzuki{SUZUKISHOTARO鈴木翔太郎すずきしょうたろう}|KeiichiSakurai{SAKURAIKEIICHI櫻井恵一さくらいけいいち}|KumikoTonooka{TONOOKAKUMIKO殿岡久美子とのおかくみこ}|YukikoTakakuwa{TAKAKUWAYUKIKO高桑由希子たかくわゆきこ}|HirokoNagahuthi{NAGAHUTHIHIROKO永渕裕子ながふちひろこ}|SeidoOoka{OOKASEIDO大岡正道おおおかせいどう}|KimitoKawahata{KAWAHATAKIMITO川畑仁人かわはたきみと}|AyakaIshida{ISHIDAAYAKA石田彩夏いしだあやか}|TakahiroAwayama{AWAYAMATAKAHIRO粟山高寛あわやまたかひろ}|IkumaOkada{OKADAIKUMA岡田幾磨おかだいくま}|MasatoshiKawataka{KAWATAKAMASATOSHI川高正聖かわたかまさとし}|MihoYamazaki{YAMAZAKIMIHO山﨑美帆やまざきみほ}|RyokoAsano{ASANORYOKO浅野諒子あさのりょうこ}|SatoshiYamaguchi{YAMAGUCHISATOSHI山口智史やまぐちさとし}|HiroyukiHounoki{HOUNOKIHIROYUKI朴木博幸ほうのきひろゆき}|MasaruKato{KATOMASARU加藤将かとうまさる}|HiroakiKuraoka{KURAOKAHIROAKI倉岡裕明くらおかひろあき}|ZuishinFurutsuki{FURUTSUKIZUISHIN古月瑞新ふるつきずいしん}|YoshitakeSato{SATOYOSHITAKE佐藤義剛さとうよしたけ}|DaigoKato{KATODAIGO加藤大吾かとうだいご}|MinakoTomiita{TOMIITAMINAKO冨板美奈子とみいたみなこ}____Workshop 16Polymyositis and dermatomyositis (clinical trial3)____Prevalence and Characteristics of Arthritis in Anti-Synthetase antibody positive Interstitial Lung Disease (ARS-ILD)|Association Between Chronic Progressive Pulmonary Fibrosis and Skeletal Muscle Histopathological Findings in Anti-Synthetase Syndrome|Clinical characteristics, treatment response, and functional outcomes in anti-SS-A antibody-positive myositis: a single-center retrospective study|Clinical Significance of Anti-CCP Antibodies in Anti-synthetase Syndrome With Interstitial Lung Disease|Post-remission relapse of interstitial lung disease in anti-MDA5 antibody-positive dermatomyositis: a single-center exploratory study|Clinical features and muscle prognosis in anti-SRP antibody-positive juvenile idiopathic inflammatory myopathy

W16

Workshop 16
Polymyositis and dermatomyositis (clinical trial3)

Chair：Tohru Takeuchi

YoshikazuTanaka{TANAKAYOSHIKAZU田中良和たなかよしかず}|YukoKaneko{KANEKOYUKO金子祐子かねこゆうこ}____HirotoTsuboi{TSUBOIHIROTO坪井洋人つぼいひろと}|SakaeTanaka{TANAKASAKAE田中栄たなかさかえ}________Evening Seminar 1Unmet Needs in Rheumatoid Arthritis: Next-Generation Antibody Structures and Evidence____Cryo-Electron Microscopy Reveals Structural Insights into Ozoralizumab Complex|Future Perspectives of Ozoralizumab Based on the SORAIRO trial

ES1

Evening Seminar 1
Unmet Needs in Rheumatoid Arthritis: Next-Generation Antibody Structures and Evidence

【Sponsored by Taisho Pharmaceutical Co., Ltd】

Chair：Hiroto Tsuboi, Chair：Sakae Tanaka

Speaker：Yoshikazu Tanaka

Speaker：Yuko Kaneko

AkihitoMaruyama{MARUYAMAAKIHITO丸山暁人まるやまあきひと}|MaoMizusaki{MIZUSAKIMAO水﨑旬音みずさきまお}|EitaroYoshida{YOSHIDAEITARO吉田英太郎よしだえいたろう}|MasahiroIida{IIDAMASAHIRO飯田雅博いいだまさひろ}|TakaoFujii{FUJIITAKAO藤井隆夫ふじいたかお}|KazukiMatsukawa{MATSUKAWAKAZUKI松川和樹まつかわかずき}____KunihiroIchinose{ICHINOSEKUNIHIRO一瀬邦弘いちのせくにひろ}____MasayoshiSaida{SAIDAMASAYOSHI才田正義さいだまさよし}|MikiyaKomatsu{KOMATSUMIKIYA小松実樹也こまつみきや}|GoshiKomine{KOMINEGOSHI小峯豪心こみねごうし}|TsubasaMaeda{MAEDATSUBASA前田翼まえだつばさ}|MarikoSakai{SAKAIMARIKO堺真梨子さかいまりこ}|YukikoTakeyama{TAKEYAMAYUKIKO竹山悠希子たけやまゆきこ}|MitsuteruAkahoshi{AKAHOSHIMITSUTERU赤星光輝あかほしみつてる}|RisaWakiya{WAKIYARISA脇谷理沙わきやりさ}|YusukeUshio{USHIOYUSUKE牛尾友亮うしおゆうすけ}|KouichiSugihara{SUGIHARAKOUICHI杉原幸一すぎはらこういち}|KanakoChujo{CHUJOKANAKO中條加奈子ちゅうじょうかなこ}|RyokoKagawa{KAGAWARYOKO香川涼子かがわりょうこ}|NaotoManabe{MANABENAOTO眞鍋直人まなべなおと}|MayukoWada{WADAMAYUKO和田真優子わだまゆこ}|ShusakuNakashima{NAKASHIMASHUSAKU中島崇作なかしましゅうさく}|TaichiMiyagi{MIYAGITAICHI宮城太一みやぎたいち}|HiromiShimada{SHIMADAHIROMI島田裕美しまだひろみ}|HiroakiDobashi{DOBASHIHIROAKI土橋浩章どばしひろあき}|TaigaKuga{KUGATAIGA久我大雅くがたいが}|YusukeYanagimoto{YANAGIMOTOYUSUKE柳本悠佑やなぎもとゆうすけ}|TakuyaNishi{NISHITAKUYA西卓也にしたくや}|AyakoMakiyama{MAKIYAMAAYAKO牧山彩子まきやまあやこ}|GoMurayama{MURAYAMAGO村山豪むらやまごう}|YoshiyukiAbe{ABEYOSHIYUKI安倍能之あべよしゆき}|KentaroMinowa{MINOWAKENTARO箕輪健太郎みのわけんたろう}|KenYamaji{YAMAJIKEN山路健やまじけん}|NaotoTamura{TAMURANAOTO田村直人たむらなおと}|NaotoYokogawa{YOKOGAWANAOTO横川直人よこがわなおと}|JunjiMorisawa{MORISAWAJUNJI森澤淳司もりさわじゅんじ}|MasashiInoue{INOUEMASASHI井上将いのうえまさし}|SairiTakahashi{TAKAHASHISAIRI髙橋彩理たかはしさいり}|KazuhikoHirokawa{HIROKAWAKAZUHIKO廣川和彦ひろかわかずひこ}|KotaroKomori{KOMORIKOTARO小森宏太郎こもりこうたろう}|YukiTerashima{TERASHIMAYUKI寺島侑希てらしまゆうき}|KeiichiUchiyama{UCHIYAMAKEIICHI内山桂一うちやまけいいち}|IsseiTakahashi{TAKAHASHIISSEI高橋一世たかはしいっせい}|TomohiroKato{KATOTOMOHIRO加藤智大かとうともひろ}|HirofumiSaito{SAITOHIROFUMI齋藤浩史さいとうひろふみ}|YoshitakaUeda{UEDAYOSHITAKA上田佳孝うえだよしたか}|EisukeTakamasu{TAKAMASUEISUKE髙增英輔たかますえいすけ}|KaeOnishi{ONISHIKAE大西香絵おおにしかえ}|YujiMiyoshi{MIYOSHIYUJI三好雄二みよしゆうじ}|YoshikiNagai{NAGAIYOSHIKI永井佳樹ながいよしき}|KotaShimada{SHIMADAKOTA島田浩太しまだこうた}|ShingoNakayamada{NAKAYAMADASHINGO中山田真吾なかやまだしんご}|AyakoNakajima{NAKAJIMAAYAKO中島亜矢子なかじまあやこ}|AsamiAbe{ABEASAMI阿部麻美あべあさみ}|MichiakiTakagi{TAKAGIMICHIAKI髙木理彰たかぎみちあき}|NobunoriTakahashi{TAKAHASHINOBUNORI高橋伸典たかはしのぶのり}|AtsuoNakajima{NAKAJIMAATSUO中島敦夫なかじまあつお}|KeiichiroNishida{NISHIDAKEIICHIRO西田圭一郎にしだけいいちろう}|TatsuyaAtsumi{ATSUMITATSUYA渥美達也あつみたつや}|YukoTakumi{TAKUMIYUKO多久美裕子たくみゆうこ}|KeiSakamoto{SAKAMOTOKEI坂本慶さかもとけい}|MasatakaKuwana{KUWANAMASATAKA桑名正隆くわなまさたか}|NamiOkamoto{OKAMOTONAMI岡本奈美おかもとなみ}|YoshiyaTanaka{TANAKAYOSHIYA田中良哉たなかよしや}|YasuhiroKato{KATOYASUHIRO加藤保宏かとうやすひろ}|EriItotagawa{ITOTAGAWAERI糸田川英里いとたがわえり}|KazumaKosaka{KOSAKAKAZUMA小坂一真こさかかずま}|HachiroKonaka{KONAKAHACHIRO小中八郎こなかはちろう}|MasaoKatsushima{KATSUSHIMAMASAO勝島將夫かつしままさお}|MotomuHashimoto{HASHIMOTOMOTOMU橋本求はしもともとむ}|YuriHiramatsu{HIRAMATSUYURI平松ゆりひらまつゆり}|YumikoWada{WADAYUMIKO和田裕美子わだゆみこ}|HidekiOka{OKAHIDEKI岡秀樹おかひでき}|ShujiSumitomo{SUMITOMOSHUJI住友秀次すみともしゅうじ}|HirofumiMiyake{MIYAKEHIROFUMI三宅啓史みやけひろふみ}|AkiraOnishi{ONISHIAKIRA大西輝おおにしあきら}|HideakiTsuji{TSUJIHIDEAKI辻英輝つじひであき}|ToshihikoShiga{SHIGATOSHIHIKO志賀俊彦しがとしひこ}|YujiNozaki{NOZAKIYUJI野﨑祐史のざきゆうじ}|ShigeruIwata{IWATASHIGERU岩田慈いわたしげる}|TakaoFujii{FUJIITAKAO藤井隆夫ふじいたかお}|WataruYamamoto{YAMAMOTOWATARU山本渉やまもとわたる}|AtsushiKumanogoh{KUMANOGOHATSUSHI熊ノ郷淳くまのごうあつし}____Workshop 3SLE treatment: anifrolumab____Association Between Neutrophil-to-Lymphocyte Ratio and Treatment Continuation in Patients With Systemic Lupus Erythematosus Treated With Anifrolumab|Effect of concomitant hydroxychloroquine use on the efficacy of anifrolumab in systemic lupus erythematosus|Evaluation of fatigue improvement and clinical data changes in SLE patients with low disease activity treated with anifrolumab|Patient-Reported Outcome Transitions in Systemic Lupus Erythematosus Patients Treated with Anifrolumab|Post-Marketing Surveillance of Anifrolumab in Patients with Systemic Lupus Erythematosus in Japan (follow up of Interim Report)|Comparative Clinical Efficacy of Anifrolumab and Belimumab in Patients with Systemic Lupus Erythematosus: The Multicenter ANSWER-SLE Cohort Analysis

W3

Workshop 3
SLE treatment: anifrolumab

Chair：Kunihiro Ichinose

SatokoNozato{NOZATOSATOKO野里聡子のざとさとこ}|HirofumiMiyake{MIYAKEHIROFUMI三宅啓史みやけひろふみ}|YasuhiroHasegawa{HASEGAWAYASUHIRO長谷川靖浩はせがわやすひろ}|KeisukeMiyamoto{MIYAMOTOKEISUKE宮本啓佑みやもとけいすけ}|YutaShimomura{SHIMOMURAYUTA下邨優太しもむらゆうた}|TakeruSonoda{SONODATAKERU園田健留そのだたける}____HirofumiAmano{AMANOHIROFUMI天野浩文あまのひろふみ}|YumiTsuchida{TSUCHIDAYUMI土田優美つちだゆみ}____KeijyuYamada{YAMADAKEIJYU山田恵壽やまだけいじゅ}|TasukuTogashi{TOGASHITASUKU富樫救とがしたすく}|MasayasuKitano{KITANOMASAYASU北野将康きたのまさやす}|AkiNishioka{NISHIOKAAKI西岡亜紀にしおかあき}|ShinichiroTsunoda{TSUNODASHINICHIRO角田慎一郎つのだしんいちろう}|AkiraOnishi{ONISHIAKIRA大西輝おおにしあきら}|HideakiTsuji{TSUJIHIDEAKI辻英輝つじひであき}|TakuyaKotani{KOTANITAKUYA小谷卓矢こたにたくや}|YumikoWada{WADAYUMIKO和田裕美子わだゆみこ}|YujiNozaki{NOZAKIYUJI野﨑祐史のざきゆうじ}|ToshihikoShiga{SHIGATOSHIHIKO志賀俊彦しがとしひこ}|TakaoFujii{FUJIITAKAO藤井隆夫ふじいたかお}|ShigeruIwata{IWATASHIGERU岩田慈いわたしげる}|YasuhiroKato{KATOYASUHIRO加藤保宏かとうやすひろ}|EriItotagawa{ITOTAGAWAERI糸田川英里いとたがわえり}|ShujiSumitomo{SUMITOMOSHUJI住友秀次すみともしゅうじ}|HidekiOka{OKAHIDEKI岡秀樹おかひでき}|WataruYamamoto{YAMAMOTOWATARU山本渉やまもとわたる}|MasaoKatsushima{KATSUSHIMAMASAO勝島將夫かつしままさお}|MotomuHashimoto{HASHIMOTOMOTOMU橋本求はしもともとむ}|KeisukeIkeda{IKEDAKEISUKE池田慶介いけだけいすけ}|KazukiHaru{HARUKAZUKI治和樹はるかずき}|AyanoAndo{ANDOAYANO安藤彬乃あんどうあやの}|NaoTsugita{TSUGITANAO次田奈央つぎたなお}|YosukeIwadate{IWADATEYOSUKE岩楯洋祐いわだてようすけ}|EriShishido{SHISHIDOERI宍戸瑛理ししどえり}|HirotomoAsakura{ASAKURAHIROTOMO朝倉啓友あさくらひろとも}|RisaShindo{SHINDORISA進藤理沙しんどうりさ}|KazumaIno{INOKAZUMA伊野和馬いのかずま}|TomokiTanaka{TANAKATOMOKI田中知樹たなかともき}|YuMatsueda{MATSUEDAYU松枝佑まつえだゆう}|TatsuhikoWada{WADATATSUHIKO和田達彦わだたつひこ}|KunihiroYamaoka{YAMAOKAKUNIHIRO山岡邦宏やまおかくにひろ}|YukikoTakakuwa{TAKAKUWAYUKIKO高桑由希子たかくわゆきこ}|ShotaroSuzuki{SUZUKISHOTARO鈴木翔太郎すずきしょうたろう}|KeiichiSakurai{SAKURAIKEIICHI櫻井恵一さくらいけいいち}|YoshikiIshizaki{ISHIZAKIYOSHIKI石﨑克樹いしざきよしき}|TakayasuAndo{ANDOTAKAYASU安藤貴泰あんどうたかやす}|KumikoTonooka{TONOOKAKUMIKO殿岡久美子とのおかくみこ}|TakeshiSuzuki{SUZUKITAKESHI鈴木豪すずきたけし}|SeidoOoka{OOKASEIDO大岡正道おおおかせいどう}|KimitoKawahata{KAWAHATAKIMITO川畑仁人かわはたきみと}|TaroNishikawa{NISHIKAWATARO西川太朗にしかわたろう}|RyoMatsumiya{MATSUMIYARYO松宮遼まつみやりょう}|NatsukoEsa{ESANATSUKO江左夏子えさなつこ}|YuheiFujisawa{FUJISAWAYUHEI藤澤雄平ふじさわゆうへい}|AkiraOhnishi{OHNISHIAKIRA大西輝おおにしあきら}|HirofumiMiyake{MIYAKEHIROFUMI三宅啓史みやけひろふみ}|TakaoFuji{FUJITAKAO藤井隆夫ふじいたかお}|TakashiKato{KATOTAKASHI加藤喬かとうたかし}|YutaShimomura{SHIMOMURAYUTA下邨優太しもむらゆうた}|KodaiUeno{UENOKODAI上野滉大うえのこうだい}____Workshop 4SLE treatment: belimumab____Long-Term Discontinuation of Belimumab in SLE after Achieving Low Disease Activity|Risk factors and effect of belimumab on flare during glucocorticoid tapering in systemic lupus erythematosus: a multicenter ANSWER-SLE cohort study|Evaluation of relapse rate and predictive factors in patients with systemic lupus erythematosus treated with belimumab|Efficacy of Early BIO Introduction in Mild-to-Moderate SLE: Insights from Treatment Sequence|Differences in treatment responsiveness to biologics based on positive or negative of anti-SS-A antibodies in Systemic lupus erythematosus|Long-term effects of tacrolimus and mycophenolate mofetil on renal function in patients with SLE - A study using ANSWER-SLE cohort -

W4

Workshop 4
SLE treatment: belimumab

Chair：Hirofumi Amano, Chair：Yumi Tsuchida

AyaeTanaka{TANAKAAYAE田中彩絵たなかあやえ}|MotomuHashimoto{HASHIMOTOMOTOMU橋本求はしもともとむ}____YuichiMochida{MOCHIDAYUICHI持田勇一もちだゆういち}|TakaoFujii{FUJIITAKAO藤井隆夫ふじいたかお}________Luncheon Seminar 2Personalized medicine for rheumatoid arthritis ~Role and optimization of TNFα inhibitors~____Clinical Care in Rheumatoid Arthritis for Female Patients Looking Ahead to Life Events|Reconsidering TNF Inhibitor Therapy from a Structural Perspective

LS2

Luncheon Seminar 2
Personalized medicine for rheumatoid arthritis ~Role and optimization of TNFα inhibitors~

【Sponsored by UCB Japan Co. Ltd.】

Chair：Yuichi Mochida, Chair：Takao Fujii

Speaker：Ayae Tanaka

Speaker：Motomu Hashimoto

TomoyaNakamizo{NAKAMIZOTOMOYA中溝智也なかみぞともや}|TakashiKida{KIDATAKASHI木田節きだたかし}|YumikoWada{WADAYUMIKO和田裕美子わだゆみこ}|YoshiyukiArinuma{ARINUMAYOSHIYUKI有沼良幸ありぬまよしゆき}|AyaneGoto{GOTOAYANE後藤文音ごとうあやね}|YuheiFujisawa{FUJISAWAYUHEI藤澤雄平ふじさわゆうへい}____YuichiroFujieda{FUJIEDAYUICHIRO藤枝雄一郎ふじえだゆういちろう}____MasaoOgura{OGURAMASAO小椋雅夫おぐらまさお}|KentaroNishi{NISHIKENTARO西健太朗にしけんたろう}|ShuichiIto{ITOSHUICHI伊藤秀一いとうしゅういち}|YushiroKida{KIDAYUSHIRO木田祐之朗きだゆうしろう}|KosukeMiyagi{MIYAGIKOSUKE宮城浩輔みやぎこうすけ}|ShunsukeFujieda{FUJIEDASHUNSUKE藤枝俊輔ふじえだしゅんすけ}|TomoyaSagawa{SAGAWATOMOYA佐川友哉さがわともや}|NaokaKamio{KAMIONAOKA神尾尚馨かみおなおか}|TakahiroSeno{SENOTAKAHIRO妹尾高宏せのおたかひろ}|MasatakaKohno{KOHNOMASATAKA河野正孝こうのまさたか}|YutakaKawahito{KAWAHITOYUTAKA川人豊かわひとゆたか}|TakuyaKotani{KOTANITAKUYA小谷卓矢こたにたくや}|NatsukoEsa{ESANATSUKO江左夏子えさなつこ}|YuriHiramatsu{HIRAMATSUYURI平松ゆりひらまつゆり}|YujiNozaki{NOZAKIYUJI野﨑祐史のざきゆうじ}|ToshihikoShiga{SHIGATOSHIHIKO志賀俊彦しがとしひこ}|RyuWatanabe{WATANABERYU渡部龍わたなべりゅう}|MotomuHashimoto{HASHIMOTOMOTOMU橋本求はしもともとむ}|ShujiSumitomo{SUMITOMOSHUJI住友秀次すみともしゅうじ}|HidekiOka{OKAHIDEKI岡秀樹おかひでき}|HirofumiMiyake{MIYAKEHIROFUMI三宅啓史みやけひろふみ}|AkiraOnishi{ONISHIAKIRA大西輝おおにしあきら}|HideakiTsuji{TSUJIHIDEAKI辻英輝つじひであき}|TakaoFujii{FUJIITAKAO藤井隆夫ふじいたかお}|ShigeruIwata{IWATASHIGERU岩田慈いわたしげる}|YasuhiroKato{KATOYASUHIRO加藤保宏かとうやすひろ}|EriItotagawa{ITOTAGAWAERI糸田川英里いとだがわえり}|WataruYamamoto{YAMAMOTOWATARU山本渉やまもとわたる}|TohruTakeuchi{TAKEUCHITOHRU武内徹たけうちとおる}|AsakoMitsui{MITSUIASAKO三井安沙子みついあさこ}|YuheiIto{ITOYUHEI伊藤有平いとうゆうへい}|NaohiroSugitani{SUGITANINAOHIRO杉谷直大すぎたになおひろ}|SeitaroSakakura{SAKAKURASEITARO坂倉星太朗さかくらせいたろう}|YosuketakumaShibahara{SHIBAHARAYOSUKETAKUMA芝原拓真しばはらたくま}|YosukeNakamura{NAKAMURAYOSUKE中村洋輔なかむらようすけ}|AndoRufuto{RUFUTOANDO安藤流布人あんどるふと}|RyoshinMizuno{MIZUNORYOSHIN水野僚真みずのりょうしん}|YoshikiTachi{TACHIYOSHIKI舘佳樹たちよしき}|MotohiroIto{ITOMOTOHIRO伊藤基博いとうもとひろ}|AyakoNakajima{NAKAJIMAAYAKO中島亜矢子なかじまあやこ}|TsuchidaYumi{YUMITSUCHIDA土田優美つちだゆみ}|HarukaTsuchiya{TSUCHIYAHARUKA土屋遥香つちやはるか}|ToruMoro{MOROTORU茂呂徹もろとおる}|SakaeTanaka{TANAKASAKAE田中栄たなかさかえ}|KeishiFujio{FUJIOKEISHI藤尾圭志ふじおけいし}|KenyaSugimoto{SUGIMOTOKENYA杉本健哉すぎもとけんや}|KentaroMaruo{MARUOKENTARO丸尾健太郎まるおけんたろう}|HarukaYasuba{YASUBAHARUKA安場遥香やすばはるか}|RyuheiIshihara{ISHIHARARYUHEI石原龍平いしはらりゅうへい}|YuyaFujita{FUJITAYUYA藤田雄也ふじたゆうや}|MasaoKatsushima{KATSUSHIMAMASAO勝島將夫かつしままさお}|KazuoFukumoto{FUKUMOTOKAZUO福本一夫ふくもとかずお}|ShinsukeYamada{YAMADASHINSUKE山田真介やまだしんすけ}____Workshop 17Various Clinical Manifestations of SLE____A Case of SLE with FGF23-Related Hypophosphatemia Due to Anti-PHEX Autoantibodies: Implications for a Novel Autoimmune Mechanism|Systemic Capillary Leak Syndrome Presenting with Digital Gangrene in a Patient with Systemic Lupus Erythematosus|Clinical characteristics and predictors of disease flare in male patients with systemic lupus erythematosus: the multicenter ANSWER-SLE cohort study|Cognitive Impairment and Associated Factors in Patients with Systemic Lupus Erythematosus (SLE) during Remission Maintenance Phase: A Multi-Center Cross-Sectional Study|Bone Mineral Density Trends and Correlates in Systemic Lupus Erythematosus: A Retrospective Analysis Using an AI-Assisted Osteoporosis Diagnostic System Based on Chest X-ray|Prevalence and recurrence of herpes zoster, associated factors, and attitudes toward vaccination in patients with systemic lupus erythematosus

W17

Workshop 17
Various Clinical Manifestations of SLE

Chair：Yuichiro Fujieda

MasanobuUeno{UENOMASANOBU上野匡庸うえのまさのぶ}|KimitoKawahata{KAWAHATAKIMITO川畑仁人かわはたきみと}____TatsuyaAtsumi{ATSUMITATSUYA渥美達也あつみたつや}________Evening Seminar 2Strategies for the Treatment of Autoimmune Diseases____Impact of Eosinophil-Targeted Therapy in EGPA: Early Treatment and Achieving Glucocorticoid-Free Management|Advances in Anifrolumab for Systemic Lupus Erythematosus: Considering the Importance of Therapeutic Intervention in Type I IFN

ES2

Evening Seminar 2
Strategies for the Treatment of Autoimmune Diseases

【Sponsored by AstraZeneca K.K.】

Chair：Tatsuya Atsumi

Speaker：Masanobu Ueno

Speaker：Kimito Kawahata

YuyaTakakubo{TAKAKUBOYUYA髙窪祐弥たかくぼゆうや}____MakotoHirao{HIRAOMAKOTO平尾眞ひらおまこと}________Educational Lecture 1Tips for Rehabilitation, Orthotic Therapy, and Joint Injections in Rheumatic Diseases____Tips for Rehabilitation, Orthotic Therapy, and Joint Injections in Rheumatic Diseases

EL1

Educational Lecture 1
Tips for Rehabilitation, Orthotic Therapy, and Joint Injections in Rheumatic Diseases

Chair：Makoto Hirao

Speaker：Yuya Takakubo

TakanoriTeshima{TESHIMATAKANORI豊嶋崇徳てしまたかのり}____KenjiOku{OKUKENJI奥健志おくけんじ}________Educational Lecture 2The current and future landscape of CAR-T cell therapy____The current and future landscape of CAR-T cell therapy

EL2

Educational Lecture 2
The current and future landscape of CAR-T cell therapy

Chair：Kenji Oku

Speaker：Takanori Teshima

YoshiyaTanaka{TANAKAYOSHIYA田中良哉たなかよしや}____KazuhikoYamamoto{YAMAMOTOKAZUHIKO山本一彦やまもとかずひこ}________Educational Lecture 5Precision medicine and safety management for rheumatic diseases____Precision medicine and safety management for rheumatic diseases

EL5

Educational Lecture 5
Precision medicine and safety management for rheumatic diseases

Chair：Kazuhiko Yamamoto

Speaker：Yoshiya Tanaka

YoshimasaNagao{NAGAOYOSHIMASA長尾能雅ながおよしまさ}____NaokiIshiguro{ISHIGURONAOKI石黒直樹いしぐろなおき}________Educational Lecture 6____患者安全の全体像と展望

EL6

Educational Lecture 6

Chair：Naoki Ishiguro

Speaker：Yoshimasa Nagao

MasaakiMori{MORIMASAAKI森雅亮もりまさあき}|MasakiShimizu{SHIMIZUMASAKI清水正樹しみずまさき}____TakakoMiyamae{MIYAMAETAKAKO宮前多佳子みやまえたかこ}________Evening Seminar 3Evidence and Practice-Based Knowledge in Still’s Disease Care____Current Status of Validating Pathophysiological Hypotheses: Considering Still's Disease Through the Lens of Recent Research|Early Recognition and Intervention for Severe Complications in Still's Disease: Bridging International and National Guidelines with Bedside Clinical Judgment

ES3

Evening Seminar 3
Evidence and Practice-Based Knowledge in Still’s Disease Care

【Sponsored by Sobi Japan Co. Ltd.,】

Chair：Takako Miyamae

Speaker：Masaaki Mori

Speaker：Masaki Shimizu

ShigeruIwata{IWATASHIGERU岩田慈いわたしげる}|RyujiKoike{KOIKERYUJI小池竜司こいけりゅうじ}|HarukaTsuchiya{TSUCHIYAHARUKA土屋遥香つちやはるか}|YukikoTakakuwa{TAKAKUWAYUKIKO高桑由希子たかくわゆきこ}|TakahikoSugihara{SUGIHARATAKAHIKO杉原毅彦すぎはらたかひこ}|NaokiSawa{SAWANAOKI澤直樹さわなおき}____KunihiroYamaoka{YAMAOKAKUNIHIRO山岡邦宏やまおかくにひろ}|ToshihiroMatsui{MATSUITOSHIHIRO松井利浩まついとしひろ}____MasahiroTada{TADAMASAHIRO多田昌弘ただまさひろ}|RyujiKoike{KOIKERYUJI小池竜司こいけりゅうじ}|YujiYamanishi{YAMANISHIYUJI山西裕司やまにしゆうじ}|MieFusama{FUSAMAMIE房間美恵ふさまみえ}|HarukaTsuchiya{TSUCHIYAHARUKA土屋遥香つちやはるか}|KunihiroYamaoka{YAMAOKAKUNIHIRO山岡邦宏やまおかくにひろ}|HidetoKameda{KAMEDAHIDETO亀田秀人かめだひでと}|ShigeruIwata{IWATASHIGERU岩田慈いわたしげる}____Symposium 2____MTX Treatment for Rheumatoid Arthritis Patients with Malignancy|Management strategies in liver dysfunction during methotrexate therapy|Paternal use of methotrexate and preconception care|Strategic Positioning of Subcutaneous Methotrexate in the Management of Elderly Patients with Rheumatoid Arthritis: Focus on Efficacy and Safety|Current Practice and Challenges of Methotrexate-Anchored Therapy in Older Patients with Rheumatoid Arthritis|Methotrexate-Sparing Strategies in Elderly Patients with Rheumatoid Arthritis: A Nephro-rheumatologist's Perspective

S2

Symposium 2

Chair：Kunihiro Yamaoka, Chair：Toshihiro Matsui

Speaker：Shigeru Iwata

Speaker：Ryuji Koike

Speaker：Haruka Tsuchiya

Speaker：Yukiko Takakuwa

Speaker：Takahiko Sugihara

Speaker：Naoki Sawa

MasayukiNishide{NISHIDEMASAYUKI西出真之にしでまさゆき}|MitsumasaKishimoto{KISHIMOTOMITSUMASA岸本暢將きしもとみつまさ}____HidetoKameda{KAMEDAHIDETO亀田秀人かめだひでと}________Luncheon Seminar 3Deep Insights into Autoimmune Diseases Through Patient Sample Analysis____Decoding Autoimmune Diseases through the Analysis of Patient-Derived Samples|The Importance of Early Diagnosis in Autoimmune Disease

LS3

Luncheon Seminar 3
Deep Insights into Autoimmune Diseases Through Patient Sample Analysis

【Sponsored by Bristol Myers Squibb K.K. Medical】

Chair：Hideto Kameda

Speaker：Masayuki Nishide

Speaker：Mitsumasa Kishimoto

YasuhiroKatsumata{KATSUMATAYASUHIRO勝又康弘かつまたやすひろ}|MasanoriNakayama{NAKAYAMAMASANORI中山政憲なかやままさのり}|RyusukeYoshimi{YOSHIMIRYUSUKE吉見竜介よしみりゅうすけ}|YasushiKondo{KONDOYASUSHI近藤泰こんどうやすし}____AyakoNakajima{NAKAJIMAAYAKO中島亜矢子なかじまあやこ}|ToshihisaKojima{KOJIMATOSHIHISA小嶋俊久こじまとしひさ}____AyakoNakajima{NAKAJIMAAYAKO中島亜矢子なかじまあやこ}|ToshihisaKojima{KOJIMATOSHIHISA小嶋俊久こじまとしひさ}|ShintaroHirata{HIRATASHINTARO平田信太郎ひらたしんたろう}____Symposium 6____Responsibilities and Practical Measures for the Japan College of Rheumatology in an Era of Drug Supply Concerns: Subcommittee on Ensuring a Stable Pharmaceutical Supply|Challenges to Improving the Evaluation of Surgical Operations for Rheumatoid Arthritis -Subcommittee on Japanese Health Insurance Federation for Surgery(JHIFS)|Evaluation of Medications and Diagnostic Technologies in Rheumatoid Arthritis Treatment and Institutional Challenges|Current Status of Quality and Evaluation in Inpatient Care or Rheumatology: From Acute to Chronic Phases and Multidisciplinary Collaboration

S6

Symposium 6

Chair：Ayako Nakajima, Chair：Toshihisa Kojima

Speaker：Yasuhiro Katsumata

Speaker：Masanori Nakayama

Speaker：Ryusuke Yoshimi

Speaker：Yasushi Kondo

KentaMakabe{MAKABEKENTA真壁健太まかべけんた}|AtsushiKaneko{KANEKOATSUSHI金子敦史かねこあつし}|ShogoToyama{TOYAMASHOGO遠山将吾とおやましょうご}|YuMori{MORIYU森優もりゆう}|HiroshiHatakeyama{HATAKEYAMAHIROSHI畠山拡はたけやまひろし}____MochihitoSuzuki{SUZUKIMOCHIHITO鈴木望人すずきもちひと}|YukioAkasaki{AKASAKIYUKIO赤崎幸穂あかさきゆきお}____RyutarouTakeda{TAKEDARYUTAROU武田龍太郎たけだりゅうたろう}|TarouKasai{KASAITAROU笠井太郎かさいたろう}|AkihiroUchio{UCHIOAKIHIRO内尾明博うちおあきひろ}|RikyoKuhara{KUHARARIKYO九原利京くはらりきょう}|KumikoOno{ONOKUMIKO大野久美子おおのくみこ}|YasunoriOmata{OMATAYASUNORI小俣康徳おまたやすのり}|ToshihiroMatsui{MATSUITOSHIHIRO松井利浩まついとしひろ}|ShigetoTohma{TOHMASHIGETO當間重人とうましげと}|SakaeTanaka{TANAKASAKAE田中栄たなかさかえ}|TakumiMatsumoto{MATSUMOTOTAKUMI松本卓巳まつもとたくみ}|HajimeIshikawa{ISHIKAWAHAJIME石川肇いしかわはじめ}|AsamiAbe{ABEASAMI阿部麻美あべあさみ}|SatoshiIto{ITOSATOSHI伊藤聡いとうさとし}|NakazonoKiyoshi{KIYOSHINAKAZONO中園清なかぞのきよし}|RyoOda{ODARYO小田良おだりょう}|KenjiTakahashi{TAKAHASHIKENJI高橋謙治たかはしけんじ}|AkiraMurasawa{MURASAWAAKIRA村澤章むらさわあきら}|KiyoshiNakazono{NAKAZONOKIYOSHI中園清なかぞのきよし}|RyuichiKanabuchi{KANABUCHIRYUICHI金淵龍一かなぶちりゅういち}|HiroshiHatakeyama{HATAKEYAMAHIROSHI畠山拡はたけやまひろし}|ToshimiAizawa{AIZAWATOSHIMI相澤俊峰あいざわとしみ}|YuMori{MORIYU森優もりゆう}____Workshop 5Surgery for Rheumatic Disease1____Time course Changes in Background Factors in Cases of Joint Replacement Surgery for Rheumatoid Arthritis Patients: Analysis of a Large-Scale Database NinJa|Annual new joint replacement and revision surgery for RA patients in Japan using NinJa2023|The Effect of Surgical Intervention in Rheumatoid Arthritis: A Model Comparison Considering Disease Activity and Surgical Site Inflammation|Surgical Outcomes in Difficult-to-Treat Rheumatoid Arthritis by Inflammatory Subsets: A Mixed-Effects Model Adjusted for Disease Activity and Synovial Histopathology|Postoperative Risk Profile of Rheumatoid Arthritis Patients Undergoing Total Hip Arthroplasty: Insights From a Nationwide Database Study|Elevated Risk of Postoperative Complications After TKA in Rheumatoid Arthritis Patients: Insights From a Japanese Nationwide Medical Claims Database

W5

Workshop 5
Surgery for Rheumatic Disease1

Chair：Mochihito Suzuki, Chair：Yukio Akasaki

KazukiOrita{ORITAKAZUKI織田一貴おりたかずき}|KaneakiTawada{TAWADAKANEAKI多和田兼章たわだかねあき}|TakashiNakamura{NAKAMURATAKASHI中村卓司なかむらたかし}|KokiOtani{OTANIKOKI大谷洸貴おおたにこうき}|HirokoIkeuchi{IKEUCHIHIROKO池内寛子いけうちひろこ}|MitsukiKushida{KUSHIDAMITSUKI串田光生くしだみつき}____KoichiMurata{MURATAKOICHI村田浩一むらたこういち}____HidetomiTerai{TERAIHIDETOMI寺井秀富てらいひでとみ}|RyouNaruse{NARUSERYOU成瀬龍なるせりょう}|YukiAkatsuka{AKATSUKAYUKI赤塚夕紀あかつかゆき}|KunioYamada{YAMADAKUNIO山田邦雄やまだくにお}|AyakoKubota{KUBOTAAYAKO窪田綾子くぼたあやこ}|RyoTakamatsu{TAKAMATSURYO高松諒たかまつりょう}|KentaroTsuji{TSUJIKENTARO辻健太郎つじけんたろう}|HiroshiTakahashi{TAKAHASHIHIROSHI高橋寛たかはしひろし}|TomotakaAkamatsu{AKAMATSUTOMOTAKA赤松智隆あかまつともたか}|HyonminChoe{CHOEHYONMIN崔賢民ちぇひょんみん}|ShuntaroNejima{NEJIMASHUNTARO子島俊太郎ねじましゅんたろう}|KenKumagai{KUMAGAIKEN熊谷研くまがいけん}|YuichiMochida{MOCHIDAYUICHI持田勇一もちだゆういち}|KengoHarigane{HARIGANEKENGO針金健吾はりがねけんご}|YutakaInaba{INABAYUTAKA稲葉裕いなばゆたか}|ShinichiMizuki{MIZUKISHINICHI水木伸一みずきしんいち}|EijiroAdachi{ADACHIEIJIRO安達永二朗あだちえいじろう}|HajimeIshikawa{ISHIKAWAHAJIME石川肇いしかわはじめ}|KazuhiroNishikawa{NISHIKAWAKAZUHIRO西川和博にしかわかずひろ}|TakahitoSuto{SUTOTAKAHITO須藤貴仁すとうたかひと}|HideoSakane{SAKANEHIDEO坂根英夫さかねひでお}|ShinatoTokunaga{TOKUNAGASHINATO徳永伸太郎とくながしんたろう}|TakashiIto{ITOTAKASHI伊藤崇いとうたかし}|TakeruOgawa{OGAWATAKERU尾川武おがわたける}|HirotakaChikuda{CHIKUDAHIROTAKA筑田博隆ちくだひろたか}____Workshop 6Surgery for Rheumatic Disease2____Is there a difference in functional outcomes and living space after total hip arthroplasty between patients with rheumatoid arthritis and osteoarthritis ?|Postoperative Changes in Lower Limb Alignment After Total Knee Arthroplasty for Valgus Knees in Patients with Rheumatoid Arthritis|Ingenuity of wound closure in total knee arthroplasty for valgus knee on rheumatoid arthritis|Clinical factors associated with loss of correction after hallux valgus surgery in patients with rheumatoid arthritis|The effects of lower limb arthroplasty on upper limb function in patients with rheumatoid arthritis: a prospective cohort study|Bilateral Total Hip Arthroplasty after Spinal Osteotomy for Ankylosing Spondylitis: A Case Report

W6

Workshop 6
Surgery for Rheumatic Disease2

Chair：Koichi Murata

MasatakaKuwana{KUWANAMASATAKA桑名正隆くわなまさたか}____ToshihisaKojima{KOJIMATOSHIHISA小嶋俊久こじまとしひさ}________Luncheon Seminar 4Safety Management for Baricitinib Use Based on Post-Marketing Surveillance Data____Safety Management for Baricitinib Use Based on Post-Marketing Surveillance Data

LS4

Luncheon Seminar 4
Safety Management for Baricitinib Use Based on Post-Marketing Surveillance Data

【Sponsored by Eli Lilly Japan K.K.】

Chair：Toshihisa Kojima

Speaker：Masataka Kuwana

NaokoKoenuma{KOENUMANAOKO肥沼直子こえぬまなおこ}|KotaroImatani{IMATANIKOTARO今谷紘太郎いまたにこうたろう}|ToshiharuOkuda{OKUDATOSHIHARU奥田敏治おくだとしはる}|AtsuoUefuji{UEFUJIATSUO上藤淳郎うえふじあつお}|NoriakiOtsuka{OTSUKANORIAKI大塚憲昭おおつかのりあき}|YukiAkatsuka{AKATSUKAYUKI赤塚夕紀あかつかゆうき}____AsamiAbe{ABEASAMI阿部麻美あべあさみ}|RyoOda{ODARYO小田良おだりょう}____KoeiOh{OHKOEI王興栄おうこうえい}|KoichiroYano{YANOKOICHIRO矢野紘一郎やのこういちろう}|KatsunoriIkari{IKARIKATSUNORI猪狩勝則いかりかつのり}|KenOkazaki{OKAZAKIKEN岡崎賢おかざきけん}|NoriakiOtsuka{OTSUKANORIAKI大塚憲昭おおつかのりあき}|ChinatsuIchikawa{ICHIKAWACHINATSU市川千夏いちかわちなつ}|NoriyukiShimizu{SHIMIZUNORIYUKI志水紀之しみずのりゆき}|MasahiroHorita{HORITAMASAHIRO堀田昌宏ほりたまさひろ}|RyuichiNakahara{NAKAHARARYUICHI中原龍一なかはらりゅういち}|KeiichiroNishida{NISHIDAKEIICHIRO西田圭一郎にしだけいいちろう}|ToshifumiOzaki{OZAKITOSHIFUMI尾﨑敏文おざきとしふみ}|ShunsukeTakahara{TAKAHARASHUNSUKE高原俊介たかはらしゅんすけ}|NatsukoNakagawa{NAKAGAWANATSUKO中川夏子なかがわなつこ}|KoutaroImatani{IMATANIKOUTARO今谷紘太郎いまたにこうたろう}|KaneakiTawada{TAWADAKANEAKI多和田兼章たわだかねあき}|RyoNaruse{NARUSERYO成瀬龍なるせりょう}|KunioYamada{YAMADAKUNIO山田邦雄やまだくにお}____Workshop 18Surgery for Rheumatic Disease3____Five-Year Implant Survival of INTEGRA and AVANTA Silicone MCP Joint Arthroplasty in Rheumatoid Arthritis|Long-term outcomes of metacarpophalangeal joint arthroplasty for rheumatoid fingers of the index to little fingers|Long-Term Follow-Up of Patients Treated with Silicone Implants for Finger Deformities in Rheumatoid Arthritis|Risk factor for the decrease of carpal height after Sauve-Kapandji procedure in patients with rheumatoid arthritis|Mid-term clinical outcomes of the PROSNAP total elbow arthroplasty for rheumatoid arthritis|Multiple Ipsilateral Upper Limb Fractures in a Patient with Rheumatoid Arthritis: A Case Report

W18

Workshop 18
Surgery for Rheumatic Disease3

Chair：Asami Abe, Chair：Ryo Oda

RyotaTakatori{TAKATORIRYOTA髙取良太たかとりりょうた}|KensukeYoshino{YOSHINOKENSUKE吉野謙輔よしのけんすけ}|YutaHieda{HIEDAYUTA稗田裕太ひえだゆうた}|DaisukeNishiyama{NISHIYAMADAISUKE西山大介にしやまだいすけ}|YoshikiOkamoto{OKAMOTOYOSHIKI岡本吉輝おかもとよしき}|AyumiShimazu{SHIMAZUAYUMI嶋津歩しまづあゆみ}|KokiTakao{TAKAOKOKI髙尾航希たかおこうき}____YukiEtani{ETANIYUKI惠谷悠紀えたにゆうき}____AtsuhikoSunaga{SUNAGAATSUHIKO須永敦彦すながあつひこ}|TakuyaInoue{INOUETAKUYA井上拓也いのうえたくや}|YoshitadaHarada{HARADAYOSHITADA原田義忠はらだよしただ}|HyonminChoe{CHOEHYONMIN崔賢民ちぇひょんみん}|AkiraMorita{MORITAAKIRA森田彰もりたあきら}|HironoriYamane{YAMANEHIRONORI山根裕則やまねひろのり}|TomotakaAkamatsu{AKAMATSUTOMOTAKA赤松智隆あかまつともたか}|ShuntaroNejima{NEJIMASHUNTARO子島俊太郎ねじましゅんたろう}|TakahiroFuzimori{FUZIMORITAKAHIRO藤森翔大ふじもりたかひろ}|KenKumagai{KUMAGAIKEN熊谷研くまがいけん}|KengoHarigane{HARIGANEKENGO針金健吾はりがねけんご}|YuichiMochida{MOCHIDAYUICHI持田勇一もちだゆういち}|YutakaInaba{INABAYUTAKA稲葉裕いなばゆたか}|ShigeruIwata{IWATASHIGERU岩田慈いわたしげる}|TakaoFujii{FUJIITAKAO藤井隆夫ふじいたかお}|KentaroInui{INUIKENTARO乾健太郎いぬいけんたろう}|TakuyaTachibana{TACHIBANATAKUYA橘拓也たちばなたくや}|TaisukeNozu{NOZUTAISUKE野津太佑のずたいすけ}|MasatoshiSato{SATOMASATOSHI佐藤雅俊さとうまさとし}|AkiraYamauchi{YAMAUCHIAKIRA山内彬やまうちあきら}|HidetomiTerai{TERAIHIDETOMI寺井秀富てらいひでとみ}|YukiEtani{ETANIYUKI惠谷悠紀えたにゆうき}|TakaakiNoguchi{NOGUCHITAKAAKI野口貴明のぐちたかあき}|KosukeEbina{EBINAKOSUKE蛯名耕介えびなこうすけ}|GensukeOkamura{OKAMURAGENSUKE岡村元佑おかむらげんすけ}|AtsushiGoshima{GOSHIMAATSUSHI五島篤史ごしまあつし}|TaiheiMiura{MIURATAIHEI三浦泰平みうらたいへい}|TakuyaKurihara{KURIHARATAKUYA栗原拓也くりはらたくや}|YujiFukuda{FUKUDAYUJI福田悠二ふくだゆうじ}|AtsushiSugimoto{SUGIMOTOATSUSHI杉本篤史すぎもとあつし}|YuseiHiguchi{HIGUCHIYUSEI樋口佑成ひぐちゆうせい}|SeijiOkada{OKADASEIJI岡田誠司おかだせいじ}|HyunhoLee{LEEHYUNHO李賢鎬りひゅんほ}|MasahikoYanagisawa{YANAGISAWAMASAHIKO柳澤正彦やなぎさわまさひこ}|YosukeSano{SANOYOSUKE佐野陽亮さのようすけ}|YutakaSano{SANOYUTAKA佐野有隆さのゆたか}____Workshop 19Evaluation after rheumatoid arthritis surgery and dependence/complications____A case of immune-mediated necrotizing myopathy presenting with dropped head syndrome after spinal surgery|Short flat-tapered cementless stem total hip arthroplasty in elderly patients provides comparable mid- to long-term clinical and radiological outcomes comparable with those in younger patients|Mid- to Long-Term Clinical Outcomes of Total Hip Arthroplasty in Patients with Rheumatoid Arthritis|Mid-term Outcomes of Total Hip Arthroplasty in Hip Osteoarthritis Patients with Rheumatoid Arthritis: Comparison with Osteoarthritis without Rheumatoid Arthritis|Knee Flexion and Extension Strength Increases After Total Knee Arthroplasty and Correlates With Lower Limb Muscle Mass Measured by DXA|Predictive factors for postoperative SAFE-Q outcomes after forefoot surgery in patients with rheumatoid arthritis|Evaluation of Osteotomy Angle and Level in Distal Shortening Oblique Osteotomy of the Metatarsal

W19

Workshop 19
Evaluation after rheumatoid arthritis surgery and dependence/complications

Chair：Yuki Etani

KazuyoshiIshigaki{ISHIGAKIKAZUYOSHI石垣和慶いしがきかずよし}|HiroyukiYoshitomi{YOSHITOMIHIROYUKI吉富啓之よしとみひろゆき}|TakeshiBamba{BAMBATAKESHI馬場健史ばんばたけし}|MasakiMatsumoto{MATSUMOTOMASAKI松本雅記まつもとまさき}|HiroshiTsugawa{TSUGAWAHIROSHI津川裕司つがわひろし}____MasaruIshii{ISHIIMASARU石井優いしいまさる}|MotomuHashimoto{HASHIMOTOMOTOMU橋本求はしもともとむ}________Symposium 3____Decoding autoimmune pathology through functional genetics investigation|Elucidation of Autoimmune Disease Pathogenesis Through Multimodal Analysis|Development of advanced analytical methodologies for next-generation metabolomics|A Multi-dimensional Strategy to Unravel the Complexity and Organization of the Proteome|Using multimodal mass spectrometry data to understand metabolisms of living organisms

S3

Symposium 3

Chair：Masaru Ishii, Chair：Motomu Hashimoto

Speaker：Kazuyoshi Ishigaki

Speaker：Hiroyuki Yoshitomi

Speaker：Takeshi Bamba

Speaker：Masaki Matsumoto

Speaker：Hiroshi Tsugawa

YukikoTakakuwa{TAKAKUWAYUKIKO高桑由希子たかくわゆきこ}____MasatoOkada{OKADAMASATO岡田正人おかだまさと}________Luncheon Seminar 5Optimization of MTX in Phase1 Treatment and Clinical Significance of Subcutaneous MTX____Optimization of MTX in Phase1 Treatment and Clinical Significance of Subcutaneous MTX

LS5

Luncheon Seminar 5
Optimization of MTX in Phase1 Treatment and Clinical Significance of Subcutaneous MTX

【Sponsored by Eisai Co., Ltd. / medac Japan Co., Ltd.】

Chair：Masato Okada

Speaker：Yukiko Takakuwa

SatoshiIto{ITOSATOSHI伊藤聡いとうさとし}|TatsuyaAtsumi{ATSUMITATSUYA渥美達也あつみたつや}|YuyaTakakubo{TAKAKUBOYUYA髙窪祐弥たかくぼゆうや}|YukoIshizaki{ISHIZAKIYUKO石﨑優子いしざきゆうこ}|KoichiMurata{MURATAKOICHI村田浩一むらたこういち}____TakakoMiyamae{MIYAMAETAKAKO宮前多佳子みやまえたかこ}|TatsuyaAtsumi{ATSUMITATSUYA渥美達也あつみたつや}________Special Symposium 1____ドイツ（ジェンダーギャップランキング９位）|スペイン（ジェンダーギャップランキング12位）|フィンランド（ジェンダーギャップランキング2位）|日本小児科学会の男女共同参画の歩み|日本のある整形外科医局の現状

SS1

Special Symposium 1

Chair：Takako Miyamae, Chair：Tatsuya Atsumi

Speaker：Satoshi Ito

Speaker：Tatsuya Atsumi

Speaker：Yuya Takakubo

Speaker：Yuko Ishizaki

Speaker：Koichi Murata

HiromichiTamaki{TAMAKIHIROMICHI田巻弘道たまきひろみち}|YoshinoriMatsumoto{MATSUMOTOYOSHINORI松本佳則まつもとよしのり}____NaotoTamura{TAMURANAOTO田村直人たむらなおと}________Evening Seminar 4Latest Topics in Giant Cell Arteritis____New Frontiers in GCA Pathophysiology and Diagnosis|Giant Cell Arteritis: Novel JAK-Targeted Therapies and Strategies for Improving Prognosis

ES4

Evening Seminar 4
Latest Topics in Giant Cell Arteritis

【Sponsored by AbbVie GK】

Chair：Naoto Tamura

Speaker：Hiromichi Tamaki

Speaker：Yoshinori Matsumoto

YujiNozaki{NOZAKIYUJI野﨑祐史のざきゆうじ}|KatsuakiOnishi{ONISHIKATSUAKI大西勝亮おおにしかつあき}|KosukeEbina{EBINAKOSUKE蛯名耕介えびなこうすけ}|SuguruHonda{HONDASUGURU本田卓ほんだすぐる}|YumiMorimoto{MORIMOTOYUMI森本祐美もりもとゆみ}____KatsunoriIkari{IKARIKATSUNORI猪狩勝則いかりかつのり}____ToshihikoShiga{SHIGATOSHIHIKO志賀俊彦しがとしひこ}|JinhaiRi{RIJINHAI李進海りしんかい}|TetsuItami{ITAMITETSU伊丹哲いたみてつ}|DaisukeTomita{TOMITADAISUKE冨田大介とみただいすけ}|HirotakaYamazawa{YAMAZAWAHIROTAKA山澤広嵩やまざわひろたか}|YumiMorimoto{MORIMOTOYUMI森本祐美もりもとゆみ}|RikaFukuda{FUKUDARIKA福田里香ふくだりか}|TakashiTsutimoto{TSUTIMOTOTAKASHI土本和司つちもとたかし}|SayoMorita{MORITASAYO森田紗代もりたさよ}|HirokiAkazawa{AKAZAWAHIROKI赤澤宗輝あかざわひろき}|KoichiMurata{MURATAKOICHI村田浩一むらたこういち}|AkiraOnishi{ONISHIAKIRA大西輝おおにしあきら}|KosukeEbina{EBINAKOSUKE蛯名耕介えびなこうすけ}|YukiEtani{ETANIYUKI惠谷悠紀えたにゆうき}|IkuShirasugi{SHIRASUGIIKU白杉郁しらすぎいく}|HirotakaYamada{YAMADAHIROTAKA山田啓貴やまだひろたか}|MotomuHashimoto{HASHIMOTOMOTOMU橋本求はしもともとむ}|RyuWatanabe{WATANABERYU渡部龍わたなべりゅう}|TanakaAkihiro{AKIHIROTANAKA田中晶大たなかあきひろ}|YumikoWada{WADAYUMIKO和田裕美子わだゆみこ}|TohruTakeuchi{TAKEUCHITOHRU武内徹たけうちとおる}|AmuroHideki{HIDEKIAMURO安室秀樹あむろひでき}|KatayamaMasaki{MASAKIKATAYAMA片山昌紀かたやままさき}|WataruYamamoto{YAMAMOTOWATARU山本渉やまもとわたる}|KojiKinoshita{KINOSHITAKOJI木下浩二きのしたこうじ}|TadashiOkano{OKANOTADASHI岡野匡志おかのただし}|ShuichiroNakabo{NAKABOSHUICHIRO中坊周一郎なかぼうしゅういちろう}|YoUeda{UEDAYO上田洋うえだよう}|KoheiTsujimoto{TSUJIMOTOKOHEI辻本考平つじもとこうへい}|YujiNozaki{NOZAKIYUJI野﨑祐史のざきゆうじ}|YuriHiramatsu{HIRAMATSUYURI平松ゆりひらまつゆり}|MahiroYamamoto{YAMAMOTOMAHIRO山本真大やまもとまひろ}|AkihiroTanaka{TANAKAAKIHIRO田中晶大たなかあきひろ}|KenjiMamoto{MAMOTOKENJI真本建司まもとけんじ}|YutaroYamada{YAMADAYUTARO山田祐太郎やまだゆうたろう}|TakahitoKojima{KOJIMATAKAHITO小島孝仁こじまたかひと}|MasaoKatsushima{KATSUSHIMAMASAO勝島將夫かつしままさお}|YuyaFujita{FUJITAYUYA藤田雄也ふじたゆうや}|HidetomiTerai{TERAIHIDETOMI寺井秀富てらいひでとみ}|TakaakiNoguchi{NOGUCHITAKAAKI野口貴明のぐちたかあき}|YasutakaOkita{OKITAYASUTAKA沖田康孝おきたやすたか}|YuichiMaeda{MAEDAYUICHI前田悠一まえだゆういち}|AyakaYoshiakwa{YOSHIAKWAAYAKA吉川紋佳よしかわあやか}|MasanoriTsubosaka{TSUBOSAKAMASANORI壺坂正徳つぼさかまさのり}|HidekiAmuro{AMUROHIDEKI安室秀樹あむろひでき}|MasakiKatayama{KATAYAMAMASAKI片山昌紀かたやままさき}|AtsushiKumanogoh{KUMANOGOHATSUSHI熊ノ郷淳くまのごうあつし}|SeijiOkada{OKADASEIJI岡田誠司おかだせいじ}|KatsunoriIkari{IKARIKATSUNORI猪狩勝則いかりかつのり}|MayukoFujisaki{FUJISAKIMAYUKO藤﨑真由子ふじさきまゆこ}|EiichiTanaka{TANAKAEIICHI田中榮一たなかえいいち}|MasayoshiHarigai{HARIGAIMASAYOSHI針谷正祥はりがいまさよし}|TakayukiFujii{FUJIITAKAYUKI藤井貴之ふじいたかゆき}|HideyukiShiba{SHIBAHIDEYUKI斯波秀行しばひでゆき}|YonsuSon{SONYONSU孫瑛洙そんよんす}|HidehikoMakino{MAKINOHIDEHIKO槇野秀彦まきのひでひこ}|YuichiMorimoto{MORIMOTOYUICHI森本優一もりもとゆういち}|KaoriIshimura{ISHIMURAKAORI石村香織いしむらかおり}|ChisatoAshida{ASHIDACHISATO芦田千聖あしだちさと}|ShinkaiRi{RISHINKAI李進海りしんかい}|JunSaegusa{SAEGUSAJUN三枝淳さえぐさじゅん}|AyakaYoshikawa{YOSHIKAWAAYAKA吉川紋佳よしかわあやか}____Workshop 9Outcome measures and prediction for RA treatment 1____Dose-Dependent Clinical Efficacy of Janus Kinase Inhibitors in Rheumatoid Arthritis Patients With Poor Prognostic Factors: An ANSWER Cohort Analysis|Treatment Response to Drug Switching in Inflammatory and Non-inflammatory Difficult-to-treat Rheumatoid Arthritis : The ANSWER Cohort|Impact of Serum MMP-3 Levels on the Therapeutic Response to Biologic and Targeted Synthetic DMARDs in Patients with Rheumatoid Arthritis: Analysis from the ANSWER Cohort|Medical pre-training and fine-tuning improve large language model prediction of rheumatoid arthritis disease activity|Optimizing Treatment Strategies for Elderly-Onset Rheumatoid Arthritis Using an AI-Based Model - Insights from the Multicenter ANSWER Cohort -|Quantitative Evaluation of Early Treatment Response in Rheumatoid Arthritis Using Machine Learning: Analysis of delta CDAI from the ANSWER Cohort

W9

Workshop 9
Outcome measures and prediction for RA treatment 1

Chair：Katsunori Ikari

MochihitoSuzuki{SUZUKIMOCHIHITO鈴木望人すずきもちひと}|YoshifumiOhashi{OHASHIYOSHIFUMI大橋禎史おおはしよしふみ}|MasahiroTada{TADAMASAHIRO多田昌弘ただまさひろ}|MasahiroHorita{HORITAMASAHIRO堀田昌宏ほりたまさひろ}|TakuyaKurihara{KURIHARATAKUYA栗原拓也くりはらたくや}|RyotaHara{HARARYOTA原良太はらりょうた}____TakayukiFujii{FUJIITAKAYUKI藤井貴之ふじいたかゆき}|KoichiroTakahi{TAKAHIKOICHIRO髙樋康一郎たかひこういちろう}____YoshifumiOhashi{OHASHIYOSHIFUMI大橋禎史おおはしよしふみ}|YasumoriSobue{SOBUEYASUMORI祖父江康司そぶえやすもり}|KenyaTerabe{TERABEKENYA寺部健哉てらべけんや}|ShujiAsai{ASAISHUJI浅井秀司あさいしゅうじ}|ShiroImagama{IMAGAMASHIRO今釜史郎いまがましろう}|MochihitoSuzuki{SUZUKIMOCHIHITO鈴木望人すずきもちひと}|NobunoriTakahashi{TAKAHASHINOBUNORI高橋伸典たかはしのぶのり}|YoshinariMatsumoto{MATSUMOTOYOSHINARI松本佳也まつもとよしなり}|TatsuyaKoike{KOIKETATSUYA小池達也こいけたつや}|KenjiMamoto{MAMOTOKENJI真本建司まもとけんじ}|TomoyukiNakamura{NAKAMURATOMOYUKI中村友之なかむらともゆき}|SyoheiAnno{ANNOSYOHEI安野翔平あんのしょうへい}|TakahiroIida{IIDATAKAHIRO飯田高広いいだたかひろ}|HitoshiGoto{GOTOHITOSHI後藤仁志ごとうひとし}|MasanoriMatsuura{MATSUURAMASANORI松浦正典まつうらまさのり}|KotaroImatani{IMATANIKOTARO今谷紘太郎いまたにこうたろう}|NoriakiOtsuka{OTSUKANORIAKI大塚憲昭おおつかのりあき}|ChinatsuIchikawa{ICHIKAWACHINATSU市川千夏いちかわちなつ}|RyuichiNakahara{NAKAHARARYUICHI中原龍一なかはらりゅういち}|ToshifumiOzaki{OZAKITOSHIFUMI尾﨑敏文おざきとしふみ}|KeiichiroNishida{NISHIDAKEIICHIRO西田圭一郎にしだけいいちろう}|TakurouNii{NIITAKUROU新居卓朗にいたくろう}|YukiHara{HARAYUKI原侑紀はらゆうき}|KoichiroTakahi{TAKAHIKOICHIRO髙樋康一郎たかひこういちろう}|HirotoNishimura{NISHIMURAHIROTO西村碩人にしむらひろと}|TomohiroNakamura{NAKAMURATOMOHIRO中村友洋なかむらともひろ}|HiroyukiTaguchi{TAGUCHIHIROYUKI田口浩之たぐちひろゆき}|NobushiroNishimura{NISHIMURANOBUSHIRO西村信城にしむらのぶしろ}|HiromasaKawashima{KAWASHIMAHIROMASA川島浩正かわしまひろまさ}|RyoYoneima{YONEIMARYO米今諒よねいまりょう}|HidetoshiMatsuoka{MATSUOKAHIDETOSHI松岡秀俊まつおかひでとし}|ShiroOno{ONOSHIRO大野史郎おおのしろう}|MasakiMatsubara{MATSUBARAMASAKI松原正樹まつばらまさき}|NoritakaYada{YADANORITAKA矢田憲孝やだのりたか}|Ken-ichiSamejima{SAMEJIMAKEN-ICHI鮫島謙一さめじまけんいち}|YasuhiroAkai{AKAIYASUHIRO赤井靖宏あかいやすひろ}|TakayoshiMorita{MORITATAKAYOSHI森田貴義もりたたかよし}|KiyomiYoshimoto{YOSHIMOTOKIYOMI吉本清巳よしもときよみ}____Workshop 10Outcome measures and prediction for RA treatment 2____Prevalence of oral frailty and association with nutritional status in patients with rheumatoid arthritis: The T-FLAG Study|Pre-frailty-centered five-year tendencies toward robust or frail states in rheumatoid arthritis|Direct Effects of b/tsDMARD on Muscle Mass and Quality Improvement in Patients with Rheumatoid Arthritis- A Study Using Parallel Mediation Analysis-|Development of the Japanese version of Rheumatoid Arthritis Foot Disease Activity Index-5|Baseline Foot Assessment at the Onset of Rheumatoid Arthritis Is Important for Predicting Long-term Outcomes: A 5-year Longitudinal Analysis|Factors Associated with Changes in Forefoot Joint Damage in Patients with Rheumatoid Arthritis

W10

Workshop 10
Outcome measures and prediction for RA treatment 2

Chair：Takayuki Fujii, Chair：Koichiro Takahi

KosukeEbina{EBINAKOSUKE蛯名耕介えびなこうすけ}____TakeshiMiyamoto{MIYAMOTOTAKESHI宮本健史みやもとたけし}________Luncheon Seminar 6Rebooting Bone Metabolism: The Emerging Role of Sclerostin Inhibition and Evolving Guidelines in RA-Associated Osteoporosis____Rebooting Bone Metabolism: The Emerging Role of Sclerostin Inhibition and Evolving Guidelines in RA-Associated Osteoporosis

LS6

Luncheon Seminar 6
Rebooting Bone Metabolism: The Emerging Role of Sclerostin Inhibition and Evolving Guidelines in RA-Associated Osteoporosis

【Sponsored by AMGEN K.K. / Astellas Pharma Inc.】

Chair：Takeshi Miyamoto

Speaker：Kosuke Ebina

KoichiSugihara{SUGIHARAKOICHI杉原幸一すぎはらこういち}|YutaNakayama{NAKAYAMAYUTA中山裕太なかやまゆうた}|YukiIizuka{IIZUKAYUKI飯塚友紀いいづかゆき}|ShunseiHirohata{HIROHATASHUNSEI廣畑俊成ひろはたしゅんせい}|ShinichiroNishimi{NISHIMISHINICHIRO西見慎一郎にしみしんいちろう}|YukiTerashima{TERASHIMAYUKI寺島侑希てらしまゆき}____NobuyukiOno{ONONOBUYUKI小野伸之おののぶゆき}____RisaWakiya{WAKIYARISA脇谷理沙わきやりさ}|YusukeUshio{USHIOYUSUKE牛尾友亮うしおゆうすけ}|KanakoChujo{CHUJOKANAKO中條加奈子ちゅうじょうかなこ}|RyokoKagawa{KAGAWARYOKO香川涼子かがわりょうこ}|NaotoManabe{MANABENAOTO眞鍋直人まなべなおと}|MayukoWada{WADAMAYUKO和田真優子わだまゆこ}|ShusakuNakashima{NAKASHIMASHUSAKU中島崇作なかしましゅうさく}|TaichiMiyagi{MIYAGITAICHI宮城太一みやぎたいち}|HiromiShimada{SHIMADAHIROMI島田裕美しまだひろみ}|HiroakiDobashi{DOBASHIHIROAKI土橋浩章どばしひろあき}|YukiIizuka{IIZUKAYUKI飯塚友紀いいづかゆき}|AyakaMaeda{MAEDAAYAKA前田彩花まえだあやか}|KaoruMinegishi{MINEGISHIKAORU峯岸薫みねぎしかおる}|KentoIchikawa{ICHIKAWAKENTO市川健斗いちかわけんと}|RisaHirahara{HIRAHARARISA平原理紗ひらはらりさ}|YutaroSoejima{SOEJIMAYUTARO副島裕太郎そえじまゆうたろう}|RyusukeYoshimi{YOSHIMIRYUSUKE吉見竜介よしみりゅうすけ}|YoheiKirino{KIRINOYOHEI桐野洋平きりのようへい}|HideakiNakajima{NAKAJIMAHIDEAKI中島秀明なかじまひであき}|LisaHirahara{HIRAHARALISA平原理紗ひらはらりさ}|SoejimaYutaro{YUTAROSOEJIMA副島裕太郎そえじまゆうたろう}|HirotoshiKikuchi{KIKUCHIHIROTOSHI菊地弘敏きくちひろとし}|MitsuhiroTakeno{TAKENOMITSUHIRO岳野光洋たけのみつひろ}|MasatakaKuwana{KUWANAMASATAKA桑名正隆くわなまさたか}|KawakamiAtsushi{ATSUSHIKAWAKAMI川上純かわかみあつし}|KunihiroYamaoka{YAMAOKAKUNIHIRO山岡邦宏やまおかくにひろ}|ToshihiroTono{TONOTOSHIHIRO東野俊洋とうのとしひろ}|YoshiyaTanaka{TANAKAYOSHIYA田中良哉たなかよしや}|IppeiMiyagawa{MIYAGAWAIPPEI宮川一平みやがわいっぺい}|HirokoNagafuchi{NAGAFUCHIHIROKO永渕裕子ながふちひろこ}|TakaharuIkeda{IKEDATAKAHARU池田高治いけだこうじ}|TatsuyaAtsumi{ATSUMITATSUYA渥美達也あつみたつや}|YuichiroFujieda{FUJIEDAYUICHIRO藤枝雄一郎ふじえだゆういちろう}|DaisukeKobayashi{KOBAYASHIDAISUKE小林大介こばやしだいすけ}|TakuyaYamamoto{YAMAMOTOTAKUYA山本託矢やまもとたくや}|TetsujiSawada{SAWADATETSUJI沢田哲治さわだてつじ}|AiriNishimi{NISHIMIAIRI西見愛里にしみあいり}|RyoYanai{YANAIRYO柳井亮やないりょう}|NobuyukiYajima{YAJIMANOBUYUKI矢嶋宣幸やじまのぶゆき}|MarisaKawabata{KAWABATAMARISA川端真里佐かわばたまりさ}|IppeiMiyakawa{MIYAKAWAIPPEI宮川一平みやかわいっぺい}|TakahiroIkeda{IKEDATAKAHIRO池田高治いけだたかひろ}|YujiMiyoshi{MIYOSHIYUJI三好雄二みよしゆうじ}|JunjiMorisawa{MORISAWAJUNJI森澤淳司もりさわじゅんじ}|MasashiInoue{INOUEMASASHI井上将いのうえまさし}|HirokazuTatsumi{TATSUMIHIROKAZU辰巳裕和たつみひろかず}|SairiTakahashi{TAKAHASHISAIRI髙橋彩理たかはしさいり}|KazuhikoHirokawa{HIROKAWAKAZUHIKO廣川和彦ひろかわかずひこ}|KotaroKomori{KOMORIKOTARO小森宏太郎こもりこうたろう}|KeiichiUchiyama{UCHIYAMAKEIICHI内山桂一うちやまけいいち}|TomohiroKato{KATOTOMOHIRO加藤智大かとうともひろ}|IsseiTakahashi{TAKAHASHIISSEI高橋一世たかはしいっせい}|MasahiroIida{IIDAMASAHIRO飯田雅博いいだまさひろ}|HirofumiSaitou{SAITOUHIROFUMI齋藤浩史さいとうひろふみ}|YoshitakaUeda{UEDAYOSHITAKA上田佳孝うえだよしたか}|EisukeTakamasu{TAKAMASUEISUKE髙增英輔たかますえいすけ}|KaeOnishi{ONISHIKAE大西香絵おおにしかえ}|YoshikiNagai{NAGAIYOSHIKI永井佳樹ながいよしき}|NaotoYokogawa{YOKOGAWANAOTO横川直人よこがわなおと}|KotaShimada{SHIMADAKOTA島田浩太しまだこうた}____Workshop 20Exploring Behcet disease____Relationship between Fecal Calprotectin and Intestinal Lesions in Patients with Behçet's Disease|Efficacy of IL-6 Inhibitors in Neuro-Behçet's Disease: Systematic Review and Analysis of Clinical Characteristics Using a Single-Center Registry|Development of a Treat-to-Target Strategy for Behçet's Disease Integrating the Clinical Activity Index BDCAF with Multi-Omics Profiling|Development of severity classification criteria for chronic progressive neuro-Behcet's disease|Development of a Quality Indicators (QIs) for Behçet's Disease: Behçet's Disease Research Committee, the MHLW, JapanDiseases|A Case of Behcet's Arthritis Evaluated for Lesion Distribution and Longitudinal Changes by Musculoskeletal Ultrasound

W20

Workshop 20
Exploring Behcet disease

Chair：Nobuyuki Ono

MasayaTaki{TAKIMASAYA瀧昌也たきまさや}|WataruIriyama{IRIYAMAWATARU入山渉いりやまわたる}|YasushiMiura{MIURAYASUSHI三浦靖史みうらやすし}|ShinjiSato{SATOSHINJI佐藤信治さとうしんじ}|MasakazuShimizu{SHIMIZUMASAKAZU清水正一しみずまさかず}|TakumaWada{WADATAKUMA和田琢わだたくま}____GensukeOkamura{OKAMURAGENSUKE岡村元佑おかむらげんすけ}|MasahiroTada{TADAMASAHIRO多田昌弘ただまさひろ}____MasanariKodera{KODERAMASANARI小寺雅也こでらまさなり}|MarieMabuchi{MABUCHIMARIE馬渕まりえまぶちまりえ}|YoshikoNagata{NAGATAYOSHIKO永田善子ながたよしこ}|KumikoKato{KATOKUMIKO加藤久美子かとうくみこ}|YukaNakazawa{NAKAZAWAYUKA中澤佑香なかざわゆか}|AkiraInoue{INOUEAKIRA井上彰いのうえあきら}|KeioAyabe{AYABEKEIO綾部敬生あやべけいお}|IkukoYamazaki{YAMAZAKIIKUKO山崎郁子やまざきいくこ}|KenyaOga{OGAKENYA雄鹿賢哉おがけんや}|RyosukeKuroda{KURODARYOSUKE黒田良祐くろだりょうすけ}|NoriyoshiShimahara{SHIMAHARANORIYOSHI島原範芳しまはらのりよし}|NaoyaSawada{SAWADANAOYA澤田直哉さわだなおや}|YasuakiOkuda{OKUDAYASUAKI奥田恭章おくだやすあき}|MakotoOonishi{OONISHIMAKOTO大西誠おおにしまこと}|TakumaWada{WADATAKUMA和田琢わだたくま}|HarukiKobayashi{KOBAYASHIHARUKI小林春樹こばやしはるき}|YujiMoriyama{MORIYAMAYUJI森山悠司もりやまゆうじ}|HirokiSaito{SAITOHIROKI齋藤浩紀さいとうひろき}|TomonariHoriuchi{HORIUCHITOMONARI堀内智成ほりうちともなり}|YasuhisaUeda{UEDAYASUHISA上田泰久うえだやすひさ}|KatsunoriIkari{IKARIKATSUNORI猪狩勝則いかりかつのり}|TakanoriAzuma{AZUMATAKANORI東孝典あずまたかのり}|MasakazuShimizu{SHIMIZUMASAKAZU清水正一しみずまさかず}|TakakiUra{URATAKAKI浦高希うらたかき}|YumikoArai{ARAIYUMIKO新井由美子あらいゆみこ}____Workshop 21Assessment of physical ability and social activity____Effects of differences in exercise on skeletal muscle in patients with rheumatoid arthritis|Characteristics of elderly patients with rheumatoid arthritis according to exercise load|Hybrid music therapy for patients with rheumatoid arthritis: differences between face-to-face and online participation|Report on the Effects of Cosmetics on Social Participation in Patients with Rheumatoid Arthritis|Relationship between the presence of calluses and foot function in patients with rheumatoid arthritis|Foot Disorders in Patients with Rheumatoid Arthritis Who Achieved Clinical Remission

W21

Workshop 21
Assessment of physical ability and social activity

Chair：Gensuke Okamura, Chair：Masahiro Tada

Shin-yaKawashiri{KAWASHIRISHIN-YA川尻真也かわしりしんや}____NatsukoNakagawa{NAKAGAWANATSUKO中川夏子なかがわなつこ}________Educational Lecture 3Utilizing Musculoskeletal Ultrasound for the Management of Rheumatic Diseases____Utilizing Musculoskeletal Ultrasound for the Management of Rheumatic Diseases

EL3

Educational Lecture 3
Utilizing Musculoskeletal Ultrasound for the Management of Rheumatic Diseases

Chair：Natsuko Nakagawa

Speaker：Shin-ya Kawashiri

KimitoKawahata{KAWAHATAKIMITO川畑仁人かわはたきみと}|MasakiShimizu{SHIMIZUMASAKI清水正樹しみずまさき}____NamiOkamoto{OKAMOTONAMI岡本奈美おかもとなみ}________Educational Lecture 4Research and Future Directions in Still's Disease: Translating the EULAR/PReS Research Agenda into Clinical Practice in Japan / Update on the diagnosis and treatment of Still's disease____Research and Future Directions in Still's Disease: Translating the EULAR/PReS Research Agenda into Clinical Practice in Japan|Update on the diagnosis and treatment of Still's disease

EL4

Educational Lecture 4
Research and Future Directions in Still's Disease: Translating the EULAR/PReS Research Agenda into Clinical Practice in Japan / Update on the diagnosis and treatment of Still's disease

Chair：Nami Okamoto

Speaker：Kimito Kawahata

Speaker：Masaki Shimizu

NaokoOkiyama{OKIYAMANAOKO沖山奈緒子おきやまなおこ}____YasushiKawaguchi{KAWAGUCHIYASUSHI川口鎮司かわぐちやすし}________Luncheon Seminar 7Treatment strategies for systemic sclerosis: Focusing on skin sclerosis____Treatment strategies for systemic sclerosis: Focusing on skin sclerosis

LS7

Luncheon Seminar 7
Treatment strategies for systemic sclerosis: Focusing on skin sclerosis

【Sponsored by ZENYAKU KOGYO CO.,LTD.】

Chair：Yasushi Kawaguchi

Speaker：Naoko Okiyama

MasaruKato{KATOMASARU加藤将かとうまさる}____MotomuHashimoto{HASHIMOTOMOTOMU橋本求はしもともとむ}________Educational Lecture 7Insights into autoimmune diseases from ancient genomics____Insights into autoimmune diseases from ancient genomics

EL7

Educational Lecture 7
Insights into autoimmune diseases from ancient genomics

Chair：Motomu Hashimoto

Speaker：Masaru Kato

KosakuMurakami{MURAKAMIKOSAKU村上孝作むらかみこうさく}____HidetoKameda{KAMEDAHIDETO亀田秀人かめだひでと}________Educational Lecture 8Onco-Rheumatology Basics: A Focus on immune-Related Adverse Events (irAE)____Onco-Rheumatology Basics: A Focus on immune-Related Adverse Events (irAE)

EL8

Educational Lecture 8
Onco-Rheumatology Basics: A Focus on immune-Related Adverse Events (irAE)

Chair：Hideto Kameda

Speaker：Kosaku Murakami

IainB.Mcinnes{MCINNESIAINB.}|MichihitoKono{KONOMICHIHITO河野通仁こうのみちひと}|Anna-MariaHoffmann-Vold{HOFFMANN-VOLDANNA-MARIA}|TahseenMozaffar{MOZAFFARTAHSEEN}|HiroakiNiiro{NIIROHIROAKI新納宏昭にいろひろあき}____YukoKaneko{KANEKOYUKO金子祐子かねこゆうこ}|TahseenMozaffar{MOZAFFARTAHSEEN}________Symposium 4State-of-the-art; the latest clinical perspectives in systemic autoimmune diseases____Rheumatoid arthritis: advances in therapeutic discovery and clinical strategic approaches|State-of-the-art of the systemic lupus erythematosus|Interstitial lung disease related with connective tissue diseases|Idiopathic inflammatory myopathies|Systemic vasculitis

S4

Symposium 4
State-of-the-art; the latest clinical perspectives in systemic autoimmune diseases

Chair：Yuko Kaneko, Chair：Tahseen Mozaffar

Speaker：Iain B. Mcinnes

Speaker：Michihito Kono

Speaker：Anna-Maria Hoffmann-Vold

Speaker：Tahseen Mozaffar

Speaker：Hiroaki Niiro

Anna-MariaHoffmann-Vold{HOFFMANN-VOLDANNA-MARIA}____HidekataYasuoka{YASUOKAHIDEKATA安岡秀剛やすおかひでかた}________Luncheon Seminar 8Interstitial Lung Disease in connective tissue disease: from diagnosis to management What is new (WIN)____Interstitial Lung Disease in connective tissue disease: from diagnosis to management What is new (WIN)

LS8

Luncheon Seminar 8
Interstitial Lung Disease in connective tissue disease: from diagnosis to management What is new (WIN)

【Sponsored by Nippon Boehringer Ingelheim Co., Ltd. Medicine Division】

Chair：Hidekata Yasuoka

Speaker：Anna-Maria Hoffmann-Vold

FrancescoCiccia{CICCIAFRANCESCO}|KeishiFujio{FUJIOKEISHI藤尾圭志ふじおけいし}|HiroyukiYoshitomi{YOSHITOMIHIROYUKI吉富啓之よしとみひろゆき}|FeliceRivellese{RIVELLESEFELICE}|RicardoGrieshaber-Bouyer{GRIESHABER-BOUYERRICARDO}____SachikoMiyake{MIYAKESACHIKO三宅幸子みやけさちこ}|KeishiFujio{FUJIOKEISHI藤尾圭志ふじおけいし}________Symposium 7Recent advances in translational and basic research of autoimmune diseases____Resident memory T cells in Sjogren's disease|Identification of immunological pathways associated with the clinical phenotypes of rheumatic diseases|Peripheral helper T cells go beyond B-cell help in rheumatoid arthritis|Synovial biopsies in the personalised treatment of arthritis|Precision cell depletion as the next therapeutic frontier in autoimmune diseases

S7

Symposium 7
Recent advances in translational and basic research of autoimmune diseases

Chair：Sachiko Miyake, Chair：Keishi Fujio

Speaker：Francesco Ciccia

Speaker：Keishi Fujio

Speaker：Hiroyuki Yoshitomi

Speaker：Felice Rivellese

Speaker：Ricardo Grieshaber-Bouyer

IainB.Mcinnes{MCINNESIAINB.}|MasatakaKuwana{KUWANAMASATAKA桑名正隆くわなまさたか}____TsutomuTakeuchi{TAKEUCHITSUTOMU竹内勤たけうちつとむ}|KunihiroYamaoka{YAMAOKAKUNIHIRO山岡邦宏やまおかくにひろ}________Evening Seminar 5The Importance of Interleukin-6 for autoimmune diseases____The importance of IL-6 for autoimmune diseases|Initial Treatment Strategies for Rheumatoid Arthritis: Different approach depending on age

ES5

Evening Seminar 5
The Importance of Interleukin-6 for autoimmune diseases

【Sponsored by CHUGAI PHARMACEUTICAL CO., LTD.】

Chair：Tsutomu Takeuchi, Chair：Kunihiro Yamaoka

Speaker：Iain B. Mcinnes

Speaker：Masataka Kuwana

SatoshiTakanashi{TAKANASHISATOSHI髙梨敏史たかなしさとし}|YukiEtani{ETANIYUKI惠谷悠紀えたにゆうき}|AwirutCharoensappakit{CHAROENSAPPAKITAWIRUT}|RyuWatanabe{WATANABERYU渡部龍わたなべりゅう}|NariakiHao{HAONARIAKI羽尾成昭はおなりあき}____MitsumasaKishimoto{KISHIMOTOMITSUMASA岸本暢將きしもとみつまさ}____KoichiroOhmura{OHMURAKOICHIRO大村浩一郎おおむらこういちろう}|ShujiSumitomo{SUMITOMOSHUJI住友秀次すみともしゅうじ}|HidekiOka{OKAHIDEKI岡秀樹おかひでき}|KentaMisaki{MISAKIKENTA三崎健太みさきけんた}|AtsushiIhata{IHATAATSUSHI井畑淳いはたあつし}|ToshihiroMatsui{MATSUITOSHIHIRO松井利浩まついとしひろ}|ShigetoTohma{TOHMASHIGETO當間重人とうましげと}|JunSaegusa{SAEGUSAJUN三枝淳さえぐさじゅん}|YuichiroOta{OTAYUICHIRO太田裕一朗おおたゆういちろう}|TsukasaMatsubara{MATSUBARATSUKASA松原司まつばらつかさ}|KunihiroYamaoka{YAMAOKAKUNIHIRO山岡邦宏やまおかくにひろ}|KoichiAmano{AMANOKOICHI天野宏一あまのこういち}|HironariHanaoka{HANAOKAHIRONARI花岡洋成はなおかひろなり}|JunKikuchi{KIKUCHIJUN菊池潤きくちじゅん}|YasushiKondo{KONDOYASUSHI近藤泰こんどうやすし}|MasaruTakeshita{TAKESHITAMASARU竹下勝たけしたまさる}|YukoKaneko{KANEKOYUKO金子祐子かねこゆうこ}|KosukeEbina{EBINAKOSUKE蛯名耕介えびなこうすけ}|YasutakaOkita{OKITAYASUTAKA沖田康孝おきたやすたか}|KoheiTsujimoto{TSUJIMOTOKOHEI辻本考平つじもとこうへい}|YuichiMaeda{MAEDAYUICHI前田悠一まえだゆういち}|TakayukiFuijii{FUIJIITAKAYUKI藤井貴之ふじいたかゆき}|AkiraOnishi{ONISHIAKIRA大西輝おおにしあきら}|TadashiOkano{OKANOTADASHI岡野匡志おかのただし}|MotomuHashimoto{HASHIMOTOMOTOMU橋本求はしもともとむ}|IkuShirasugi{SHIRASUGIIKU白杉郁しらすぎいく}|ShinyaHayashi{HAYASHISHINYA林申也はやししんや}|YujiNozaki{NOZAKIYUJI野﨑祐史のざきゆうじ}|DaisukeTomita{TOMITADAISUKE冨田大介とみただいすけ}|AkihiroTanaka{TANAKAAKIHIRO田中晶大たなかあきひろ}|HidekiAmuro{AMUROHIDEKI安室秀樹あむろひでき}|HideyukiShiba{SHIBAHIDEYUKI斯波秀行しばひでゆき}|MahiroYamamoto{YAMAMOTOMAHIRO山本真大やまもとまひろ}|MasakiKatayama{KATAYAMAMASAKI片山昌紀かたやままさき}|WataruYamamoto{YAMAMOTOWATARU山本渉やまもとわたる}|AtsushiKumanogoh{KUMANOGOHATSUSHI熊ノ郷淳くまのごうあつし}|SeijiOkada{OKADASEIJI岡田誠司おかだせいじ}|KritsanawanSae-Khow{SAE-KHOWKRITSANAWAN}|AsadaLeelahavanichkul{LEELAHAVANICHKULASADA}|ShinsukeYamada{YAMADASHINSUKE山田真介やまだしんすけ}|YukiFurusawa{FURUSAWAYUKI古澤祐樹ふるさわゆうき}|RyuheiIshihara{ISHIHARARYUHEI石原龍平いしはらりゅうへい}|MasaoKatsushima{KATSUSHIMAMASAO勝島將夫かつしままさお}|KazuoFukumoto{FUKUMOTOKAZUO福本一夫ふくもとかずお}|YutaroYamada{YAMADAYUTARO山田祐太郎やまだゆうたろう}|KenjiMamoto{MAMOTOKENJI真本建司まもとけんじ}|NaokiKondo{KONDONAOKI近藤直樹こんどうなおき}|RikaKakutani{KAKUTANIRIKA角谷梨花かくたにりか}|YasufumiKijima{KIJIMAYASUFUMI木島靖文きじまやすふみ}____International Concurrent Workshop 1Clinical Study in RA -1____Optimal Timing of Recombinant Herpes Zoster Virus Vaccination And a JAK Inhibitor Initiation in Rheumatoid Arthritis; A Multicentre, Open-label, Randomised Comparative Study (STOP-HZ study)|Large-scale real-world comparison of drug retention and efficacy among five JAK inhibitors in rheumatoid arthritis: analysis of 1,798 treatment courses from the ANSWER cohort|Comparative efficacy of Janus kinase inhibitors for rheumatoid arthritis patients with an inadequate response to conventional synthetic or biological disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis|Immunogenicity and Safety of Recombinant Zoster Vaccine in Japanese Patients with Rheumatoid Arthritis Receiving Upadacitinib: A Prospective, Parallel Triple-Arm Study (End Zoster-J)|Five-Year Drug Survival and Discontinuation Reasons for Eight Biological Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: A Retrospective Analysis of 1,182 Patients from the Niigata Orthopaedic Surgery Rheumatoid Arthritis Database (NOSRAD)

ICW1

International Concurrent Workshop 1
Clinical Study in RA -1

Chair：Mitsumasa Kishimoto

YukoTakenaka{TAKENAKAYUKO竹中祐子たけなかゆうこ}|KenyaSugimoto{SUGIMOTOKENYA杉本健哉すぎもとけんや}|NaohiroSugitani{SUGITANINAOHIRO杉谷直大すぎたになおひろ}|RyoTakeuchi{TAKEUCHIRYO竹内遼たけうちりょう}|ShokoTsuji{TSUJISHOKO辻尚子つじしょうこ}|KouKatayama{KATAYAMAKOU片山耕かたやまこう}____HiromichiTamaki{TAMAKIHIROMICHI田巻弘道たまきひろみち}____TakuroNii{NIITAKURO新居卓朗にいたくろう}|TakuyaKurihara{KURIHARATAKUYA栗原拓也くりはらたくや}|KoichiroTakahi{TAKAHIKOICHIRO髙樋康一郎たかひこういちろう}|HiroshiKida{KIDAHIROSHI木田博きだひろし}|RyuWatanabe{WATANABERYU渡部龍わたなべりゅう}|TakayukiFujii{FUJIITAKAYUKI藤井貴之ふじいたかゆき}|AkiraOnishi{ONISHIAKIRA大西輝おおにしあきら}|YujiNozaki{NOZAKIYUJI野﨑祐史のざきゆうじ}|TetsuItami{ITAMITETSU伊丹哲いたみてつ}|KosukeEbina{EBINAKOSUKE蛯名耕介えびなこうすけ}|YukiEtani{ETANIYUKI惠谷悠紀えたにゆうき}|HirotakaYamada{YAMADAHIROTAKA山田啓貴やまだひろたか}|ShoSendo{SENDOSHO千藤荘せんどうしょう}|AkihiroTanaka{TANAKAAKIHIRO田中晶大たなかあきひろ}|HidekiAmuro{AMUROHIDEKI安室秀樹あむろひでき}|AyakaYoshikawa{YOSHIKAWAAYAKA吉川紋佳よしかわあやか}|TakuyaKotani{KOTANITAKUYA小谷卓矢こたにたくや}|MasakiKatayama{KATAYAMAMASAKI片山昌紀かたやままさき}|WataruYamamoto{YAMAMOTOWATARU山本渉やまもとわたる}|RyuheiIshihara{ISHIHARARYUHEI石原龍平いしはらりゅうへい}|YuyaFujita{FUJITAYUYA藤田雄也ふじたゆうや}|MasaoKatsushima{KATSUSHIMAMASAO勝島將夫かつしままさお}|KazuoFukumoto{FUKUMOTOKAZUO福本一夫ふくもとかずお}|ShinsukeYamada{YAMADASHINSUKE山田真介やまだしんすけ}|MotomuHashimoto{HASHIMOTOMOTOMU橋本求はしもともとむ}|EisukeInoue{INOUEEISUKE井上永介いのうええいすけ}|EriSugano{SUGANOERI菅野瑛梨すがのえり}|KatsunoriIkari{IKARIKATSUNORI猪狩勝則いかりかつのり}|EiichiTanaka{TANAKAEIICHI田中榮一たなかえいいち}|ShuichiroNakabo{NAKABOSHUICHIRO中坊周一郎なかぼうしゅういちろう}|AkikoYoshida{YOSHIDAAKIKO吉田亜希子よしだあきこ}|KosakuMurakami{MURAKAMIKOSAKU村上孝作むらかみこうさく}|AkiraOhnishi{OHNISHIAKIRA大西輝おおにしあきら}|KoichiMurata{MURATAKOICHI村田浩一むらたこういち}|AkioMorinobu{MORINOBUAKIO森信暁雄もりのぶあきお}|KoichiroOhmura{OHMURAKOICHIRO大村浩一郎おおむらこういちろう}|ShunichiFujita{FUJITASHUNICHI藤田俊一ふじたしゅんいち}|SumieAsano{ASANOSUMIE浅野澄恵あさのすみえ}|YukaKoide{KOIDEYUKA小出侑佳こいでゆか}|MasatomoYamada{YAMADAMASATOMO山田雅智やまだまさとも}|MasakatsuIkeda{IKEDAMASAKATSU池田政勝いけだまさかつ}|YoMizuta{MIZUTAYO水田耀みずたよう}|HikaruHarada{HARADAHIKARU原田光はらだひかる}|YukiFujita{FUJITAYUKI藤田裕生ふじたゆうき}|AkikoNagasu{NAGASUAKIKO長洲晶子ながすあきこ}|HiroyasuHirano{HIRANOHIROYASU平野紘康ひらのひろやす}|YoshitakaMorita{MORITAYOSHITAKA守田吉孝もりたよしたか}|KazuhisaNakano{NAKANOKAZUHISA中野和久なかのかずひさ}____International Concurrent Workshop 2Clinical Study in RA -2____Pulmonary Structural Abnormalities Predict Respiratory Mortality in Rheumatoid Arthritis: Development of a Practical Risk Score|Early Rheumatoid Factor Reduction Predicts Clinical Remission in Rheumatoid Arthritis: Insights from the ANSWER Cohort|Predictors of Functional Non-Response in Late-Onset Rheumatoid Arthritis: An IORRA Cohort Study|Leucine-Rich a2-Glycoprotein as an Inflammation Marker under IL-6 Blockade in Rheumatoid Arthritis|Composite Risk Factors for Persistent Disease Activity in Elderly Patients with Rheumatoid Arthritis (RA): Finding from the SETOUCHI-RA Registry|Bone Marrow Edema on MRI May Serve as a Predictor of Rapid Radiographic Progression in Very Elderly Rheumatoid Arthritis Patients

ICW2

International Concurrent Workshop 2
Clinical Study in RA -2

Chair：Hiromichi Tamaki

ShintaroHirata{HIRATASHINTARO平田信太郎ひらたしんたろう}____ShigekiMomohara{MOMOHARASHIGEKI桃原茂樹ももはらしげき}________Luncheon Seminar 9Update on biosimilar DMARDs for rheumatic diseases____Update on biosimilar DMARDs for rheumatic diseases

LS9

Luncheon Seminar 9
Update on biosimilar DMARDs for rheumatic diseases

【Sponsored by Celltrion Healthcare Japan K.K.】

Chair：Shigeki Momohara

Speaker：Shintaro Hirata

MasanobuUeno{UENOMASANOBU上野匡庸うえのまさのぶ}|－|MisaghRajabinejad{RAJABINEJADMISAGH}|HirotomoAsakura{ASAKURAHIROTOMO朝倉啓友あさくらひろとも}|JiaqingLiu{LIUJIAQING}|XinWang{WANGXIN}____ShoichiFukui{FUKUISHOICHI福井翔一ふくいしょういち}____KoshiroSonomoto{SONOMOTOKOSHIRO園本格士朗そのもとこうしろう}|SatoshiKubo{KUBOSATOSHI久保智史くぼさとし}|HiroakiTanaka{TANAKAHIROAKI田中宏明たなかひろあき}|AtsushiNasayasu{NASAYASUATSUSHI永安敦ながやすあつし}|TakafumiAritomi{ARITOMITAKAFUMI有冨貴史ありとみたかふみ}|IppeiMiyagawa{MIYAGAWAIPPEI宮川一平みやがわいっぺい}|YusukeMiyazaki{MIYAZAKIYUSUKE宮崎佑介みやざきゆうすけ}|YasuyukiTodoroki{TODOROKIYASUYUKI轟泰幸とどろきやすゆき}|YurieSatoh-Kanda{SATOH-KANDAYURIE神田友梨恵かんだゆりえ}|YuyaFujita{FUJITAYUYA藤田悠哉ふじたゆうや}|RyuichiroKanda{KANDARYUICHIRO神田龍一郎かんだりゅういちろう}|HidenoriSakai{SAKAIHIDENORI酒井秀典さかいひでのり}|YoshiyaTanaka{TANAKAYOSHIYA田中良哉たなかよしや}|ShingoNakayamada{NAKAYAMADASHINGO中山田真吾なかやまだしんご}|AzadehHossein{HOSSEINAZADEH}|YuMatsueda{MATSUEDAYU松枝佑まつえだゆう}|KeisukeIkeda{IKEDAKEISUKE池田慶介いけだけいすけ}|ShunsukeKyoda{KYODASHUNSUKE京田俊介きょうだしゅんすけ}|EriShishido{SHISHIDOERI宍戸瑛理ししどえり}|RisaShindo{SHINDORISA進藤理沙しんどうりさ}|KazumaIno{INOKAZUMA伊野和馬いのかずま}|YasuhiroHasegawa{HASEGAWAYASUHIRO長谷川靖浩はせがわやすひろ}|TomokiTanaka{TANAKATOMOKI田中知樹たなかともき}|TatsuhikoWada{WADATATSUHIKO和田達彦わだたつひこ}|SumiakiTanaka{TANAKASUMIAKI田中住明たなかすみあき}|KunihiroYamaoka{YAMAOKAKUNIHIRO山岡邦宏やまおかくにひろ}|YiWang{WANGYI}|JieHe{HEJIE}____International Concurrent Workshop 7Clinical Study in RA -3____Prediction for the progression of Difficult-to-Treat (D2T) rheumatoid arthritis by machine learning scoring system, from the FIRST registry|Withdrawn|The MALAT1/TGF-B signaling pathway is dysregulated in patients with rheumatoid arthritis|MS4A4A on nonclassical monocyte predicts early remission with JAK inhibitors in rheumatoid arthritis|CD19+CD107A+ B cells exhibit senescent features and promote disease progression via CCR1-CCL4 axis in rheumatoid arthritis|The Role of Gut-Joint Axis-Mediated Migration of CD4+ Alpha4 Beta7+T Cells in the Pathogenesis of RA

ICW7

International Concurrent Workshop 7
Clinical Study in RA -3

Chair：Shoichi Fukui

TakayukiFujii{FUJIITAKAYUKI藤井貴之ふじいたかゆき}|YoshiyaTanaka{TANAKAYOSHIYA}|YukiImai{IMAIYUKI今井悠気いまいゆうき}|ShoSendo{SENDOSHO千藤荘せんどうしょう}|ShoFukui{FUKUISHO福井翔ふくいしょう}____KatsuyaSuzuki{SUZUKIKATSUYA鈴木勝也すずきかつや}____KoichiMurata{MURATAKOICHI村田浩一むらたこういち}|ShuichiroNakabo{NAKABOSHUICHIRO中坊周一郎なかぼうしゅういちろう}|AkiraOnishi{ONISHIAKIRA大西輝おおにしあきら}|KosakuMurakami{MURAKAMIKOSAKU村上孝作むらかみこうさく}|MasaoTanaka{TANAKAMASAO田中真生たなかまさお}|KoheiTsujimoto{TSUJIMOTOKOHEI辻本考平つじもとこうへい}|TadashiOkano{OKANOTADASHI岡野匡志おかのただし}|MotomuHashimoto{HASHIMOTOMOTOMU橋本求はしもともとむ}|HirotakaYamada{YAMADAHIROTAKA山田啓貴やまだひろたか}|TomoyukiKamenaga{KAMENAGATOMOYUKI亀長智幸かめながともゆき}|YuriHiramatsu{HIRAMATSUYURI平松ゆりひらまつゆり}|TakuyaKotani{KOTANITAKUYA小谷卓矢こたにたくや}|AkihiroTanaka{TANAKAAKIHIRO田中晶大たなかあきひろ}|YujiNozaki{NOZAKIYUJI野﨑祐史のざきゆうじ}|DaisukeTomita{TOMITADAISUKE冨田大介とみただいすけ}|WataruYamamoto{YAMAMOTOWATARU山本渉やまもとわたる}|AkioMorinobu{MORINOBUAKIO森信暁雄もりのぶあきお}|ShuichiMatsuda{MATSUDASHUICHI松田秀一まつだしゅういち}|SusanneProthon{PROTHONSUSANNE}|JacobLeander{LEANDERJACOB}|UllaSeppälä{SEPPÄLÄULLA}|EduardMolins{MOLINSEDUARD}|MiaCollins{COLLINSMIA}|NicholasWhite{WHITENICHOLAS}|IvonnePuente{PUENTEIVONNE}|AndreSantaMaria{SANTAMARIAANDRE}|GarySims{SIMSGARY}|DavidHan{HANDAVID}|ObadaAlHamdan{ALHAMDANOBADA}|RonaldGoldwater{GOLDWATERRONALD}|EmonKhan{KHANEMON}|DavidClose{CLOSEDAVID}|MichihitoKono{KONOMICHIHITO河野通仁こうのみちひと}|TomonoriIshii{ISHIITOMONORI石井智徳いしいとものり}|ToshihisaKojima{KOJIMATOSHIHISA小嶋俊久こじまとしひさ}|ShintaroHirata{HIRATASHINTARO平田信太郎ひらたしんたろう}|YoshiyaTanaka{TANAKAYOSHIYA田中良哉たなかよしや}|EiichiTanaka{TANAKAEIICHI田中榮一たなかえいいち}|KoichiroOhmura{OHMURAKOICHIRO大村浩一郎おおむらこういちろう}|ShunsukeOkamoto{OKAMOTOSHUNSUKE岡本俊輔おかもとしゅんすけ}|RumikoMatsumoto{MATSUMOTORUMIKO松本留美子まつもとるみこ}|TsutomuTakeuchi{TAKEUCHITSUTOMU竹内勤たけうちつとむ}|YukoKaneko{KANEKOYUKO金子祐子かねこゆうこ}|YukiEtani{ETANIYUKI惠谷悠紀えたにゆうき}|RyuWatanabe{WATANABERYU渡部龍わたなべりゅう}|YumikoWada{WADAYUMIKO和田裕美子わだゆみこ}|AyakaYoshikawa{YOSHIKAWAAYAKA吉川紋佳よしかわあやか}|TetsuItami{ITAMITETSU伊丹哲いたみてつ}|ShinyaHayashi{HAYASHISHINYA林申也はやししんや}|MasanoriTsubosaka{TSUBOSAKAMASANORI壺坂正徳つぼさかまさのり}|NaokiNakano{NAKANONAOKI中野直樹なかのなおき}|IkuShirasugi{SHIRASUGIIKU白杉郁しらすぎいく}|TakaichiOkano{OKANOTAKAICHI岡野隆一おかのたかいち}|KeisukeNishimura{NISHIMURAKEISUKE西村啓佑にしむらけいすけ}|YoUeda{UEDAYO上田洋うえだよう}|JunSaegusa{SAEGUSAJUN三枝淳さえぐさじゅん}|MitsumasaKishimoto{KISHIMOTOMITSUMASA岸本暢将きしもとみつまさ}|YoshinoriKomagata{KOMAGATAYOSHINORI駒形嘉紀こまがたよしのり}|SolomonDaniel{DANIELSOLOMON}____International Concurrent Workshop 8Clinical Study in RA -4____Development and Internal-External Validation of a Stacking Ensemble Learning Model for Rheumatoid Arthritis Flare Prediction: An ANSWER Cohort Study|AZD1163, a Novel Bispecific Human Antibody Targeting PAD2/4 Enzymes Responsible for Generating Citrullinated Protein Auto-antigens in Rheumatoid Arthritis: Phase 1 Safety and Pharmacokinetics Following Subcutaneous Administration including Healthy Japanes|Spacing of ozoralizumab or methotrexate dose reduction in rheumatoid arthritis: a randomized, controlled SORAIRO trial (encore presentation)|JAK inhibitors reduce rheumatoid factor compared with biologic DMARDs: The ANSWER Cohort Study|Effectiveness of Biological and Target-Synthetic Treatment in Patients with Rheumatoid Arthritis and Kidney Dysfunction (encore)

ICW8

International Concurrent Workshop 8
Clinical Study in RA -4

Chair：Katsuya Suzuki

KazuotoHiramoto{HIRAMOTOKAZUOTO平本和音ひらもとかずおと}|SatsukiMatsunaga{MATSUNAGASATSUKI松永五月まつながさつき}|QianWang{WANGQIAN}|XinxinXu{XUXINXIN}|RanjanGupta{GUPTARANJAN}|KazuroKamada{KAMADAKAZURO鎌田和郎かまだかずろう}____YuichiroFujieda{FUJIEDAYUICHIRO藤枝雄一郎ふじえだゆういちろう}____HiroshiTakei{TAKEIHIROSHI武井裕史たけいひろし}|HiroyukiFukui{FUKUIHIROYUKI福井裕之ふくいひろゆき}|KojiSuzuki{SUZUKIKOJI鈴木浩司すずきこうじ}|JunKikuchi{KIKUCHIJUN菊池潤きくちじゅん}|YukoKaneko{KANEKOYUKO金子祐子かねこゆうこ}|SatoshiKubo{KUBOSATOSHI久保智史くぼさとし}|YasuyukiTodoroki{TODOROKIYASUYUKI轟泰幸とどろきやすゆき}|HiroakiTanaka{TANAKAHIROAKI田中宏明たなかひろあき}|YuyaFujita{FUJITAYUYA藤田悠哉ふじたゆうや}|IppeiMiyagawa{MIYAGAWAIPPEI宮川一平みやがわいっぺい}|YurieSatoh-Kanda{SATOH-KANDAYURIE神田友梨恵かんだゆりえ}|MasanobuUeno{UENOMASANOBU上野匡庸うえのまさのぶ}|RyuichiroKanda{KANDARYUICHIRO神田龍一郎かんだりゅういちろう}|YoshiyaTanaka{TANAKAYOSHIYA田中良哉たなかよしや}|ShingoNakayamada{NAKAYAMADASHINGO中山田真吾なかやまだしんご}|ZhuChen{CHENZHU}|DeeptiUpadhyay{UPADHYAYDEEPTI}|ArunkumarSubbiah{SUBBIAHARUNKUMAR}|UmaSharma{SHARMAUMA}|RudraP.Goswami{GOSWAMIRUDRAP.}|JayanthKumar{KUMARJAYANTH}|YukiKudo{KUDOYUKI工藤友喜くどうゆうき}|MichihitoKono{KONOMICHIHITO河野通仁こうのみちひと}|KoheiKarino{KARINOKOHEI狩野皓平かりのこうへい}|RyoHisada{HISADARYO久田諒ひさだりょう}|HiroyukiNakamura{NAKAMURAHIROYUKI中村浩之なかむらひろゆき}|TatsuyaAtsumi{ATSUMITATSUYA渥美達也あつみたつや}____International Concurrent Workshop 3Clinical Study in SLE -1____Urinary IGFBP-5 levels as a novel biomarker to predict poor response to induction therapy in patients with lupus nephritis|T peripheral helper cells (Tph) - age associated B cells (ABC) axis in the pathogenesis of kidney involvement in lupus patients: LOOPS/FLOW Study|Interleukin-18-Secreting Autologous CAR T-Cells Targeting CD19 and BCMA for Refractory Systemic Lupus Erythematosus|Exploratory Study of Fourth-Generation Autologous CAR-T Cells Targeting CD19 and BCMA in Refractory Systemic Lupus Erythematosus|Serum Metabolomic Profiles of Proliferative and Membranous Lupus Nephritis: Comparative Assessment for Immunopathogenic Correlation and As a Marker of Treatment Response|Identification of serum biomarkers predicting complete renal remission in lupus nephritis

ICW3

International Concurrent Workshop 3
Clinical Study in SLE -1

Chair：Yuichiro Fujieda

HiroshiShiba{SHIBAHIROSHI司馬煕しばひろし}|YutaInoue{INOUEYUTA井上雄太いのうえゆうた}|SatsukiMatsunaga{MATSUNAGASATSUKI松永五月まつながさつき}|TakehiroNakai{NAKAITAKEHIRO中井健宏なかいたけひろ}|Ming-HanChen{CHENMING-HAN}|RanjanGupta{GUPTARANJAN}____YoheiKirino{KIRINOYOHEI桐野洋平きりのようへい}____NobuyukiYajima{YAJIMANOBUYUKI矢嶋宣幸やじまのぶゆき}|NaoOguro{OGURONAO小黒奈緒おぐろなお}|KentaShidahara{SHIDAHARAKENTA志田原健太しだはらけんた}|KeigoHayashi{HAYASHIKEIGO林啓悟はやしけいご}|YoshiaMiyawaki{MIYAWAKIYOSHIA宮脇義亜みやわきよしあ}|NatsukiSakurai{SAKURAINATSUKI櫻井菜月さくらいなつき}|ChiharuHidekawa{HIDEKAWACHIHARU秀川智春ひでかわちはる}|RyusukeYoshimi{YOSHIMIRYUSUKE吉見竜介よしみりゅうすけ}|TakanoriIchikawa{ICHIKAWATAKANORI市川貴規いちかわたかのり}|DaiKishida{KISHIDADAI岸田大きしだだい}|YuichiIshikawa{ISHIKAWAYUICHI石川雄一いしかわゆういち}|Ken-eiSada{SADAKEN-EI佐田憲映さだけんえい}|YasuhiroShimojima{SHIMOJIMAYASUHIRO下島恭弘しもじまやすひろ}|NoriakiKurita{KURITANORIAKI栗田宜明くりたのりあき}|HiroyukiNakamura{NAKAMURAHIROYUKI中村浩之なかむらひろゆき}|MitsutakaYasuda{YASUDAMITSUTAKA安田充孝やすだみつたか}|KoheiKarino{KARINOKOHEI狩野皓平かりのこうへい}|RyoHisada{HISADARYO久田諒ひさだりょう}|YuichiroFujieda{FUJIEDAYUICHIRO藤枝雄一郎ふじえだゆういちろう}|MichihitoKono{KONOMICHIHITO河野通仁こうのみちひと}|OlgaAmengual{AMENGUALOLGA}|TatsuyaAtsumi{ATSUMITATSUYA渥美達也あつみたつや}|SatoshiKubo{KUBOSATOSHI久保智史くぼさとし}|YusukeMiyazaki{MIYAZAKIYUSUKE宮崎佑介みやざきゆうすけ}|NaoakiOhkubo{OHKUBONAOAKI大久保直紀おおくぼなおあき}|MasashiFunada{FUNADAMASASHI船田将史ふなだまさし}|IppeiMiyagawa{MIYAGAWAIPPEI宮川一平みやがわいっぺい}|YurieSatoh-Kanda{SATOH-KANDAYURIE神田友梨恵かんだゆりえ}|HiroakiTanaka{TANAKAHIROAKI田中宏明たなかひろあき}|YasuyukiTodoroki{TODOROKIYASUYUKI轟泰幸とどろきやすゆき}|MasanobuUeno{UENOMASANOBU上野匡庸うえのまさのぶ}|YuyaFujita{FUJITAYUYA藤田悠哉ふじたゆうや}|RyuichiroKanda{KANDARYUICHIRO神田龍一郎かんだりゅういちろう}|YoshiyaTanaka{TANAKAYOSHIYA田中良哉たなかよしや}|ShingoNakayamada{NAKAYAMADASHINGO中山田真吾なかやまだしんご}|ShoFukui{FUKUISHO福井翔ふくいしょう}|YukihikoIkeda{IKEDAYUKIHIKO池田行彦いけだゆきひこ}|MaseiSuda{SUDAMASEI須田万勢すだませい}|HiromichiTamaki{TAMAKIHIROMICHI田巻弘道たまきひろみち}|MitsumasaKihimoto{KIHIMOTOMITSUMASA岸本暢将きしもとみつまさ}|MasatoOkada{OKADAMASATO岡田正人おかだまさと}|BhaskarPandey{PANDEYBHASKAR}|AmitaAggarwal{AGGARWALAMITA}|RudrarpanChatterjee{CHATTERJEERUDRARPAN}|DeepakJoshi{JOSHIDEEPAK}|MollyThabah{THABAHMOLLY}|RudraP.Goswami{GOSWAMIRUDRAP.}|JayanthKumar{KUMARJAYANTH}____International Concurrent Workshop 4Clinical Study in SLE -2____Financial Toxicity in Systemic Lupus Erythematosus: Prevalence and Associated Characteristics and Patient-Reported Outcomes: a cross-sectional TRUMP2-SLE study|Longitudinal Observation of Thrombotic Events in Patients with Obstetric Antiphospholipid Syndrome|Efficacy of Anifrolumab in Patients with Systemic Lupus Erythematosus (SLE) who have not achieved LLDAS: Data from the LOOPS Registry|Long-Term Retention of Hydroxychloroquine and Effectiveness of Desensitization Protocols in Systemic Lupus Erythematosus|Longitudinal changes in regulatory T cells and Treg-associated molecules in patients with systemic lupus erythematosus|Clinical Relevance, Specific Autoantibody Correlation and Pattern Identification Using Artificial Intelligence of Anti-Nuclear Antibody Indirect Immunofluorescence Patterns in Systemic Lupus Erythematosus

ICW4

International Concurrent Workshop 4
Clinical Study in SLE -2

Chair：Yohei Kirino

KatsuhideKusaka{KUSAKAKATSUHIDE日下勝秀くさかかつひで}|YuichiroShirai{SHIRAIYUICHIRO白井悠一郎しらいゆういちろう}____ShinjiSato{SATOSHINJI佐藤慎二さとうしんじ}________Luncheon Seminar 10Diagnosis and Treatment of CTD-PAH: Exploring the Latest Strategies____Latest Treatment Strategies for CTD-PAH and the Role of Sotatercept|Management of pulmonary arterial hypertension associated with connective tissue diseases in the era of guidelines update and a new drug

LS10

Luncheon Seminar 10
Diagnosis and Treatment of CTD-PAH: Exploring the Latest Strategies

【Sponsored by MSD K.K.】

Chair：Shinji Sato

Speaker：Katsuhide Kusaka

Speaker：Yuichiro Shirai

RyoTakeuchi{TAKEUCHIRYO竹内遼たけうちりょう}|AkiraOnishi{ONISHIAKIRA大西輝おおにしあきら}|TakayukiYotsuyanagi{YOTSUYANAGITAKAYUKI四栁敬之よつやなぎたかゆき}|TomohiroKozuki{KOZUKITOMOHIRO上月友寛こうづきともひろ}|YushoIshii{ISHIIYUSHO石井悠翔いしいゆうしょう}|HideakiTsuji{TSUJIHIDEAKI辻英輝つじひであき}____HarukaTsuchiya{TSUCHIYAHARUKA土屋遥香つちやはるか}____ShujiSumitomo{SUMITOMOSHUJI住友秀次すみともしゅうじ}|HidekiOka{OKAHIDEKI岡秀樹おかひでき}|YumikoWada{WADAYUMIKO和田裕美子わだゆみこ}|TakuyaKotani{KOTANITAKUYA小谷卓矢こたにたくや}|MasaoKatsushima{KATSUSHIMAMASAO勝島將夫かつしままさお}|MotomuHashimoto{HASHIMOTOMOTOMU橋本求はしもともとむ}|YasuhiroKato{KATOYASUHIRO加藤保宏かとうやすひろ}|EriItotagawa{ITOTAGAWAERI糸田川英里いとたがわえり}|YujiNozaki{NOZAKIYUJI野﨑祐史のざきゆうじ}|ToshihikoShiga{SHIGATOSHIHIKO志賀俊彦しがとしひこ}|AkiraOhnishi{OHNISHIAKIRA大西輝おおにしあきら}|HideakiTsuji{TSUJIHIDEAKI辻英輝つじひであき}|TakaoFujii{FUJIITAKAO藤井隆夫ふじいたかお}|ShigeruIwata{IWATASHIGERU岩田慈いわたしげる}|HirofumiMiyake{MIYAKEHIROFUMI三宅啓史みやけひろふみ}|WataruYamamoto{YAMAMOTOWATARU山本渉やまもとわたる}|KoichiroOhmura{OHMURAKOICHIRO大村浩一郎おおむらこういちろう}|HideakiTsuji{TSUJIHIDEAKI辻英輝つじひでき}|TsuneoSasai{SASAITSUNEO笹井恒雄ささいつねお}|MireiShirakashi{SHIRAKASHIMIREI白柏魅怜しらかしみれい}|RyosukeHiwa{HIWARYOSUKE日和良介ひわりょうすけ}|ShuichiroNakabo{NAKABOSHUICHIRO中坊周一郎なかぼうしゅういちろう}|ShujiAkizuki{AKIZUKISHUJI秋月修治あきづきしゅうじ}|RanNakashima{NAKASHIMARAN中嶋蘭なかしまらん}|KeisukeNishimura{NISHIMURAKEISUKE西村啓佑にしむらけいすけ}|YoshiaMiyawaki{MIYAWAKIYOSHIA宮脇義亜みやわきよしあ}|MasatakaUmeda{UMEDAMASATAKA梅田雅孝うめだまさたか}|ShigeruOhno{OHNOSHIGERU大野滋おおのしげる}|HiroshiKajiyama{KAJIYAMAHIROSHI梶山浩かじやまひろし}|ShuzoSato{SATOSHUZO佐藤秀三さとうしゅうぞう}|DaiKishida{KISHIDADAI岸田大きしだだい}|MichioFujiwara{FUJIWARAMICHIO藤原道雄ふじわらみちお}|TakashiKida{KIDATAKASHI木田節きだたかし}|YusukeMatsuo{MATSUOYUSUKE松尾祐介まつおゆうすけ}|AyukoTakatani{TAKATANIAYUKO髙谷亜由子たかたにあやこ}|TakahisaOnishi{ONISHITAKAHISA大西貴久おおにしたかひさ}|TomoakiIda{IDATOMOAKI井田友明いだともあき}|KunihikoUmekita{UMEKITAKUNIHIKO梅北邦彦うめきたくにひこ}|HirotoNakano{NAKANOHIROTO仲野寛人なかのひろと}|KeiIkeda{IKEDAKEI池田啓いけだけい}|HajimeYoshifuji{YOSHIFUJIHAJIME吉藤元よしふじはじめ}|MasaoTanaka{TANAKAMASAO田中真生たなかまさお}|AkioMorinobu{MORINOBUAKIO森信暁雄もりのぶあきお}|KeiichiSakurai{SAKURAIKEIICHI櫻井恵一さくらいけいいち}|KeisukeMiyamoto{MIYAMOTOKEISUKE宮本啓佑みやもとけいすけ}|YukiTanaka{TANAKAYUKI田中雄大たなかゆうき}|MitsuhiroKiya{KIYAMITSUHIRO木屋光博きやみつひろ}|ReiHanaoka{HANAOKAREI花岡黎はなおかれい}|KoheiTonosono{TONOSONOKOHEI殿園晃平とのそのこうへい}|TakaharuNishijima{NISHIJIMATAKAHARU西島孝治にしじまたかはる}|YoshikiIshizaki{ISHIZAKIYOSHIKI石﨑克樹いしざきよしき}|TakayasuAndo{ANDOTAKAYASU安藤貴泰あんどうたかやす}|ShotaroSuzuki{SUZUKISHOTARO鈴木翔太郎すずきしょうたろう}|TakayukiMatsui{MATSUITAKAYUKI松井隆之まついたかゆき}|EtsushiToyofuku{TOYOFUKUETSUSHI豊福悦史とよふくえつし}|MarikoMouri{MOURIMARIKO毛利万里子もうりまりこ}|KumikoTonooka{TONOOKAKUMIKO殿岡久美子とのおかくみこ}|TakeshiSuzuki{SUZUKITAKESHI鈴木豪すずきたけし}|KazukoYamazaki{YAMAZAKIKAZUKO山崎和子やまざきかずこ}|YukikoTakakuwa{TAKAKUWAYUKIKO高桑由希子たかくわゆきこ}|HirokoNagafuchi{NAGAFUCHIHIROKO永渕裕子ながふちひろこ}|MasaakiMori{MORIMASAAKI森雅亮もりまさあき}|SeidoOoka{OOKASEIDO大岡正道おおおかせいどう}|KimitoKawahata{KAWAHATAKIMITO川畑仁人かわはたきみと}|KosakuMurakami{MURAKAMIKOSAKU村上孝作むらかみこうさく}|AkiraOnishi{ONISHIAKIRA大西輝おおにしあきら}|HirokoSato{SATOHIROKO佐藤紘子さとうひろこ}|TsuyoshiShirai{SHIRAITSUYOSHI白井剛志しらいつよし}|HiroshiFujii{FUJIIHIROSHI藤井博司ふじいひろし}____International Concurrent Workshop 9Clinical Study in SLE -3____Distinct characteristics of the subgroup of systemic lupus erythematosus without complement reduction: the ANSWER-SLE cohort study|Comparison of predictive validity of the Lupus Patient-Reported Outcome and Short-Form-12 for damage accrual in systemic lupus erythematosus: the LUNA cohort study|Emergency Cesarean Section Outcomes and Clinical Risk Factors in 56 Pregnant Patients with SLE: A Single-Center Retrospective Study|The absolute number of peripheral blood monocyte as a potential biomarker predicting therapeutic response to anifrolumab in systemic lupus erythematosus (SLE) patients: a single-center retrospective observational study in Japan|Improved Prognosis and Reduced Glucocorticoid Dose in Connective Tissue Disease- Associated Pulmonary Artery Hypertension without Systemic Sclerosis by Combination Therapy with Immunosuppressants and Vasodilators|The Influence of CYP3A5 Genotype on Tacrolimus Pharmacokinetics in Patients with Systemic Lupus Erythematosus

ICW9

International Concurrent Workshop 9
Clinical Study in SLE -3

Chair：Haruka Tsuchiya

YukiIshikawa{ISHIKAWAYUKI石川優樹いしかわゆうき}|HajimeInokuchi{INOKUCHIHAJIME井口創いのくちはじめ}|HiroakiHatano{HATANOHIROAKI波多野裕明はたのひろあき}|BunkiNatsumoto{NATSUMOTOBUNKI夏本文輝なつもとぶんき}|LeiChen{CHENLEI}|TaigaKuga{KUGATAIGA久我大雅くがたいが}____MasayukiNishide{NISHIDEMASAYUKI西出真之にしでまさゆき}____NaoTanaka{TANAKANAO田中奈緒たなかなお}|AtsushiManabe{MANABEATSUSHI真辺諄まなべあつし}|HideakiTsuji{TSUJIHIDEAKI辻英輝つじひであき}|AkiraOnishi{ONISHIAKIRA大西輝おおにしあきら}|HajimeYoshifuji{YOSHIFUJIHAJIME吉藤元よしふじはじめ}|MasaoTanaka{TANAKAMASAO田中真生たなかまさお}|TaikiYamaguchi{YAMAGUCHITAIKI山口泰生やまぐちたいき}|TomokoNiwano{NIWANOTOMOKO庭野智子にわのともこ}|MarinaKise{KISEMARINA木瀬真吏奈きせまりな}|ShinsukeYasuda{YASUDASHINSUKE保田晋助やすだしんすけ}|TadashiHosoya{HOSOYATADASHI細矢匡ほそやただし}|YasuhiroKatsumata{KATSUMATAYASUHIRO勝又康弘かつまたやすひろ}|JunichiNakamura{NAKAMURAJUNICHI中村順一なかむらじゅんいち}|KatsunoriIkari{IKARIKATSUNORI猪狩勝則いかりかつのり}|AkioMorinobu{MORINOBUAKIO森信暁雄もりのぶあきお}|ChikashiTerao{TERAOCHIKASHI寺尾知可史てらおちかし}|MasahiroNakano{NAKANOMASAHIRO中野正博なかのまさひろ}|TakahiroNishino{NISHINOTAKAHIRO西野貴大にしのたかひろ}|HarukaTakahashi{TAKAHASHIHARUKA髙橋悠たかはしはるか}|HiroakiHatano{HATANOHIROAKI波多野裕明はたのひろあき}|MichihiroKono{KONOMICHIHIRO河野通大こうのみちひろ}|BunkiNatumoto{NATUMOTOBUNKI夏本文輝なつもとぶんき}|YukoKaneko{KANEKOYUKO金子祐子かねこゆうこ}|KazuyoshiIshigaki{ISHIGAKIKAZUYOSHI石垣和慶いしがきかずよし}|BunkiNatsumoto{NATSUMOTOBUNKI夏本文輝なつもとぶんき}|HajimeInokuchi{INOKUCHIHAJIME井口創いのくちはじめ}|JunInamo{INAMOJUN稲毛純いなもじゅん}|WanxinTang{TANGWANXIN}|EitaroYoshida{YOSHIDAEITARO吉田英太郎よしだえいたろう}|YusukeYanagimoto{YANAGIMOTOYUSUKE柳本悠佑やなぎもとゆうすけ}|AyakoMakiyama{MAKIYAMAAYAKO牧山彩子まきやまあやこ}|GohMurayama{MURAYAMAGOH村山豪むらやまごう}|KentaroMinowa{MINOWAKENTARO箕輪健太郎みのわけんたろう}|MakioKusaoi{KUSAOIMAKIO草生真規雄くさおいまきお}|KenYamaji{YAMAJIKEN山路健やまじけん}|NaotoTamura{TAMURANAOTO田村直人たむらなおと}____International Concurrent Workshop 10Translational Study in SLE -1____Genome-wide association studies for SLE and SSc with renal involvement|Polygenic burden of lupus enhances type I interferon signaling in healthy individuals|Multimodal profiling reveals immune cell phenotypes associated with lupus polygenic risk|Comprehensive Elucidation of Gain-of-Function Rare Variant Mechanisms in Systemic Lupus Erythematosus and Systematic Exploration of Therapeutic Targets|Mendelian Randomization and Transcriptomics Reveal that RNASET2 Dysfunction in Immune Cells Increases the Risk of Systemic Lupus Erythematosus|Exploratory profiling of SLE patients with fatigue and low disease activity responding to Anifrolumab: DNA damage response in plasmacytoid dendritic cells as a characteristic of responders

ICW10

International Concurrent Workshop 10
Translational Study in SLE -1

Chair：Masayuki Nishide

TomoyaYoshida{YOSHIDATOMOYA吉田智哉よしだともや}|JunInamo{INAMOJUN稲毛純いなもじゅん}|YukaYoshiki{YOSHIKIYUKA吉木優香よしきゆか}|YukiKudo{KUDOYUKI工藤友喜くどうゆうき}|ShinyaIchikawa{ICHIKAWASHINYA市川晋也いちかわしんや}____ShujiSumitomo{SUMITOMOSHUJI住友秀次すみともしゅうじ}____HideyukiTakahashi{TAKAHASHIHIDEYUKI高橋秀侑たかはしひでゆき}|TakahiroItamiya{ITAMIYATAKAHIRO板宮孝紘いたみやたかひろ}|TakeshiIwasaki{IWASAKITAKESHI岩﨑毅いわさきたけし}|NatsukaUmezawa{UMEZAWANATSUKA梅澤夏佳うめざわなつか}|HirokazuSasaki{SASAKIHIROKAZU佐々木広和ささきひろかず}|KeitaNinagawa{NINAGAWAKEITA蜷川慶太にながわけいた}|YuichiroFujieda{FUJIEDAYUICHIRO藤枝雄一郎ふじえだゆういちろう}|YusukeMiyazaki{MIYAZAKIYUSUKE宮崎佑介みやざきゆうすけ}|YasuyukiKamata{KAMATAYASUYUKI釜田康行かまたやすゆき}|MasaruTakeshita{TAKESHITAMASARU竹下勝たけしたまさる}|MasakazuMatsushita{MATSUSHITAMASAKAZU松下雅和まつしたまさかず}|ToshioKawamoto{KAWAMOTOTOSHIO河本敏雄かわもととしお}|NaotoTamura{TAMURANAOTO田村直人たむらなおと}|YukoKaneko{KANEKOYUKO金子祐子かねこゆうこ}|TsutomuTakeuchi{TAKEUCHITSUTOMU竹内勤たけうちつとむ}|KojiroSato{SATOKOJIRO佐藤浩二郎さとうこうじろう}|ShingoNakayamada{NAKAYAMADASHINGO中山田真吾なかやまだしんご}|YoshiyaTanaka{TANAKAYOSHIYA田中良哉たなかよしや}|KenYoshida{YOSHIDAKEN吉田健よしだけん}|AtsumiTatsuya{TATSUYAATSUMI渥美達也あつみたつや}|ShinsukeYasuda{YASUDASHINSUKE保田晋助やすだしんすけ}|OhmuraKoichiro{KOICHIROOHMURA大村浩一郎おおむらこういちろう}|AkioMorinobu{MORINOBUAKIO森信暁雄もりのぶあきお}|KazuhikoYamamoto{YAMAMOTOKAZUHIKO山本一彦やまもとかずひこ}|MinetoOta{OTAMINETO太田峰人おおたみねと}|TomohisaOkamura{OKAMURATOMOHISA岡村僚久おかむらともひさ}|KeishiFujio{FUJIOKEISHI藤尾圭志ふじおけいし}|RoselynFierkens{FIERKENSROSELYN}|MichaelRClay{CLAYMICHAELR}|AnnaHelenaJonsson{JONSSONANNAHELENA}|ClaraLin{LINCLARA}|KariHayes{HAYESKARI}|NathanRogers{ROGERSNATHAN}|HeatherLeach{LEACHHEATHER}|HarukaMiki{MIKIHARUKA三木春香みきはるか}|AyakoOhyama{OHYAMAAYAKO大山綾子おおやまあやこ}|SaoriAbe{ABESAORI安部沙織あべさおり}|AyakoKitada{KITADAAYAKO北田彩子きただあやこ}|HiromitsuAsashima{ASASHIMAHIROMITSU浅島弘充あさしまひろみつ}|YuyaKondo{KONDOYUYA近藤裕也こんどうゆうや}|HirotoTsuboi{TSUBOIHIROTO坪井洋人つぼいひろと}|IsaoMatsumoto{MATSUMOTOISAO松本功まつもといさお}|MichihitoKono{KONOMICHIHITO河野通仁こうのみちひと}|ShuheiTakeyama{TAKEYAMASHUHEI竹山脩平たけやましゅうへい}|KazuroKamada{KAMADAKAZURO鎌田和郎かまだかずろう}|MariaTada{TADAMARIA多田麻里亜ただまりあ}|MasaruYoshimura{YOSHIMURAMASARU吉村大よしむらまさる}|KoheiKarino{KARINOKOHEI狩野皓平かりのこうへい}|RyoHisada{HISADARYO久田諒ひさだりょう}|HiroyukiNakamura{NAKAMURAHIROYUKI中村浩之なかむらひろゆき}|TatsuyaAtsumi{ATSUMITATSUYA渥美達也あつみたつや}|KenichiUto{UTOKENICHI生戸健一うとけんいち}|AlfonsoDelPeralFanjul{DELPERALFANJULALFONSO}|KazumaNishisaka{NISHISAKAKAZUMA西坂一馬にしさかかずま}|MaiYamashita{YAMASHITAMAI山下真依やましたまい}|YokoNose{NOSEYOKO能瀬洋子のせようこ}|IkuShirasugi{SHIRASUGIIKU白杉郁しらすぎいく}|HirotakaYamada{YAMADAHIROTAKA山田啓貴やまだひろたか}|TakaichiOkano{OKANOTAKAICHI岡野隆一おかのたかいち}|KeisukeNishimura{NISHIMURAKEISUKE西村啓佑にしむらけいすけ}|ShoSendo{SENDOSHO千藤荘せんどうしょう}|YoUeda{UEDAYO上田洋うえだよう}|JunSaegusa{SAEGUSAJUN三枝淳さえぐさじゅん}____International Concurrent Workshop 5Basic Study -1____Multimodal single-cell profiling of muscle immune infiltrates and spatial transcriptomics reveal shared and disease-specific programs in idiopathic inflammatory myopathies|Deconstruction of the juvenile idiopathic arthritis synovial microenvironment with spatial transcriptomics reveals immune-stromal crosstalk|The Role of TNFSF14 (LIGHT) in the Development of Eosinophilic Vasculitis|Serum CLEC7A levels reflect disease activity in systemic lupus erythematosus and lupus nephritis|Neutrophil-Derived Extracellular Vesicles in the Pathogenesis of ANCA-Associated Vasculitis

ICW5

International Concurrent Workshop 5
Basic Study -1

Chair：Shuji Sumitomo

HiroshiShimagami{SHIMAGAMIHIROSHI島上洋しまがみひろし}|KoheiKarino{KARINOKOHEI狩野皓平かりのこうへい}|AtsubumiOgawa{OGAWAATSUBUMI小川惇史おがわあつぶみ}|DaisukeBaba{BABADAISUKE馬場大介ばばだいすけ}|KatsumasaOe{OEKATSUMASA大江克昌おおえかつまさ}____YuyaKondo{KONDOYUYA近藤裕也こんどうゆうや}____AtsushiKumanogoh{KUMANOGOHATSUSHI熊ノ郷淳くまのごうあつし}|MasayukiNishide{NISHIDEMASAYUKI西出真之にしでまさゆき}|SeiyaOba{OBASEIYA大庭聖也おおばせいや}|MichihitoKono{KONOMICHIHITO河野通仁こうのみちひと}|GeorgeC.Tsokos{TSOKOSGEORGEC.ツォコスジョージつぉこすじょーじ}|TsuneyasuYoshida{YOSHIDATSUNEYASU吉田常恭よしだつねやす}|KeisukeHirobe{HIROBEKEISUKE廣部圭祐ひろべけいすけ}|YasuhiroNohda{NOHDAYASUHIRO納田安啓のうだやすひろ}|TsuneoSasai{SASAITSUNEO笹井恒雄ささいつねお}|MireiShirakashi{SHIRAKASHIMIREI白柏魅怜しらかしみれい}|RyosukeHiwa{HIWARYOSUKE日和良介ひわりょうすけ}|HideakiTsuji{TSUJIHIDEAKI辻英輝つじひであき}|ShujiAkizuki{AKIZUKISHUJI秋月修治あきづきしゅうじ}|KosakuMurakami{MURAKAMIKOSAKU村上孝作むらかみこうさく}|HajimeYoshifuji{YOSHIFUJIHAJIME吉藤元よしふじはじめ}|MotomuHashimoto{HASHIMOTOMOTOMU橋本求はしもともとむ}|AkioMorinobu{MORINOBUAKIO森信暁雄もりのぶあきお}|RanNakashima{NAKASHIMARAN中嶋蘭なかしまらん}|YotaroOki{OKIYOTARO沖庸太郎おきようたろう}|RyoHisada{HISADARYO久田諒ひさだりょう}|KoheiKarino{KARINOKOHEI狩野皓平かりのこうへい}|HiroyukiNakamura{NAKAMURAHIROYUKI中村浩之なかむらひろゆき}|MasaruKato{KATOMASARU加藤将かとうまさる}|TatsuyaAtsumi{ATSUMITATSUYA渥美達也あつみたつや}|ShogoMatsuda{MATSUDASHOGO松田翔悟まつだしょうご}|MahiroYamamoto{YAMAMOTOMAHIRO山本真大やまもとまひろ}|TakuyaKotani{KOTANITAKUYA小谷卓矢こたにたくや}|TohruTakeuchi{TAKEUCHITOHRU武内徹たけうちとおる}____International Concurrent Workshop 6Basic Study -2____Neutrophil heterogeneity and its association with interstitial lung disease prognosis in systemic sclerosis|HIF1 alpha Regulates Th17 Differentiation by Inducing the Expression of ADAM9 in Autoimmune Diseases|MDA5-specific T and B cells drive lung inflammation in a murine model of anti-MDA5 antibody-positive dermatomyositis|Cyclophosphamide and nintedanib combination for interstitial lung disease associated with systemic sclerosis|Serum Calprotectin, S100A8, and S100A9 as prognostic biomarkers for AE-ILD-related mortality and ILD relapse in idiopathic inflammatory myopathies

ICW6

International Concurrent Workshop 6
Basic Study -2

Chair：Yuya Kondo

SadaoJinno{JINNOSADAO神野定男じんのさだお}____YasuhiroKatsumata{KATSUMATAYASUHIRO勝又康弘}________Luncheon Seminar 11Uncontrolled Gout: Disease State, Systemic and Comorbidity-Driven Impact, and Therapeutic Strategies____Uncontrolled Gout: Disease State, Systemic and Comorbidity-Driven Impact, and Therapeutic Strategies

LS11

Luncheon Seminar 11
Uncontrolled Gout: Disease State, Systemic and Comorbidity-Driven Impact, and Therapeutic Strategies

【Sponsored by Swedish Orphan Biovitrum AB (publ)】

Chair：Yasuhiro Katsumata

Speaker：Sadao Jinno

JinyiZhao{ZHAOJINYI}|RyuyaEdahiro{EDAHIRORYUYA枝廣龍哉えだひろりゅうや}|WataruFujii{FUJIIWATARU藤井渉ふじいわたる}|YasuyukiTodoroki{TODOROKIYASUYUKI轟泰幸とどろきやすゆき}|TomohisaUchida{UCHIDATOMOHISA内田智久うちだともひさ}____TakayukiKatsuyama{KATSUYAMATAKAYUKI勝山隆行かつやまたかゆき}____FengLiu{LIUFENG}|ClaudiaWorth{WORTHCLAUDIA}|PaulBowness{BOWNESSPAUL}|LiyeChen{CHENLIYE}|YoshihikoTomofuji{TOMOFUJIYOSHIHIKO友藤嘉彦ともふじよしひこ}|TakayoshiMorita{MORITATAKAYOSHI森田貴義もりたたかよし}|YasuhiroKato{KATOYASUHIRO加藤保宏かとうやすひろ}|AtsushiKumanogoh{KUMANOGOHATSUSHI熊ノ郷淳くまのごうあつし}|YukinoriOkada{OKADAYUKINORI岡田随象おかだゆきのり}|HideakiSofue{SOFUEHIDEAKI祖父江秀晃そふえひであき}|AnnaHasegawa{HASEGAWAANNA長谷川杏奈はせがわあんな}|TomokaHiyama{HIYAMATOMOKA檜山知佳ひやまともか}|SaraKomatsu{KOMATSUSARA小松紗良こまつさら}|KaitoNakamura{NAKAMURAKAITO中村海人なかむらかいと}|TomoyukiMiyao{MIYAOTOMOYUKI宮尾智之みやおともゆき}|AyaeTanaka{TANAKAAYAE田中彩絵たなかあやえ}|SatokoArai{ARAISATOKO新井聡子あらいさとこ}|ReikaMaezawa{MAEZAWAREIKA前澤玲華まえざわれいか}|MasafumiArima{ARIMAMASAFUMI有馬雅史ありままさふみ}|YutakaKawahito{KAWAHITOYUTAKA川人豊かわひとゆたか}|KeiIkeda{IKEDAKEI池田啓いけだけい}|SatoshiKubo{KUBOSATOSHI久保智史くぼさとし}|MinoruSatoh{SATOHMINORU佐藤実さとうみのる}|HiroakiTanaka{TANAKAHIROAKI田中宏明たなかひろあき}|AtsushiNagayasu{NAGAYASUATSUSHI永安敦ながやすあつし}|KiyotakeYoshioka{YOSHIOKAKIYOTAKE吉岡聖剛よしおかきよたけ}|IppeiMiyagawa{MIYAGAWAIPPEI宮川一平みやがわいっぺい}|YusukeMiyazaki{MIYAZAKIYUSUKE宮崎佑介みやざきゆうすけ}|MasanobuUeno{UENOMASANOBU上野匡庸うえのまさのぶ}|RyuichiroKanda{KANDARYUICHIRO神田龍一郎かんだりゅういちろう}|YuyaFujita{FUJITAYUYA藤田悠哉ふじたゆうや}|HidenoriSakai{SAKAIHIDENORI酒井秀典さかいひでのり}|YoshiyaTanaka{TANAKAYOSHIYA田中良哉たなかよしや}|ShingoNakayamada{NAKAYAMADASHINGO中山田真吾なかやまだしんご}|NaokiIwamoto{IWAMOTONAOKI岩本直樹いわもとなおき}|ShoichiFukui{FUKUISHOICHI福井翔一ふくいしょういち}|MasatakaUmeda{UMEDAMASATAKA梅田雅孝うめだまさたか}|TohruMichitsuji{MICHITSUJITOHRU道辻徹みちつじとおる}|YukitakaUeki{UEKIYUKITAKA植木幸孝うえきゆきたか}|AtsushiKawakami{KAWAKAMIATSUSHI川上純かわかみあつし}____International Concurrent Workshop 11Basic Study -3____HLA-B27-Driven CCL20+CD14+ Myeloid Cells Orchestrate Inflammatory Circuits in Axial Spondyloarthritis|Multi-layered single-cell genomics deconvolutes biological mechanisms underlying clonal hematopoiesis and mitochondrial heteroplasmy in infectious and autoimmune diseases|Therapeutic effect of albumin-fused IL-10 on macrophage activation syndrome mouse model|Clinical and immunological characteristics of interstitial lung disease (ILD) relapse in anti-synthetase syndrome (ASyS)|Pathogenic Role of MED30 and Anti-MED30 Antibodies in Systemic Sclerosis: Implications for Fibroblast Activation

ICW11

International Concurrent Workshop 11
Basic Study -3

Chair：Takayuki Katsuyama

ShojiKawada{KAWADASHOJI川田翔司かわだしょうじ}|TakayukiShibahara{SHIBAHARATAKAYUKI柴原理志しばはらたかゆき}|AmiIsoda{ISODAAMI礒田杏実いそだあみ}|GhizalFatima{FATIMAGHIZAL}|KeTang{TANGKE}____MichihitoKono{KONOMICHIHITO河野通仁こうのみちひと}____MasayukiNishide{NISHIDEMASAYUKI西出真之にしでまさゆき}|AtsushiKumanogoh{KUMANOGOHATSUSHI熊ノ郷淳くまのごうあつし}|TakahiroItamiya{ITAMIYATAKAHIRO板宮孝紘いたみやたかひろ}|TatsukiAbe{ABETATSUKI安部樹あべたつき}|HarukaTsuchiya{TSUCHIYAHARUKA土屋遥香つちやはるか}|TomohisaOkamura{OKAMURATOMOHISA岡村僚久おかむらともひさ}|KeishiFujio{FUJIOKEISHI藤尾圭志ふじおけいし}|HemaliJha{JHAHEMALI}|AbbasAli.Mahdi{MAHDIABBASALI.}|ChengZhang{ZHANGCHENG}|HuaHaiJiang{JIANGHUAHAI}|NaHuiHuang{HUANGNAHUI}|AngLin{LINANG}|GuanWang{WANGGUAN}|XiaLi{LIXIA}____International Concurrent Workshop 12Basic Study -4____Semaphorin 7A promotes neutrophil extracellular trap formation and contributes to the pathogenesis of ANCA-associated vasculitis|Microbial dysbiosis promotes STING-driven autoinflammation through cyclic dinucleotides|Evaluation of the utility of interferon scores in autoimmune disease using fine-sorted immune cell subsets|Circadian Rhythm Disruption, Gut Microbiota Dysbiosis, and Environmental Toxicants in Fibromyalgia: An Integrative Multi-System Case-Control Study|Study on the Efficacy and Mechanism of DHRS2 Involvement in IL-1Ra-mRNA-LNP Therapy for Psoriasis

ICW12

International Concurrent Workshop 12
Basic Study -4

Chair：Michihito Kono

HidekiOka{OKAHIDEKI岡秀樹おかひでき}|SatoshiOmura{OMURASATOSHI大村知史おおむらさとし}|HirokaEda{EDAHIROKA江田尋香えだひろか}|MasakoUtsunomiya{UTSUNOMIYAMASAKO宇都宮雅子うつのみやまさこ}|MasahiroYasui{YASUIMASAHIRO安井昌博やすいまさひろ}|KiyohiroKai{KAIKIYOHIRO甲斐心皓かいきよひろ}____ToshihiroNanki{NANKITOSHIHIRO南木敏宏なんきとしひろ}____ShujiSumitomo{SUMITOMOSHUJI住友秀次すみともしゅうじ}|ShogoMatsuda{MATSUDASHOGO松田翔悟まつだしょうご}|AyanaOkazaki{OKAZAKIAYANA岡崎彩奈おかざきあやな}|YuichiMasuda{MASUDAYUICHI増田裕一ますだゆういち}|ShingoIwasaka{IWASAKASHINGO岩阪晋吾いわさかしんご}|MikihitoShoji{SHOJIMIKIHITO小路幹人しょうじみきひと}|KeiichiroKadoba{KADOBAKEIICHIRO門場啓一郎かどばけいいちろう}|MuneyukiHatta{HATTAMUNEYUKI八田宗之はったむねゆき}|MayuShiomi{SHIOMIMAYU塩見真由しおみまゆ}|RyuWatanabe{WATANABERYU渡部龍わたなべりゅう}|KahoJo{JOKAHO城可方じょうかほ}|WataruYamamoto{YAMAMOTOWATARU山本渉やまもとわたる}|YouheiFujiki{FUJIKIYOUHEI藤木陽平ふじきようへい}|HirofumiMiyake{MIYAKEHIROFUMI三宅啓史みやけひろふみ}|TakuyaKotani{KOTANITAKUYA小谷卓矢こたにたくや}|RyosukeHiwa{HIWARYOSUKE日和良介ひわりょうすけ}|MotomuHashimoto{HASHIMOTOMOTOMU橋本求はしもともとむ}|KoichiroOhmura{OHMURAKOICHIRO大村浩一郎おおむらこういちろう}|TakashiKida{KIDATAKASHI木田節きだたかし}|DaikiNakagomi{NAKAGOMIDAIKI中込大樹なかごみだいき}|YoshiyukiAbe{ABEYOSHIYUKI安倍能之あべよしゆき}|MakotoWada{WADAMAKOTO和田誠わだまこと}|NaohoTakizawa{TAKIZAWANAOHO滝澤直歩たきざわなおほ}|AtsushiNomura{NOMURAATSUSHI野村篤史のむらあつし}|YujiKukida{KUKIDAYUJI茎田祐司くきだゆうじ}|HirosukeTakagi{TAKAGIHIROSUKE髙木博佑たかぎひろすけ}|KojiEndo{ENDOKOJI遠藤功二えんどうこうじ}|ShintaroHirata{HIRATASHINTARO平田信太郎ひらたしんたろう}|NaotoAzuma{AZUMANAOTO東直人あずまなおと}|TohruTakeuchi{TAKEUCHITOHRU武内徹たけうちとおる}|ShoichiFukui{FUKUISHOICHI福井翔一ふくいしょういち}|KazuroKamada{KAMADAKAZURO鎌田和郎かまだかずろう}|RyoYanai{YANAIRYO柳井亮やないりょう}|YusukeMatsuo{MATSUOYUSUKE松尾祐介まつおゆうすけ}|YasuhiroShimojima{SHIMOJIMAYASUHIRO下島恭弘しもじまやすひろ}|RyoNishioka{NISHIOKARYO西岡亮にしおかりょう}|RyotaOkazaki{OKAZAKIRYOTA岡﨑亮太おかざきりょうた}|MayukoMoriyama{MORIYAMAMAYUKO森山繭子もりやままゆこ}|AyukoTakatani{TAKATANIAYUKO髙谷亜由子たかたにあゆこ}|YoshiaMiyawaki{MIYAWAKIYOSHIA宮脇義亜みやわきよしあ}|TsuyoshiShirai{SHIRAITSUYOSHI白井剛志しらいつよし}|HiroakiDobashi{DOBASHIHIROAKI土橋浩章どばしひろあき}|IsaoMatsumoto{MATSUMOTOISAO松本功まつもといさお}|ToshihikoTakada{TAKADATOSHIHIKO高田俊彦たかだとしひこ}|YutakaKawahito{KAWAHITOYUTAKA川人豊かわひとゆたか}|KeitaKimura{KIMURAKEITA木村圭汰きむらけいた}|MayukoTakekoshi{TAKEKOSHIMAYUKO竹越麻祐子たけこしまゆこ}|RikaSato{SATORIKA佐藤理華さとうりか}|SaraKomatsu{KOMATSUSARA小松紗良こまつさら}|YuhiYoshida{YOSHIDAYUHI吉田雄飛よしだゆうひ}|AnnaHasegawa{HASEGAWAANNA長谷川杏奈はせがわあんな}|TomokaHiyama{HIYAMATOMOKA檜山知佳ひやまともか}|KaitoNakamura{NAKAMURAKAITO中村海人なかむらかいと}|TomoyukiMiyao{MIYAOTOMOYUKI宮尾智之みやおともゆき}|AyaeTanaka{TANAKAAYAE田中彩絵たなかあやえ}|WataruFujii{FUJIIWATARU藤井渉ふじいわたる}|SatokoArai{ARAISATOKO新井聡子あらいさとこ}|ReikaMaezawa{MAEZAWAREIKA前澤玲華まえざわれいか}|MasafumiArima{ARIMAMASAFUMI有馬雅史ありままさふみ}|KeiIkeda{IKEDAKEI池田啓いけだけい}|JunjiMorisawa{MORISAWAJUNJI森澤淳司もりさわじゅんじ}|MasashiInoue{INOUEMASASHI井上将いのうえまさし}|HirokazuTatsumi{TATSUMIHIROKAZU辰巳裕和たつみひろかず}|SairiTakahashi{TAKAHASHISAIRI髙橋彩理たかはしさいり}|KazuhikoHirokawa{HIROKAWAKAZUHIKO廣川和彦ひろかわかずひこ}|KotaroKomori{KOMORIKOTARO小森宏太郎こもりこうたろう}|YukiTerashima{TERASHIMAYUKI寺島侑希てらしまゆき}|KeiichiUchiyama{UCHIYAMAKEIICHI内山桂一うちやまけいいち}|IsseiTakahashi{TAKAHASHIISSEI高橋一世たかはしいっせい}|TomohiroKato{KATOTOMOHIRO加藤智大かとうともひろ}|MasahiroIida{IIDAMASAHIRO飯田雅博いいだまさひろ}|HirofumiSaito{SAITOHIROFUMI齋藤浩史さいとうひろふみ}|YoshitakaUeda{UEDAYOSHITAKA上田佳孝うえだよしたか}|EisukeTakamasu{TAKAMASUEISUKE髙增英輔たかますえいすけ}|KaeOnishi{ONISHIKAE大西香絵おおにしかえ}|YujiMiyoshi{MIYOSHIYUJI三好雄二みよしゆうじ}|YoshikiNagai{NAGAIYOSHIKI永井佳樹ながいよしき}|NaotoYokogawa{YOKOGAWANAOTO横川直人よこがわなおと}|KotaShimada{SHIMADAKOTA島田浩太しまだこうた}|ShunsukeFuruta{FURUTASHUNSUKE古田俊介ふるたしゅんすけ}|MitsuteruAkahoshi{AKAHOSHIMITSUTERU赤星光輝あかほしみつてる}|MitsuhiroAkiyama{AKIYAMAMITSUHIRO秋山光浩あきやまみつひろ}|YujiAkiayama{AKIAYAMAYUJI秋山雄次あきやまゆうじ}|HiroshiFujii{FUJIIHIROSHI藤井博司ふじいひろし}|MichioFujiwara{FUJIWARAMICHIO藤原道雄ふじわらみちお}|MasashiFukuta{FUKUTAMASASHI福田匡志ふくたまさし}|KeijuHiromura{HIROMURAKEIJU廣村桂樹ひろむらけいじゅ}|TomoakiIda{IDATOMOAKI井田友明いだともあき}|Shin-ichiroKagami{KAGAMISHIN-ICHIRO加々美新一郎かがみしんいちろう}|YoshihisaKobayashi{KOBAYASHIYOSHIHISA小林芳久こばやしよしひさ}|HajimeKono{KONOHAJIME河野肇こうのはじめ}|TakahikoKurasawa{KURASAWATAKAHIKO倉沢隆彦くらさわたかひこ}|HiroakiNiiro{NIIROHIROAKI新納宏昭にいろひろあき}|YoshihiroOoya{OOYAYOSHIHIRO大矢佳寛おおやよしひろ}|ToyohikoSugimoto{SUGIMOTOTOYOHIKO杉本豊彦すぎもととよひこ}|TomohiroTamachi{TAMACHITOMOHIRO玉地智宏たまちともひろ}|NaotoTamura{TAMURANAOTO田村直人たむらなおと}|HiroshiNakajima{NAKAJIMAHIROSHI中島裕史なかじまひろし}|MariKobayashi-Iwase{KOBAYASHI-IWASEMARI小林麻里こばやしまり}|MasayaYokota{YOKOTAMASAYA横田雅也よこたまさや}|MasakiHiraguri{HIRAGURIMASAKI平栗雅樹ひらぐりまさき}____Workshop 11Treatment strategy for ANCA associated vasculitis____Association Between the Number of Rituximab Infusions and Prognosis During Remission-Induction Therapy in Microscopic Polyangiitis and Granulomatosis with Polyangiitis: the Multicenter REVEAL Cohort|Effectiveness of intravenous methylprednisolone pulse in ANCA-associated vasculitis with glomerulonephritis: using the J-CANVAS registry|Comparison of Clinical Outcomes Between Rituximab and Cyclophosphamide Therapy in Patients With Microscopic Polyangiitis or Granulomatosis With Polyangiitis|Mycophenolate Mofetil Use in ANCA-Associated Vasculitis: A Single-Center Retrospective Study in Japan|Rituximab maintenance therapy for ANCA-associated vasculitis|Evaluation of treatment efficacy for otitis media with ANCA-associated vasculitis (OMAAV)

W11

Workshop 11
Treatment strategy for ANCA associated vasculitis

Chair：Toshihiro Nanki

MakotoYamaguchi{YAMAGUCHIMAKOTO山口真やまぐちまこと}|TakeshiSuzuki{SUZUKITAKESHI鈴木豪すずきたけし}|ToshihideKimura{KIMURATOSHIHIDE木村俊英きむらとしひで}|SokoKawashima{KAWASHIMASOKO川嶋聡子かわしまそうこ}|HiroakiDobashi{DOBASHIHIROAKI土橋浩章どばしひろあき}|ErikaHorimoto{HORIMOTOERIKA堀元絵梨花ほりもとえりか}____KeijuHiromura{HIROMURAKEIJU廣村桂樹ひろむらけいじゅ}____HirokazuSugiyama{SUGIYAMAHIROKAZU杉山浩一すぎやまひろかず}|KeisukeKamiya{KAMIYAKEISUKE神谷圭介かみやけいすけ}|TakayukiKatsuno{KATSUNOTAKAYUKI勝野敬之かつのたかゆき}|ShogoBannno{BANNNOSHOGO坂野章吾ばんのしょうご}|YasuhikoIto{ITOYASUHIKO伊藤恭彦いとうやすひこ}|TakujiIshimoto{ISHIMOTOTAKUJI石本卓嗣いしもとたくじ}|MatsuiTakayuki{TAKAYUKIMATSUI松井隆之まついたかゆき}|IshizakiYoshiki{YOSHIKIISHIZAKI石﨑克樹いしざきよしき}|TakayasuAndo{ANDOTAKAYASU安藤貴泰あんどうたかやす}|ShotaroSuzuki{SUZUKISHOTARO鈴木翔太郎すずきしょうたろう}|KeiichiSakurai{SAKURAIKEIICHI櫻井恵一さくらいけいいち}|KumikoTonooka{TONOOKAKUMIKO殿岡久美子とのおかくみこ}|YukikoTakakuwa{TAKAKUWAYUKIKO高桑由希子たかくわゆきこ}|HirokoNagafuchi{NAGAFUCHIHIROKO永渕裕子ながふちひろこ}|SeidoOoka{OOKASEIDO大岡正道おおおかせいどう}|KimitoKawahata{KAWAHATAKIMITO川畑仁人かわはたきみと}|MachikoTachibana{TACHIBANAMACHIKO橘万智子たちばなまちこ}|RyutoHobo{HOBORYUTO保浦理勇斗ほぼりゅうと}|KahoKondo{KONDOKAHO近藤香歩こんどうかほ}|RisaOhara{OHARARISA小原理更おはらりさ}|NaokiDosoden{DOSODENNAOKI道祖田直紀どうそでんなおき}|KodaiIto{ITOKODAI伊藤公大いとうこうだい}|MarikaSawada{SAWADAMARIKA澤田茉莉加さわだまりか}|YumiIto{ITOYUMI伊藤佑充いとうゆみ}|NatsukoWatanabe{WATANABENATSUKO渡邉奈津子わたなべなつこ}|TatsuakiNaganawa{NAGANAWATATSUAKI長縄達明ながなわたつあき}|AiUmeda{UMEDAAI梅田愛うめだあい}|ChiaiNakata{NAKATACHIAI中田知愛なかたちあい}|KonomiAkamatsu{AKAMATSUKONOMI赤松このみあかまつこのみ}|MegumiKurumizawa{KURUMIZAWAMEGUMI胡桃沢芽久美くるみざわめぐみ}|TakakoHashimoto{HASHIMOTOTAKAKO橋本貴子はしもとたかこ}|ShusakuFukaya{FUKAYASHUSAKU深谷修作ふかやしゅうさく}|HidekataYasuoka{YASUOKAHIDEKATA安岡秀剛やすおかひでかた}|RieKunitomo{KUNITOMORIE國友理恵くにともりえ}|AyakoMiyamoto{MIYAMOTOAYAKO宮本彩子みあもとあやこ}|ShoFukui{FUKUISHO福井翔ふくいしょう}|HikaruKukimoto{KUKIMOTOHIKARU久木元光くきもとひかる}|NorihiroNishioka{NISHIOKANORIHIRO西岡典宏にしおかのりひろ}|NorikoIkegaya{IKEGAYANORIKO池谷紀子いけがやのりこ}|NobuhiroAyuzawa{AYUZAWANOBUHIRO鮎澤信宏あゆざわのぶひろ}|TakahisaKawakami{KAWAKAMITAKAHISA川上貴久かわかみたかひさ}|MitsumasaKishimoto{KISHIMOTOMITSUMASA岸本暢将きしもとみつまさ}|YoshinoriKomagata{KOMAGATAYOSHINORI駒形嘉紀こまがたよしのり}|NaotoTamura{TAMURANAOTO田村直人たむらなおと}|KeijuHiromura{HIROMURAKEIJU廣村桂樹ひろむらけいじゅ}|HiroakiEndo{ENDOHIROAKI遠藤宏明えんどうひろあき}|KazunoriAbe{ABEKAZUNORI阿部一典あべかずのり}|MasayoshiHarigai{HARIGAIMASAYOSHI針谷正祥はりがいまさよし}|JunIshizaki{ISHIZAKIJUN石﨑淳いしざきじゅん}|RisakoYamaguchi{YAMAGUCHIRISAKO山口りさこやまぐちりさこ}|KentaHorie{HORIEKENTA堀江健太ほりえけんた}|DaisukeHiraoka{HIRAOKADAISUKE平岡大輔ひらおかだいすけ}|TakuyaMatsumoto{MATSUMOTOTAKUYA松本卓也まつもとたくや}|KoichiroSuemori{SUEMORIKOICHIRO末盛浩一郎すえもりこういちろう}|KatsutoTakenaka{TAKENAKAKATSUTO竹中克斗たけなかかつと}____Workshop 12Treatment for ANCA associated vasculitis (avacopan)____Efficacy and Safety of Avacopan in Patients with ANCA-Associated Vasculitis|Impact of Avacopan on Glucocorticoid Discontinuation and Reinitiation in ANCA-Associated Vasculitis: Real-World Data Analysis|Efficacy and safety of avacopan usage for microscopic polyangitis and granumatosis with polyantitis in our hospital|Analysis of clinical outcomes in microscopic polyangiitis and granulomatosis with polyangiitis treated with avacopan for maintenance therapy|Interim Report of the Avacopan Special Drug Use-results Survey (Post-Marketing Surveillance; PMS) in Japan -2nd Report (One Year Report)-|A Case of Refractory Eosinophilic Granulomatosis with Polyangiitis with Optic Perineuritis Successfully Treated with Avacopan

W12

Workshop 12
Treatment for ANCA associated vasculitis (avacopan)

Chair：Keiju Hiromura

AtsushiKumanogoh{KUMANOGOHATSUSHI熊ノ郷淳くまのごうあつし}|ShingoNakayamada{NAKAYAMADASHINGO中山田真吾なかやまだしんご}____HirokiTakahashi{TAKAHASHIHIROKI髙橋裕樹たかはしひろき}|IsaoMatsumoto{MATSUMOTOISAO松本功まつもといさお}________Luncheon Seminar 12Pathophysiology and clinical issues of Sjögren disease____Pathophysiological mechanisms in autoimmune diseases: The role of B cells|Diagnosis and Assessment of Disease Activity in Sjögren's Disease ~ Theory and Practice ~

LS12

Luncheon Seminar 12
Pathophysiology and clinical issues of Sjögren disease

【Sponsored by Novartis Pharma K.K.】

Chair：Hiroki Takahashi, Chair：Isao Matsumoto

Speaker：Atsushi Kumanogoh

Speaker：Shingo Nakayamada

YuriSasaki{SASAKIYURI佐々木優李ささきゆり}|MasaoOgura{OGURAMASAO小椋雅夫おぐらまさお}|TaijiKosaka{KOSAKATAIJI小坂泰司こさかたいじ}|HidekazuIkeuchi{IKEUCHIHIDEKAZU池内秀和いけうちひでかず}|YujiKamijo{KAMIJOYUJI上條祐司かみじようゆうじ}|KeisukeSako{SAKOKEISUKE迫恵輔さこけいすけ}____YasuhiroShimojima{SHIMOJIMAYASUHIRO下島恭弘しもじまやすひろ}____RyotaSakai{SAKAIRYOTA酒井亮太さかいりょうた}|TakumiAoki{AOKITAKUMI青木拓海あおきたくみ}|TaijiKosaka{KOSAKATAIJI小坂泰司こさかたいじ}|ShoichiYoshinaga{YOSHINAGASHOICHI吉永正一よしながしょういち}|AkikoShibata{SHIBATAAKIKO柴田明子しばたあきこ}|TakahikoKurasawa{KURASAWATAKAHIKO倉沢隆彦くらさわたかひこ}|KoichiAmano{AMANOKOICHI天野宏一あまのこういち}|HironariHanaoka{HANAOKAHIRONARI花岡洋成はなおかひろなり}|TomoyaNakamizo{NAKAMIZOTOMOYA中溝智也なかみぞともや}|KentaroNishi{NISHIKENTARO西健太朗にしけんたろう}|ShuichiIto{ITOSHUICHI伊藤秀一いとうしゅういち}|YuriSasaki{SASAKIYURI佐々木優李ささきゆり}|SyoichiYosinaga{YOSINAGASYOICHI吉永正一よしながしょういち}|AkikoSibata{SIBATAAKIKO柴田明子しばたあきこ}|KeijuHiromura{HIROMURAKEIJU廣村桂樹ひろむらけいじゅ}|TanakaYoshiya{YOSHIYATANAKA田中良哉たなかよしや}|SatoshiKubo{KUBOSATOSHI久保智史くぼさとし}|SingoNakayamada{NAKAYAMADASINGO中山田真吾なかやまだしんご}|HirokoSato{SATOHIROKO佐藤紘子さとうひろこ}|TomonoriIshii{ISHIITOMONORI石井智徳いしいとものり}|HayatoShimizu{SHIMIZUHAYATO志水隼人しみずはやと}|ShujiSumitomo{SUMITOMOSHUJI住友秀次すみともしゅうじ}|KoichiroOhmura{OHMURAKOICHIRO大村浩一郎おおむらこういちろう}|HirokiHayashi{HAYASHIHIROKI林宏樹はやしひろき}|MichihitoKono{KONOMICHIHITO河野通仁こうのみちひと}|TatsuyaAtsumi{ATSUMITATSUYA渥美達也あつみたつや}|AkinoriYamaguchi{YAMAGUCHIAKINORI山口晃典やまぐちあきのり}|YoshitadaYoyota{YOYOTAYOSHITADA豊田善真とよたよしただ}|ShioriNakagawa{NAKAGAWASHIORI中川詩織なかがわしおり}|YutaYamamura{YAMAMURAYUTA山村雄太やまむらゆうた}|MegumiOshima{OSHIMAMEGUMI大島恵おおしまめぐみ}|SatoshiHara{HARASATOSHI原怜史はらさとし}|KiyoakiIto{ITOKIYOAKI伊藤清亮いとうきよあき}|NorihikoSakai{SAKAINORIHIKO坂井宣彦さかいのりひこ}|YasunoriIwata{IWATAYASUNORI岩田恭宜いわたやすのり}____Workshop 22pathophisiology of Lupus Nephritis____Long-term Outcomes of Lupus Nephritis with Low Proteinuria at Diagnosis|Urinary Findings and Renal Histopathological Activity in Pediatric SLE with Class III/IV Lupus Nephritis|Predictors and outcomes of rapid glucocorticoid tapering in lupus nephritis class III/IV|Impact of Rapid Glucocorticoid Tapering in Pure Membranous Lupus Nephritis: A Nationwide Multicenter Study in Japan|Usefulness of Serum Sulfatides level as a Novel Activity Marker in Lupus Nephritis|Clinical Significance of Circulating KIM-1 Measurement in Lupus Nephritis: Association with Long-term Renal Outcomes

W22

Workshop 22
pathophisiology of Lupus Nephritis

Chair：Yasuhiro Shimojima

YumiYoshitama{YOSHITAMAYUMI吉玉優美よしたまゆうみ}|AyanaOkazaki{OKAZAKIAYANA岡崎彩奈おかざきあやな}|MasahiroYokosawa{YOKOSAWAMASAHIRO横澤将宏よこさわまさひろ}|TakahikoKurasawa{KURASAWATAKAHIKO倉沢隆彦くらさわたかひこ}|KyokoTakita{TAKITAKYOKO田北響子たきたきょうこ}|YasuhiroKiyonaga{KIYONAGAYASUHIRO清永恭弘きよながやすひろ}____YoshinoriKomagata{KOMAGATAYOSHINORI駒形嘉紀こまがたよしのり}|KeneiSada{SADAKENEI佐田憲映さだけんえい}____KazutakaKawamori{KAWAMORIKAZUTAKA河森一毅かわもりかずたか}|TakuyaSaito{SAITOTAKUYA斉藤拓哉さいとうたくや}|JumpeiFukita{FUKITAJUMPEI蕗田淳平ふきたじゅんぺい}|RyoInoue{INOUERYO井上良いのうえりょう}|YokoMiura{MIURAYOKO三浦瑶子みうらようこ}|NobuyukiYajima{YAJIMANOBUYUKI矢嶋宣幸やじまのぶゆき}|ShogoMatsuda{MATSUDASHOGO松田翔悟まつだしょうご}|YuichiMasuda{MASUDAYUICHI増田裕一ますだゆういち}|TakuyaKotani{KOTANITAKUYA小谷卓矢こたにたくや}|ShingoIwasaka{IWASAKASHINGO岩阪晋吾いわさかしんご}|MikihitoShoji{SHOJIMIKIHITO小路幹人しょうじみきひと}|KeiichiroKadoba{KADOBAKEIICHIRO門場啓一郎かどばけいいちろう}|MuneyukiHatta{HATTAMUNEYUKI八田宗之はったむねゆき}|MayuShiomi{SHIOMIMAYU塩見真由しおみまゆ}|RyuWatanabe{WATANABERYU渡部龍わたなべりゅう}|KahoJo{JOKAHO城可方じょうかほ}|YouheiFujiki{FUJIKIYOUHEI藤木陽平ふじきようへい}|HirofumiMiyake{MIYAKEHIROFUMI三宅啓史みやけひろふみ}|HidekiOka{OKAHIDEKI岡秀樹おかひでき}|ShujiSumitomo{SUMITOMOSHUJI住友秀次すみともしゅうじ}|WataruYamamoto{YAMAMOTOWATARU山本渉やまもとわたる}|MotomuHashimoto{HASHIMOTOMOTOMU橋本求はしもともとむ}|TohruTakeuchi{TAKEUCHITOHRU武内徹たけうちとおる}|KahoTakahashi{TAKAHASHIKAHO髙橋香帆たかはしかほ}|KeiichiroKanai{KANAIKEIICHIRO金井慶一郎かないけいいちろう}|MasanobuHorikoshi{HORIKOSHIMASANOBU堀越正信ほりこしまさのぶ}|TakumiAoki{AOKITAKUMI青木拓海あおきたくみ}|YuriSasaki{SASAKIYURI佐々木優李ささきゆり}|TaijiKosaka{KOSAKATAIJI小坂泰司こさかたいじ}|ShoichiYoshinaga{YOSHINAGASHOICHI吉永正一よしながしょういち}|AkikoShibata{SHIBATAAKIKO柴田明子しばたあきこ}|RyotaSakai{SAKAIRYOTA酒井亮太さかいりょうた}|KoichiAmano{AMANOKOICHI天野宏一あまのこういち}|HironariHanaoka{HANAOKAHIRONARI花岡洋成はなおかひろなり}|KazuhiroOgawa{OGAWAKAZUHIRO小川和浩おがわかずひろ}|ToshitakaYukishima{YUKISHIMATOSHITAKA雪嶋俊孝ゆきしまとしたか}|MasakazuHatakeyama{HATAKEYAMAMASAKAZU畠山真和はたけやままさかず}|YusukeOkubo{OKUBOYUSUKE大久保悠介おおくぼゆうすけ}|ShogoFurukawa{FURUKAWASHOGO古川省悟ふるかわしょうご}|RyuheiYasuoka{YASUOKARYUHEI安岡竜平やすおかりゅうへい}|KumikoShimoyama{SHIMOYAMAKUMIKO下山久美子しもやまくみこ}|DaishiYoshida{YOSHIDADAISHI吉田大史よしだだいし}|TasukuAbe{ABETASUKU安部佑あべたすく}|MinekoHamano{HAMANOMINEKO濱野峰子はまのみねこ}|OzakiTakashi{TAKASHIOZAKI尾崎貴士おざきたかし}|KojiIshii{ISHIIKOJI石井宏治いしいこうじ}|ShibataHirotaka{HIROTAKASHIBATA柴田洋孝しばたひろたか}____Workshop 23Treatment for eosinophilic granulomatosis with polyangiitis (EGPA)____Clinical Characteristics and Risk Factors for Relapse in Patients with Eosinophilic Granulomatosis with Polyangiitis Who Relapsed During Mepolizumab Therapy|Efficacy of Early Mepolizumab(MEPO) Introduction During Remission Induction in Eosinophilic Granulomatosis with Polyangiitis (EGPA): The REVEAL Cohort Study|Clinical Evaluation of Mepolizumab in Patients with Eosinophilic Granulomatosis with Polyangiitis and Multiple Mononeuropathy|Exploring Factors Achieving Glucocorticoid-Free Remission in Eosinophilic Granulomatosis with Polyangiitis|Cardiac manifestations of eosinophilic granulomatosis with polyangiitis (EGPA)|Experience with mepolizumab (MEP) 100 mg every 4 weeks for eosinophilic granulomatosis with polyangiitis (EGPA)

W23

Workshop 23
Treatment for eosinophilic granulomatosis with polyangiitis (EGPA)

Chair：Yoshinori Komagata, Chair：Kenei Sada

ShoheiAnno{ANNOSHOHEI安野翔平あんのしょうへい}|TaichiHayashi{HAYASHITAICHI林太智はやしたいち}____MasatoOkada{OKADAMASATO岡田正人おかだまさと}________Evening Seminar 6Psoriatic Arthritis: A Debate on Composite Measures and Patient-Reported Outcomes in Daily Practice____The needs for T2T strategy using composite measure evaluation|What MDA Misses: The Importance of Listening to Patients' Unspoken Burdens

ES6

Evening Seminar 6
Psoriatic Arthritis: A Debate on Composite Measures and Patient-Reported Outcomes in Daily Practice

【Sponsored by UCB Japan Co. Ltd.】

Chair：Masato Okada

Speaker：Shohei Anno

Speaker：Taichi Hayashi

MikaHatano{HATANOMIKA羽多野美香はたのみか}|KotaroKitade{KITADEKOTARO北出浩太郎きたでこうたろう}|KeitaImanishi{IMANISHIKEITA今西啓太いまにしけいた}|FumiyukiShibasaki{SHIBASAKIFUMIYUKI柴崎史行しばさきふみゆき}|KanakoChujo{CHUJOKANAKO中條加奈子ちゅうじょうかなこ}|HirokiMitoma{MITOMAHIROKI三苫弘喜みとまひろき}____YasushiKawaguchi{KAWAGUCHIYASUSHI川口鎮司かわぐちやすし}____TakakoMiyamae{MIYAMAETAKAKO宮前多佳子みやまえたかこ}|NobuyukiYajima{YAJIMANOBUYUKI矢嶋宣幸やじまのぶゆき}|UtakoKaneko{KANEKOUTAKO金子詩子かねこうたこ}|ShuyaKaneko{KANEKOSHUYA金子修也かねこしゅうや}|IkukoUeda{UEDAIKUKO植田郁子うえだいくこ}|MasatoshiJinnin{JINNINMASATOSHI神人正寿じんにんまさとし}|YasushiKawaguchi{KAWAGUCHIYASUSHI川口鎮司かわぐちやすし}|YoshihitoShima{SHIMAYOSHIHITO嶋良仁しまよしひと}|HidetakaYasuoka{YASUOKAHIDETAKA安岡秀剛やすおかひでたか}|MasaruHatano{HATANOMASARU波多野将はたのまさる}|MasakiShimizu{SHIMIZUMASAKI清水正樹しみずまさき}|NaokiMugii{MUGIINAOKI麦井直樹むぎいなおき}|YuIsoda{ISODAYU礒田有いそだゆう}|AmaneNakabayashi{NAKABAYASHIAMANE中林周なかばやしあまね}|MakotoWada{WADAMAKOTO和田誠わだまこと}|AtsushiOmoto{OMOTOATSUSHI尾本篤志おもとあつし}|YutakaKawahito{KAWAHITOYUTAKA川人豊かわひとゆたか}|HirotoOjiro{OJIROHIROTO小代啓斗おじろひろと}|WataruNakamura{NAKAMURAWATARU中村航なかむらわたる}|YujinNishioka{NISHIOKAYUJIN西岡雄仁にしおかゆうじん}|AkiraKatagiri{KATAGIRIAKIRA片桐彰かたぎりあきら}|YuyaKondo{KONDOYUYA近藤裕也こんどうゆうや}|ReinaKikuchi{KIKUCHIREINA菊池怜菜きくちれいな}|YoshinoriTani{TANIYOSHINORI谷佳憲たによしのり}|KotaroTokunaga{TOKUNAGAKOTARO德永光太郎とくながこうたろう}|NaokiSugita{SUGITANAOKI杉田直輝すぎたなおき}|AkiyoshiRai{RAIAKIYOSHI頼哲誼らいあきよし}|FuminaKawashima{KAWASHIMAFUMINA川島典奈かわしまふみな}|ToshikiSugita{SUGITATOSHIKI杉田稔貴すぎたとしき}|TaiheiNishiyama{NISHIYAMATAIHEI西山泰平にしやまたいへい}|MasaruShimizu{SHIMIZUMASARU清水優しみずまさる}|AyakoOhyama{OHYAMAAYAKO大山綾子おおやまあやこ}|AyakoKitada{KITADAAYAKO北田彩子きただあやこ}|SaoriAbe{ABESAORI安部沙織あべさおり}|HarukaMiki{MIKIHARUKA三木春香みきはるか}|HiromitsuAsashima{ASASHIMAHIROMITSU浅島弘充あさしまひろみつ}|HirotoTsuboi{TSUBOIHIROTO坪井洋人つぼいひろと}|IsaoMatsumoto{MATSUMOTOISAO松本功まつもといさお}|TaichiMiyagi{MIYAGITAICHI宮城太一みやぎたいち}|RisaWakiya{WAKIYARISA脇谷理沙わきやりさ}|KoichiSugihara{SUGIHARAKOICHI杉原幸一すぎはらこういち}|RyokoKagawa{KAGAWARYOKO香川涼子かがわりょうこ}|NaotoManabe{MANABENAOTO眞鍋直人まなべなおと}|MayukoWada{WADAMAYUKO和田真優子わだまゆこ}|ShusakuNakashima{NAKASHIMASHUSAKU中島崇作なかしましゅうさく}|YusukeUshio{USHIOYUSUKE牛尾友亮うしおゆうすけ}|HiromiShimada{SHIMADAHIROMI島田裕美しまだひろみ}|HiroakiDobashi{DOBASHIHIROAKI土橋浩章どばしひろあき}|YusukeKashiwado{KASHIWADOYUSUKE柏戸佑介かしわどゆうすけ}|HiroshiTsukamoto{TSUKAMOTOHIROSHI塚本浩つかもとひろし}|MasahiroAyano{AYANOMASAHIRO綾野雅宏あやのまさひろ}|NobuyukiOno{ONONOBUYUKI小野伸之おののぶゆき}|YojiroArinobu{ARINOBUYOJIRO有信洋二郎ありのぶようじろう}|GoroDoi{DOIGORO土井吾郎どいごろう}|DaisukeOryoji{ORYOJIDAISUKE押領司大助おうりょうじだいすけ}|ShoFujimoto{FUJIMOTOSHO藤本翔ふじもとしょう}|NaoyaNishimura{NISHIMURANAOYA西村直矢にしむらなおや}|AyakoKuwahara{KUWAHARAAYAKO桑原綾子くわはらあやこ}|YasutakaKimoto{KIMOTOYASUTAKA木本泰孝きもとやすたか}|TakahikoHoriuchi{HORIUCHITAKAHIKO堀内孝彦ほりうちたかひこ}|HiroakiNiiro{NIIROHIROAKI新納宏昭にいろひろあき}____Workshop 13SSc treatment____Development of Quality Indicators for the Care of Patients with Systemic Sclerosis, Including Pediatric and Transitional care|A Case of Treatment-Resistant Anti-RNA Polymerase III Antibody-Positive Systemic Sclerosis with Microscopic Polyangiitis Responding to Plasma Exchange Combined with Glucocorticoid Therapy|Refractory Systemic Sclerosis-associtated Pulmonary Arterial Hypertension improved in respiratory and hemodynamic status after sotatercept|Usefulness of mycophenolate mofetil in patients with systemic sclerosis in daily clinical practice at Tsukuba University Hospital|Efficacy and Safety of Rituximab Therapy in Patients with Systemic Sclerosis|High-dose Cyclophosphamide Therapy Combined with CD34-Positive Cell-Selected Autologous Hematopoietic Stem Cell Transplantation for Refractory Systemic Sclerosis: Advanced Medical Care B

W13

Workshop 13
SSc treatment

Chair：Yasushi Kawaguchi

ShusakuNakashima{NAKASHIMASHUSAKU中島崇作なかしましゅうさく}|HikaruHirose{HIROSEHIKARU廣瀬光ひろせひかる}|YoheiIsomura{ISOMURAYOHEI磯村洋平いそむらようへい}|DaisukeHiraoka{HIRAOKADAISUKE平岡大輔ひらおかだいすけ}|KaeTakagi{TAKAGIKAE高木香恵たかぎかえ}|MasakoTsukamoto{TSUKAMOTOMASAKO塚本昌子つかもとまさこ}____YuichiroShirai{SHIRAIYUICHIRO白井悠一郎しらいゆういちろう}____MayukoWada{WADAMAYUKO和田真優子わだまゆこ}|NaotoManabe{MANABENAOTO眞鍋直人まなべなおと}|RyokoKagawa{KAGAWARYOKO香川涼子かがわりょうこ}|KanakoChujo{CHUJOKANAKO中條加奈子ちゅうじょうかなこ}|YusukeUshio{USHIOYUSUKE牛尾友亮うしおゆうすけ}|KoichiSugihara{SUGIHARAKOICHI杉原幸一すぎはらこういち}|TaichiMiyagi{MIYAGITAICHI宮城太一みやぎたいち}|HiromiShimada{SHIMADAHIROMI島田裕美しまだひろみ}|HiroakiDobashi{DOBASHIHIROAKI土橋浩章どばしひろあき}|YukiIchimura{ICHIMURAYUKI市村裕輝いちむらゆうき}|TomoakiHiguchi{HIGUCHITOMOAKI樋口智昭ひぐちともあき}|AkikoTochimoto{TOCHIMOTOAKIKO栃本明子とちもとあきこ}|YasushiKawaguchi{KAWAGUCHIYASUSHI川口鎮司かわぐちやすし}|MasatakaKuwana{KUWANAMASATAKA桑名正隆くわなまさたか}|JunIshizaki{ISHIZAKIJUN石﨑淳いしざきじゅん}|RisakoYamaguchi{YAMAGUCHIRISAKO山口りさこやまぐちりさこ}|ErikaHorimoto{HORIMOTOERIKA堀元絵梨花ほりもとえりか}|KentaHorie{HORIEKENTA堀江健太ほりえけんた}|TakuyaMatsumoto{MATSUMOTOTAKUYA松本卓也まつもとたくや}|KoichiroSuemori{SUEMORIKOICHIRO末盛浩一郎すえもりこういちろう}|HitoshiHasegawa{HASEGAWAHITOSHI長谷川均はせがわひとし}|KatsutoTakenaka{TAKENAKAKATSUTO竹中克斗たけなかかつと}|HikariHirose{HIROSEHIKARI廣瀬光ひろせひかり}|YukiIchimura{ICHIMURAYUKI市村裕輝いちむらゆき}____Workshop 14SSc: pathogenesis and ILD____Title: Differences in Biomarkers Between Peripheral Blood and Pulmonary Capillaries in Connective Tissue Disease-Associated Pulmonary Hypertension|Serum Interleukin-19 was elevated in Systemic Sclerosis|Transcriptomic Analysis of Myocardial Biopsies from Patients with Systemic Sclerosis-Associated Primary Heart Involvement (secondary report)|Platelet function in patients with systemic sclerosis according to disease duration evaluated by the total thrombus-formation analysis system (T-TAS)|A Combined Predictive Model for Interstitial Lung Disease in Systemic Sclerosis: Risk Stratification into Low-, Intermediate-, and High-Risk Groups|Progression risk of limited systemic sclerosis-associated interstitial lung disease (SSc-ILD) toward progressive pulmonary fibrosis (PPF): A 3-year prospective single-center registry study

W14

Workshop 14
SSc: pathogenesis and ILD

Chair：Yuichiro Shirai

AsukaTakayama{TAKAYAMAASUKA髙山明日香たかやまあすか}|MasatoshiYoshimoto{YOSHIMOTOMASATOSHI吉本雅俊よしもとまさとし}|YukiOtsuka{OTSUKAYUKI大塚勇輝おおつかゆうき}|ShuheiYao{YAOSHUHEI八百脩平やおしゅうへい}|ShuntaKaneko{KANEKOSHUNTA金子駿太かねこしゅんた}|HironoriYamane{YAMANEHIRONORI山根裕則やまねひろのり}____NatsukaUmezawa{UMEZAWANATSUKA梅澤夏佳うめざわなつか}|YokoWada{WADAYOKO和田庸子わだようこ}____KazuyukiMeguro{MEGUROKAZUYUKI目黒和行めぐろかずゆき}|MasayaYokota{YOKOTAMASAYA横田雅也よこたまさや}|HiroshiNakajima{NAKAJIMAHIROSHI中島裕史なかじまひろし}|YukiOba{OBAYUKI大庭悠貴おおばゆうき}|HirokiMizuno{MIZUNOHIROKI水野裕基みずのひろき}|MasayukiYamanouchi{YAMANOUCHIMASAYUKI山内真之やまのうちまさゆき}|TatsuyaSuwabe{SUWABETATSUYA諏訪部達也すわべたつや}|EikoHasegaw{HASEGAWEIKO長谷川詠子はせがわえいこ}|YoshifumiUbara{UBARAYOSHIFUMI乳原善文うばらよしふみ}|TakehikoWada{WADATAKEHIKO和田健彦わだたけひこ}|NaokiSawa{SAWANAOKI澤直樹さわなおき}|FumioOtsuka{OTSUKAFUMIO大塚文男おおつかふみお}|WataruKiyohara{KIYOHARAWATARU清原航きよはらわたる}|SaekoMorishita{MORISHITASAEKO森下冴子もりしたさえこ}|YusukeHanioka{HANIOKAYUSUKE埴岡裕介はにおかゆうすけ}|RyotaNakamura{NAKAMURARYOTA中村遼太なかむらりょうた}|TomoyukiNakamura{NAKAMURATOMOYUKI中村友之なかむらともゆき}|KeikoYamagami{YAMAGAMIKEIKO山上啓子やまがみけいこ}|HitoshiGoto{GOTOHITOSHI後藤仁志ごとうひとし}|KeitaYamauchi{YAMAUCHIKEITA山内啓太やまうちけいた}|TakahiroYagi{YAGITAKAHIRO八木貴寛やぎたかひろ}|MiwaKannaji{KANNAJIMIWA金地美和かなじみわ}|KenjiIshiguro{ISHIGUROKENJI石黒賢志いしぐろけんじ}|HyonminChoe{CHOEHYONMIN崔賢民ちぇひょんみん}|AkiraMorita{MORITAAKIRA森田彰もりたあきら}|YutaHieda{HIEDAYUTA稗田裕太ひえだゆうた}|TomotakaAkamatsu{AKAMATSUTOMOTAKA赤松智隆あかまつともたか}|ShuntaroNejima{NEJIMASHUNTARO子島俊太郎ねじましゅんたろう}|KenKumagai{KUMAGAIKEN熊谷研くまがいけん}|YuichiMochida{MOCHIDAYUICHI持田勇一もちだゆういち}|KengoHarigane{HARIGANEKENGO針金健吾はりがねけんご}|YutakaInaba{INABAYUTAKA稲葉裕いなばゆたか}____Workshop 24Systemic Inflammatory and Metabolic Diseases with Prominent Pain____Adult-Onset X-linked Agammaglobulinemia (XLA) Preceded by Arthritis|Evaluation of Initial Glucocorticoid Dose for Induction of Remission in Polymyalgia Rheumatica|Clinical characteristics of adult hypophosphatasia underlying chronic fatigue syndrome and fibromyalgia|A Case of Hypophosphatasia (HPP) Presenting with Various Systemic Pain|The efficacy of sarilumab in steroid dose reduction for polymyalgia rheumatica at our hospital|Quantitative CT Evaluation of Hip and Paraspinal Muscles in Patients with Steroid-Induced Osteonecrosis of the Femoral Head

W24

Workshop 24
Systemic Inflammatory and Metabolic Diseases with Prominent Pain

Chair：Natsuka Umezawa, Chair：Yoko Wada

RyoOkino{OKINORYO沖野遼おきのりょう}|HachiroKonaka{KONAKAHACHIRO小中八郎こなかはちろう}|MayukoWada{WADAMAYUKO和田真優子わだまゆこ}|KumikoTonooka{TONOOKAKUMIKO殿岡久美子とのおかくみこ}|KazukiOrita{ORITAKAZUKI織田一輝おりたかずき}|YasutoAraki{ARAKIYASUTO荒木靖人あらきやすと}____KimitoKawahata{KAWAHATAKIMITO川畑仁人かわはたきみと}____YoshitadaToyota{TOYOTAYOSHITADA豊田善真とよたよしただ}|TakaakiKaji{KAJITAKAAKI加治貴彰かじたかあき}|SouichirouKagitani{KAGITANISOUICHIROU鍵谷聡一郎かぎたにそういちろう}|HiromitsuAkamatsu{AKAMATSUHIROMITSU赤松洋光あかまつひろみつ}|AnriMori{MORIANRI森杏里もりあんり}|MomokaSatou{SATOUMOMOKA佐藤百花さとうももか}|RioUeda{UEDARIO上田莉央うえだりお}|ShunsukeEndo{ENDOSHUNSUKE遠藤俊祐えんどうしゅんすけ}|HiroyukiKawahara{KAWAHARAHIROYUKI川原寛之かわはらひろゆき}|MisakiYoshida{YOSHIDAMISAKI吉田美咲よしだみさき}|AkariTakeji{TAKEJIAKARI竹治明梨たけじあかり}|AkihikoKoshino{KOSHINOAKIHIKO越野瑛久こしのあきひこ}|KeisukeSako{SAKOKEISUKE迫恵輔さこけいすけ}|TakahiroYuasa{YUASATAKAHIRO湯浅貴博ゆあさたかひろ}|ShunsukeTsuge{TSUGESHUNSUKE柘植俊介つげしゅんすけ}|MegumiOshima{OSHIMAMEGUMI大島恵おおしまめぐみ}|RyoNishioka{NISHIOKARYO西岡亮にしおかりょう}|YutaYamamura{YAMAMURAYUTA山村雄太やまむらゆうた}|SatoshiHara{HARASATOSHI原怜史はらさとし}|KiyoakiIto{ITOKIYOAKI伊藤清亮いとうきよあき}|IchiroMizushima{MIZUSHIMAICHIRO水島伊知郎みずしまいちろう}|NorihikoSakai{SAKAINORIHIKO坂井宣彦さかいのりひこ}|YasunoriIwata{IWATAYASUNORI岩田恭宜いわたやすのり}|YasuhiroKato{KATOYASUHIRO加藤保宏かとうやすひろ}|MasayukiNishide{NISHIDEMASAYUKI西出真之にしでまさゆき}|MasashiNarazaki{NARAZAKIMASASHI楢崎雅司ならざきまさし}|AtsushiKumanogoh{KUMANOGOHATSUSHI熊ノ郷淳くまのごうあつし}|YusukeUshio{USHIOYUSUKE牛尾友亮うしおゆうすけ}|HiromiShimada{SHIMADAHIROMI島田裕美しまだひろみ}|TaichiMiyagi{MIYAGITAICHI宮城太一みやぎたいち}|KanakoChujo{CHUJOKANAKO中條加奈子ちゅうじょうかなこ}|RyokoKagawa{KAGAWARYOKO香川涼子かがわりょうこ}|NaotoManabe{MANABENAOTO眞鍋直人まなべなおと}|ShusakuNakashima{NAKASHIMASHUSAKU中島崇作なかしましゅうさく}|KoichiSugihara{SUGIHARAKOICHI杉原幸一すぎはらこういち}|RisaWakiya{WAKIYARISA脇谷理沙わきやりさ}|HiroakiDobasi{DOBASIHIROAKI土橋浩章どばしひろあき}|SeidoOoka{OOKASEIDO大岡正道おおおかせいどう}|MarikoMouri{MOURIMARIKO毛利万里子もうりまりこ}|ShotaroSuzuki{SUZUKISHOTARO鈴木翔太郎すずきしょうたろう}|KeiichiSakurai{SAKURAIKEIICHI櫻井恵一さくらいけいいち}|YukikoTakakuwa{TAKAKUWAYUKIKO高桑由希子たかくわゆきこ}|KimitoKawahata{KAWAHATAKIMITO川畑仁人かわはたきみと}|YudaiKoshida{KOSHIDAYUDAI越田悠太こしだゆうだい}|KoheiYo{YOKOHEI楊宏平ようこうへい}|MariHara{HARAMARI原真里はらまり}|YuriNishida{NISHIDAYURI西田優理にしだゆり}|TakumiNagamoto{NAGAMOTOTAKUMI永本匠ながもとたくみ}|HiroyukiMurabe{MURABEHIROYUKI村部浩之むらべひろゆき}|HiroshiKajiyama{KAJIYAMAHIROSHI梶山浩かじやまひろし}|KazuhiroYokota{YOKOTAKAZUHIRO横田和浩よこたかずひろ}|YuFunakubo{FUNAKUBOYU舟久保ゆうふなくぼゆう}|ToshihideMimura{MIMURATOSHIHIDE三村俊英みむらとしひで}|YujiAkiyama{AKIYAMAYUJI秋山雄次あきやまゆうじ}____Workshop 25Pathophysiology-Based Treatment of Inflammatory Diseases____A Case Report: Effective Treatment with Anti-Complement C5 Monoclonal Antibody for Atypical Hemolytic Uremic Syndrome Complicating Anti-GBM Antibody-Mediated Glomerulonephritis|Investigation of the Pathological Significance of Type I Interferon in Connective Tissue Disease-Associated Pulmonary Hypertension|efficacy of antifibrotic agent in combination with immunosuppressive agents for SARD-ILD|A Study on Cases Following Steroid Withdrawal in Severe Recurrent Polyostotic Chondritis|Association Between Anti-Type II Collagen Antibody Positivity and Clinical Features and Relapse Risk in Relapsing Polychondritis|A Two-Year Study of Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors in the Rheumatology Department of Our Hospital

W25

Workshop 25
Pathophysiology-Based Treatment of Inflammatory Diseases

Chair：Kimito Kawahata

TakaoFujii{FUJIITAKAO藤井隆夫ふじいたかお}____－________Meet the Expert 1Clinical significance and pathogenesis of autoantibodies in the treatment of systemic autoimmune rheumatic diseases____Clinical significance and pathogenesis of autoantibodies in the treatment of systemic autoimmune rheumatic diseases

MTE1

Meet the Expert 1
Clinical significance and pathogenesis of autoantibodies in the treatment of systemic autoimmune rheumatic diseases

Speaker：Takao Fujii

IsaoMatsumoto{MATSUMOTOISAO松本功まつもといさお}____－________Meet the Expert 5Optimal Treatment Considering the Immunopathogenesis of RA____Optimal Treatment Considering the Immunopathogenesis of RA

MTE5

Meet the Expert 5
Optimal Treatment Considering the Immunopathogenesis of RA

Speaker：Isao Matsumoto

HirotoTsuboi{TSUBOIHIROTO坪井洋人つぼいひろと}____－________Meet the Expert 6On the eve of a paradigm shift: Current landscape and future perspectives in the management of Sjögren's disease (SjD)-From pathogenic insights to the development of molecular targeted therapy____On the eve of a paradigm shift: Current landscape and future perspectives in the management of Sjögren's disease (SjD)-From pathogenic insights to the development of molecular targeted therapy

MTE6

Meet the Expert 6
On the eve of a paradigm shift: Current landscape and future perspectives in the management of Sjögren's disease (SjD)-From pathogenic insights to the development of molecular targeted therapy

Speaker：Hiroto Tsuboi

NaotoTamura{TAMURANAOTO田村直人たむらなおと}____－________Meet the Expert 2Optimizing Axial Spondyloarthritis Management: An Update____Optimizing Axial Spondyloarthritis Management: An Update

MTE2

Meet the Expert 2
Optimizing Axial Spondyloarthritis Management: An Update

Speaker：Naoto Tamura

YuhoKadono{KADONOYUHO門野夕峰かどのゆうほ}____－________Meet the Expert 7Imaging of axial spondyloarthritis____Imaging of axial spondyloarthritis

MTE7

Meet the Expert 7
Imaging of axial spondyloarthritis

Speaker：Yuho Kadono

UtakoKaneko{KANEKOUTAKO金子詩子かねこうたこ}____－________Meet the Expert 8Approaches to Off-Label Use in Rheumatic Diseases____Approaches to Off-Label Use in Rheumatic Diseases

MTE8

Meet the Expert 8
Approaches to Off-Label Use in Rheumatic Diseases

Speaker：Utako Kaneko

TakakoMiyamae{MIYAMAETAKAKO宮前多佳子みやまえたかこ}____－________Meet the Expert 3Pitfalls and Best Practices in the Use of IL-1 Inhibitors Across the IL-1-Mediated Disease Spectrum____Pitfalls and Best Practices in the Use of IL-1 Inhibitors Across the IL-1-Mediated Disease Spectrum

MTE3

Meet the Expert 3
Pitfalls and Best Practices in the Use of IL-1 Inhibitors Across the IL-1-Mediated Disease Spectrum

Speaker：Takako Miyamae

YukinoriTakagi{TAKAGIYUKINORI高木幸則たかぎゆきのり}____－________Meet the Expert 4Unraveling Sjögren's syndrome and IgG4-related disease through images____Unraveling Sjögren's syndrome and IgG4-related disease through images

MTE4

Meet the Expert 4
Unraveling Sjögren's syndrome and IgG4-related disease through images

Speaker：Yukinori Takagi

AkioMorinobu{MORINOBUAKIO森信暁雄もりのぶあきお}____－________Meet the Expert 9Basics of Cytokines: for Understanding Biologic Therapies____Basics of Cytokines: for Understanding Biologic Therapies

MTE9

Meet the Expert 9
Basics of Cytokines: for Understanding Biologic Therapies

Speaker：Akio Morinobu

YuichiMochida{MOCHIDAYUICHI持田勇一もちだゆういち}____－________Meet the Expert 10The essential techniques to evaluate the bone and joint radiographs in rheumatoid arthritis for rheumatologists____The essential techniques to evaluate the bone and joint radiographs in rheumatoid arthritis for rheumatologists

MTE10

Meet the Expert 10
The essential techniques to evaluate the bone and joint radiographs in rheumatoid arthritis for rheumatologists

Speaker：Yuichi Mochida

FutabaMiyaoka{MIYAOKAFUTABA宮岡双葉みやおかふたば}|ChiakiMasuda{MASUDACHIAKI桝田千晶ますだちあき}|KoshiroIkebe{IKEBEKOSHIRO池邉晃嗣朗いけべこうしろう}|NamiOkamoto{OKAMOTONAMI岡本奈美おかもとなみ}|MayukoFujisaki{FUJISAKIMAYUKO藤﨑真由子ふじさきまゆこ}|TakahiroFujimori{FUJIMORITAKAHIRO藤森翔大ふじもりたかひろ}____YuzaburoInoue{INOUEYUZABURO井上祐三朗いのうえゆうざぶろう}|YuichiYamasaki{YAMASAKIYUICHI山﨑雄一やまさきゆういち}____MahoHatano{HATANOMAHO畠野真帆はたのまほ}|ShuyaKaneko{KANEKOSHUYA金子修也かねこしゅうや}|AsamiShimbo{SHIMBOASAMI真保麻実しんぼあさみ}|HitoshiIrabu{IRABUHITOSHI伊良部仁いらぶひとし}|YukoAkutsu{AKUTSUYUKO阿久津裕子あくつゆうこ}|YukoHayashi{HAYASHIYUKO林祐子はやしゆうこ}|FumikaYurugi{YURUGIFUMIKA萬木文佳ゆるぎふみか}|KenichiNishimura{NISHIMURAKENICHI西村謙一にしむらけんいち}|MaoMizuta{MIZUTAMAO水田麻雄みずたまお}|YasuoNakagishi{NAKAGISHIYASUO中岸保夫なかぎしやすお}|UtakoKaneko{KANEKOUTAKO金子詩子かねこうたこ}|YuichiYamasaki{YAMASAKIYUICHI山﨑雄一やまさきゆういち}|MasaakiMori{MORIMASAAKI森雅亮もりまさあき}|MasakiShimizu{SHIMIZUMASAKI清水正樹しみずまさき}|RyosukeYamaguchi{YAMAGUCHIRYOSUKE山口亮介やまぐちりょうすけ}|YukioAkasaki{AKASAKIYUKIO赤崎幸穂あかさきゆきお}|ToshifumiFujiwara{FUJIWARATOSHIFUMI藤原稔史ふじわらとしふみ}|IchiroKurakazu{KURAKAZUICHIRO倉員市郎くらかずいちろう}|KeitaroYasumoto{YASUMOTOKEITARO安元慧大朗やすもとけいたろう}|TakahiroNatori{NATORITAKAHIRO名取孝弘なとりたかひろ}|ToshiakiSugita{SUGITATOSHIAKI杉田敏明すぎたとしあき}|ShotaroKawamura{KAWAMURASHOTARO河村正太郎かわむらしょうたろう}|YasuharuNakashima{NAKASHIMAYASUHARU中島康晴なかしまやすはる}|StuartYKeller{KELLERSTUARTY}|JonathanTSims{SIMSJONATHANT}|ChingyunChang{CHANGCHINGYUN}|ErnstRDow{DOWERNSTR}|AyakoKonomi{KONOMIAYAKO許斐綾子このみあやこ}|JensGammeltoftGerwien{GERWIENJENSGAMMELTOFT}|AthimalaipetVRamanan{RAMANANATHIMALAIPETV}|YukoOkamoto{OKAMOTOYUKO岡本祐子おかもとゆうこ}|MasayoshiHarigai{HARIGAIMASAYOSHI針谷正祥はりがいまさよし}|TakakoMiyamae{MIYAMAETAKAKO宮前多佳子みやまえたかこ}|HyonminChoe{CHOEHYONMIN崔賢民ちぇひょんみん}|YutaHieda{HIEDAYUTA稗田裕太ひえだゆうた}|HironoriYamane{YAMANEHIRONORI山根裕則やまねひろのり}|AkiraMorita{MORITAAKIRA森田彰もりたあきら}|NaomiKobayashi{KOBAYASHINAOMI小林直実こばやしなおみ}|HiroyukiIke{IKEHIROYUKI池裕之いけひろゆき}|SyuichiIto{ITOSYUICHI伊藤秀一いとうしゅういち}|YutakaInaba{INABAYUTAKA稲葉裕いなばゆたか}____Workshop 7Juvenile idiopathic arthritis____Clinical utility of serum IL-18 as a disease activity marker of systemic juvenile idiopathic arthritis during biologic therapy|Drug-free remission rates and current treatment patterns in systemic juvenile idiopathic arthritis: a 20-year, single-center retrospective analysis|Has Joint Outcomes in Juvenile Idiopathic Arthritis Improved? - An Analysis of Prognostic Factors|Serum biomarkers associated with baricitinib response in patients with juvenile idiopathic arthritis|Clinical features of adult patients with oligoarticular and polyarticular juvenile idiopathic arthritis|Factors affecting activity of daily life in systemic juvenile idiopathic arthritis

W7

Workshop 7
Juvenile idiopathic arthritis

Chair：Yuzaburo Inoue, Chair：Yuichi Yamasaki

UtakoKaneko{KANEKOUTAKO金子詩子かねこうたこ}|TomohiroTachikawa{TACHIKAWATOMOHIRO立川智広たちかわともひろ}|YukoAkutsu{AKUTSUYUKO阿久津裕子あくつゆうこ}|YukoHayashi{HAYASHIYUKO林祐子はやしゆうこ}|YoichiNakayama{NAKAYAMAYOICHI中山洋一なかやまよういち}|TomoyukiNakamura{NAKAMURATOMOYUKI中村友之なかむらともゆき}____KazushiIzawa{IZAWAKAZUSHI井澤和司いざわかずし}|NaomiIwata{IWATANAOMI岩田直美いわたなおみ}____TakakoMiyamae{MIYAMAETAKAKO宮前多佳子みやまえたかこ}|MasakiShimizu{SHIMIZUMASAKI清水正樹しみずまさき}|IkukoUeda{UEDAIKUKO植田郁子うえだいくこ}|YoshihideAsano{ASANOYOSHIHIDE浅野善英あさのよしひで}|MasatakaKuwana{KUWANAMASATAKA桑名正隆くわなまさたか}|YasushiKawaguchi{KAWAGUCHIYASUSHI川口鎮司かわぐちやすし}|ManabuFujimoto{FUJIMOTOMANABU藤本学ふじもとまなぶ}|AtsushiInagaki{INAGAKIATSUSHI稲垣篤志いながきあつし}|MahoShimizu{SHIMIZUMAHO清水真帆しみずまほ}|NaokiAbe{ABENAOKI阿部直紀あべなおき}|HarunaNakaseko{NAKASEKOHARUNA中瀬古春奈なかせこはるな}|ShinjiKawabe{KAWABESHINJI河邉慎司かわべしんじ}|NaomiIwata{IWATANAOMI岩田直美いわたなおみ}|ShuyaKaneko{KANEKOSHUYA金子修也かねこしゅうや}|YukoHayashi{HAYASHIYUKO林祐子はやしゆうこ}|HitoshiIrabu{IRABUHITOSHI伊良部仁いらぶひとし}|YukoAkutsu{AKUTSUYUKO阿久津裕子あくつゆうこ}|MireiShirakashi{SHIRAKASHIMIREI白柏魅怜しらかしみれい}|KazushiIzawa{IZAWAKAZUSHI井澤和司いざわかずし}|YukariAida{AIDAYUKARI合田由香利あいだゆかり}|TsuneoSasai{SASAITSUNEO笹井恒雄ささいつねお}|RyosukeHiwa{HIWARYOSUKE日和良介ひわりょうすけ}|HideakiTsuji{TSUJIHIDEAKI辻英輝つじひであき}|ShujiAkizuki{AKIZUKISHUJI秋月修治あきづきしゅうじ}|RanNakashima{NAKASHIMARAN中嶋蘭なかしまらん}|HajimeYoshifuji{YOSHIFUJIHAJIME吉藤元よしふじはじめ}|AkioMorinobu{MORINOBUAKIO森信暁雄もりのぶあきお}|WataruKiyohara{KIYOHARAWATARU清原航きよはらわたる}|KentaroMaruo{MARUOKENTARO丸尾健太郎まるおけんたろう}|SaekoMorishita{MORISHITASAEKO森下冴子もりしたさえこ}|ShuheiYao{YAOSHUHEI八百脩平やおしゅうへい}|YusukeHanioka{HANIOKAYUSUKE埴岡裕介はにおかゆうすけ}|RyotaNakamura{NAKAMURARYOTA中村遼太なかむらりょうた}|KeikoYamagami{YAMAGAMIKEIKO山上啓子やまがみけいこ}|HitoshiGoto{GOTOHITOSHI後藤仁志ごとうひとし}____Workshop 8Juvenile connective tissue diseases and Autoinflammatory disorders____Clinical characteristics of anti-SS-A antibody-positive patients with juvenile-onset systemic sclerosis in Japan|Comparison of Salivary Gland Ultrasonography and Labial Salivary Gland Biopsy in the Diagnosis of Pediatric Sjögren Disease|Evaluation of voclosporin efficacy in childhood-onset lupus nephritis|Efficacy of Adalimumab for Pediatric Chronic Nonbacterial Osteomyelitis|Coexistence of Familial Mediterranean Fever and Cutaneous Polyarteritis Nodosa with Heterozygous MEFV and ADA2 Variants|A case of siblings in which the younger brother, whose recurrent fevers since infancy were diagnosed in adulthood as A20 haploinsufficiency, led to the diagnosis of A20 haploinsufficiency in the older brother who also presented with fevers, leukoencephalo

W8

Workshop 8
Juvenile connective tissue diseases and Autoinflammatory disorders

Chair：Kazushi Izawa, Chair：Naomi Iwata

－____－________Hands-on Seminar 1____－

HS1

Hands-on Seminar 1

－____－________Exhibition____－

NO17

Exhibition

YoshimasaNagao{NAGAOYOSHIMASA長尾能雅ながおよしまさ}____NaokiIshiguro{ISHIGURONAOKI石黒直樹いしぐろなおき}________[Satellite] Educational Lecture 6____患者安全の全体像と展望

EL6_satellite

[Satellite] Educational Lecture 6

Chair：Naoki Ishiguro

Speaker：Yoshimasa Nagao